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ABSTRACT
Positron Emission Tomography has experienced several advances in the last decade. 
This thesis assesses the recent developments in PET scanners: New, fast
scintillators, higher resolution detectors, hilly 3D imaging and increased sensitivity, 
iterative reconstruction algorithms with implementation o f point spread function 
modelling and time-of-flight. The physical performance characteristics o f  three 
multi-ring and one panel based configuration were quantified using phantom 
experiments. The clinical impact o f increased sensitivity was explored. Figures o f  
merit to assess image quality were established and a method to optimise 
reconstruction algorithms for signal-to-noise was developed and applied. The 
improvements o f  implementing point spread function modelling into image 
reconstruction were investigated and quantified. The implementation o f  time-of- 
flight in addition to point-spread-function modelling was explored in substantial 
detail and compared. Experimental results were obtained and the clinical impact o f  
time-of-flight was assessed. In a final investigation, the panel based PET scanner 
design was successfully applied in veterinary medicine.
To Those 
Who Made This Journey 
An Adventure 
I Will Never Forget
11
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Chapter 1.
1 INTRODUCTION
The development in Positron Emission Tomography (PET) has progressed 
considerably since the first images were acquired with a positron emitting isotope in 
1973 [1]. The steps firom 2D to 3D and brain to whole-body imaging were major 
milestones. The availability o f new and faster scintillator materials was and might 
still be the most important factor that is driving the direction o f developments in PET 
to date. Not only was it possible to develop higher resolution detectors but also to 
reawaken interest in time-of-flight (TOF). The parallel progression in iterative 
reconstruction eliminated more and more approximations about the physical PET 
detection process by incorporating additional information into the algorithm, such as 
the system’s point spread functions (PSFs).
While PET instrumentation and methodologies have advanced significantly during 
the last decade, the clinical relevance as well as impact o f these developments has yet 
to be established. This is what motivated the research investigated in this thesis on 
four different 3D LSO PET scanners. Two scanners, the 3-Ring (Biograph 
TruePoint) and the panel detector PET scanner (P5-Head), were both manufactured 
by Siemens Molecular Imaging (former CTI PET Systems, Inc.) and installed at the 
University o f Tennessee Medical Centre (Knoxville, TN, USA). The 3-Ring is a 
whole-body combined PET/CT scanner, while the P5-Head was a prototype PET- 
only scanner, which never became a product. The 3-Ring scanner was replaced later 
by a 4-Ring scanner (Biograph TruePoint with TrueV), followed with the additional 
installation o f the 4-Ring+ scanner (Biograph mCT). As aheady revealed by the 
descriptions, the scanners were based on two different architectures, a ring and a 
panel. There were several objectives o f  the research carried out. Firstly, the physical 
performance o f the available scanners was to be assessed and compared. Secondly, 
the clinical impact o f adding an additional ring was to be investigated using human 
data acquired on both the 3-Ring and 4-Ring scanner. The third objective o f  this 
research was to define PET image quality and investigate the potential improvements 
that were implied employing PSF without and with the incorporation o f TOF. Both, 
the physical and the clinical implication o f these developments were to be assessed
with a particular focus on time-of-flight. Finally, the fourth area o f  investigation was 
the clinical application o f  the panel detector PET scanner for veterinary medicine.
1.1 Structure of the thesis
Following this introduction, the technical details and physical principles o f PET are 
briefly reviewed (Chapter 2). Thereafter, one chapter is dedicated to the most recent 
advances in PET, which form the cornerstone o f  this work (Chapter 3). The 
important characteristics o f  the PET scanners that are then investigated are given in 
Chapter 4. Chapter 5 concerns the investigation o f  the physical performance o f  the 
different PET scanners, followed by a clinical performance comparison o f  the 3-Ring 
and 4-Ring scanners in Chapter 6. While Chapter 7 defines methods to assess PET 
image quality and explores the impact o f PSF modelling. Chapter 8 extends the use 
o f these methods for the physical and clinical investigations o f  TOF. Chapter 9 
explores the clinical application o f the panel detector PET scanner in veterinary 
medicine. The final Chapter o f the thesis concludes the research and suggests further 
work for future investigations.
Chapter 2.
2 PHYSICAL PRINCIPLES OF PET
PET is a functional imaging modality based on nuclear physics. Figure 2.1 
summarizes the multiple steps that are involved in the PET process. The basis is a 
positron-emitting radionuclide, such as the ones listed in Table 2.1
Table 2.1. List o f common radionuclides used in PET [2].
Radionuclide
V-^ max
(MeV)
T i/2
(min)
Mean range 
in water 
(mm)
18p 0.633 109.8 0.6
0.959 20.4 1.1
1.197 9.96 1.5
15q 1.738 2.03 2.5
^^ Rb 3.4 1.25 5.9
Positron emitters are proton-rich isotopes which can gain stability through the 
nuclear transmutation o f  a proton into a neutron. During this process, a positron (eQ 
and a neutrino ( v e) are emitted, as shown in Figure 2.1 A. The positron loses energy 
through interactions with surrounding matter until it annihilates with an electron, as 
shown schematically in Figure 2. IB. The range o f the travelling positron is a 
function o f the emission energy, which in turn depends on the isotope. Depending 
on the endpoint energy o f  the isotope (0.6 MeV for ^^ F up to 3.4 MeV for ^^Rb), the 
positron will travel a certain distance (0.6 mm for ^^ F up to 5.9 mm for ^^Rb) before 
it encounters an electron. Following the annihilation process two gamma rays are 
emitted in almost opposite directions. I f a detector pair registers both back to back 
photons within a predefined coincidence timing window A r, a subsequent line-of- 
response (LOR) is formed between the events and registered as coincidence. I f the 
energy o f the positron is not entirely dissipated during its journey in tissue the 
annihilation process may have a residual momentum. To conserve momentum, the 
annihilation photons are emitted less than 180° apart and not collinear as assumed by
the detection system. Both effects positron range and non-collinearity contribute to a 
degradation o f spatial resolution and are discussed later in this work.
In order to apply this principle in humans or animals, positron-emitters such as 
are used to label substrates like deoxyglucose to create the radiopharmaceutical 
^^FDG (Figure 2.1C). When injected into a patient, the radioactive tag allows the 
metabolic process o f the pharmaceutical to be followed, which is glucose utilisation 
for ^^FDG. For this procedure, the patient is positioned in the PET scanner, 
comprising a surrounding configuration o f detectors, as shown in Figure 2. ID. The 
gamma ray pairs from positron annihilation are recorded in matrices or so-called 
sinograms. As shown in Figure 2 .IE, each row in a sinogram represents a parallel 
projection p(b, O) o f the activity distribution in the patient along a line o f  response 
(LOR) (b) from the centre o f the scanner field o f view (FOV) at a specific angle (0 )  
and axial position (z). If the data are acquired in list mode, additional information 
such as the energies and arrival times o f  incident photons are also stored. The data 
can then be sampled or rebinned into time dependent sinograms and, for example, 
activity curves at different time points can be created and the bio-kinetics o f  a 
specific organ studied. Applying a reconstruction algorithm to the sinogram data 
recovers the underlying radioactivity distribution, as shown in Figure 2.1, which is 
mapping glucose utilisation for ^^FDG.
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Figure 2.1. PET Principle: (A) A positron-emitting radionuclide can stabilize 
through nuclear transformation o f a proton into a neutron. (B) The emitted positron 
travels until it annihilates with an electron forming two anti-parallel gamma rays 
which can be detected in coincidence. (C) A radiopharmaceutical such as *^FDG is 
prepared, and (D) injected into the patient. (E) Coincidence photons are recorded in 
sinograms which represent a parallel projection p(b, O) o f the activity distribution in 
the patient along a line o f response (LOR) (b) at a specific angle O and axial position 
z. (F) Image reconstruction forms an image o f the underlying activity distribution.
2.1 Radiopharmaceutîcals and Standard Uptake Value
PET is a nuclear medicine technique that uses radiopharmaceuticals in one o f  its 
major applications in order to diagnose, stage and monitor neoplastic, neurological 
and cardiac disease [3, 4]. A  list o f common radiopharmaceuticals and their 
applications is given in Table 2.2.
The most popular radiopharmaceutical is ^^FDG [5]. This glucose analogue is 
phosphorylated into ^^FDG-6-P, which is the first step o f glucose metabolism. 
However, the presence o f ^^ F in this molecule results in altered stereochemistry and 
subsequent trapping o f the phosphorylated tracer within the cell [6]. This allows 
mapping o f tracer uptake within most tissues as a measure o f glucose metabolism, 
which is known to be altered in various inflammatory and neoplastic diseases [5].
Table 2.2. Example o f available PET radiopharmaceuticals and their applications
U l
Radiopharmaceutical Physiological imaging application
[^^O] Cerebral oxygen metabolism and extraction
H2[^^0] Cerebral and myocardial blood flow
C[^^0] Cerebral and myocardial blood volume
[ ^  ^  C] -N-methylspiperone Cerebral dopamine receptor binding
 ^  ^  ^ Cerebral and myocardial glucose
[ ] uoro eoxyg ucose metabolism and tumour localization
Myocardial blood flow  
[^^C]-acetate Myocardial metabolism
[^^Rb]  ^ Myocardial blood flow
In order to quantify uptake o f a radiopharmaceutical in clinical settings, 
measurements have primarily been limited to a semi-quantitative method using the 
standardized uptake value (SUV). The SUV is derived from images that were 
acquired 60-90 minutes following injection [8, 9]. The radiopharmaceutical 
concentration in the tissue o f interest is normalized to the injected dose and body 
weight [10]. With '^FDG, the SUV allows for a semi-quantitative estimation o f the 
rate o f glycolysis in tissues based on the metabolic pathway o f this 
radiopharmaceutical. SUVs can help elucidate the etiology o f disease by the 
magnitude o f ^^FDG uptake. Increased glucose metabolism is a known cellular 
characteristic o f  the malignant phenotype [11]. SUVs are also used to identify 
undetected pulmonary nodules, or to monitor a lesion over time after anti-neoplastic 
therapy has been initiated. The SUV method is generally helpful in these clinical 
situations if  performed under standardized conditions, with consideration given to 
tracer dose, blood glucose level, time after tracer injection, and data processing [12].
2.2 Coincidence Events
During PET acquisition three main types o f events can be registered: True, random.
True Random
•  Annihilation event
 ► Gamma ray
Scatter
Assigned LOR
Figure 2.2. Main events that are detected during a PET acquisition: True, Random, 
and Scatter.
and scatter events. The different events are illustrated in Figure 2.2.
A True (T) coincidence is registered if  the annihilating photons derive from a single 
positron-electron annihilation. Both annihilation photons reach the opposing 
detectors without any other significant interactions within the coincidence time 
window. Random (R) coincidences occur when photons from two unrelated 
positron-electron annihilations are registered. Scatter (S) coincidences arise when 
one or both annihilation photons have undergone a Compton interaction prior to 
detection. The assigned LOR deviates from its initial path. The sum o f  True, 
Random and Scatter coincidences are referred to as prom pts (P). A  single hit o f  a 
photon that is detected is referred to as a single.
2.3 Data Storage
During a PET acquisition, the number o f true coincidences along an LOR is 
proportional to the line integral through the radioactivity distribution in the absence 
of attenuation. Therefore, PET data are represented by sets o f  line-integrals or 
parallel projections^ which are normally stored in either histogram or list mode. The 
histogram mode is represented by sinograms and is therefore also referred to as 
sinogram mode. An example o f the construction o f  a sinogram is shown in Figure
2.3 for two different cylindrical sources that are located off-centre FOV. Each 
parallel projection represents the activity distribution along the radial projection bins 
b for one angular step 0  (Figure 2.3A), which corresponds to one row in a sinogram 
(Figure 2.3B). Therefore, the sinogram representations o f objects that are located 
off-centre FOV result in a sinusoidal shape along the projection angles. A  point 
source located in the centre o f the FOV would be represented by a vertical line that is 
horizontally centred in the sinogram.
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Figure 2.3. Example o f a sinogram construction: (A) Parallel projections for two 
cylindrical sources under the projection angles 0= 0° and 0=90°. (B)
Corresponding sinogram o f the two cylindrical sources.
2.4 Data Corrections
The projection data in the sinograms includes numerous unwanted physical effects, 
such as attenuation, Compton scattering, and the measuring method itself. In order 
to reconstruct these data into accurate images, the errors resulting from these effects 
need to be corrected. The corrections that are applied to PET data are explained.
2.4.1 Randoms
Random coincidences are a direct consequence o f having a large coincidence time 
window. This window width, in which two events are detected, cannot be less than 
3-4 ns, considering a distance as large as the scanner’s diameter (80-100 cm) for a 
photon to travel with the speed o f light (c = 30 cm/ns). Also depending on the 
characteristics o f the detecting scintillation crystal and the processing time o f the 
electronics, the coincidence time window in modem whole-body PET scanners 
varies between 4.1 and 12 ns.
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Random coincidences arise not only from the radiation events in the scanner FOV 
but also from radiation outside the FOV, when one o f  the annihilations photons 
enters the scanner FOV and reaches the detectors. Randoms increase with the square 
o f the singles event rate. The most common method to correct for random 
coincidences is by introducing a delayed coincidence channel, which is many times 
greater (i.e. 64 or 128 ns) than the coincidence window [13]. Since a delayed 
coincidence event cannot arise from a true or scattered coincidence, a delayed 
sinogram only contains random events. The corresponding prompts sinogram also 
includes true and scattered coincidences, which have been detected within the 
coincidence time window, as well as random coincidences. On average, the number 
o f  random coincidences in the delayed sinogram equals the number o f  randoms in the 
prompts sinogram. With online randoms correction, the delayed events are 
subtracted from the prompt events as they occur. While this method is a noisy 
estimate o f  the randoms and increases data variance, a different method is to collect a 
complete delayed sinogram and smooth the delayed randoms prior to subtraction 
from the prompts {smoothed randoms correction).
2.4.2 Scatter
As mentioned in section 2.2, some o f the emitted photons deviate from their initial 
path and are assigned to the wrong LOR. Since scatter involves loss o f  energy, in 
principle some o f these scattered coincidences can be rejected using a narrow energy 
window, which is usually between 400 keV minimum and 650 keV maximum for 
current scanners. However, increasing the lower energy threshold is limited, since 
otherwise, true events will also be rejected due to the insufficient energy resolution 
o f typical detector systems. Additional scatter correction techniques, which estimate 
the distribution o f scattered radiation, are employed in order to remove scatter from 
the image and improve image contrast (simulation based techniques: [14, 15]; 
filtering and subtraction techniques: [16, 17]; multiple energy window technique:
[18].
The level o f scatter is characterized by the scatter fraction, the ratio o f  scattered to 
trues plus scattered events. In a typical clinical imaging situation the fraction o f
1 2
scattered events can be as high as 40% or greater o f  the total events in the image
[19].
2.4.3 Attenuation
Part o f the photons penetrating through a subject’s body are attenuated and do not 
reach the detector. Attenuation depends on the density and thickness o f the tissue 
and lies in between 75-80 % around the head area; for the area around the chest, it 
may reach even 95 % or more. Raising the subject’s arms above their head can 
already reduce the effects caused by attenuation significantly. Fortunately in PET, 
attenuation can be measured very accurately.
Figure 2.4 illustrates a positron annihilation at location x inside an object with the 
total thickness D. The probability o f  attenuation for the two annihilation photons pi 
and p2 along an LOR can be computed with [2]:
where p (1/cm) is the linear attenuation coefficient for the penetrated object.
The probability that both annihilation photons are attenuated is given by:
P  = P\Pi -   ^ ^  eq. 2.2
Therefore, photon attenuation in PET does not depend on the point along the LOR at 
which the annihilation occurs, but only on the total thickness D o f  the attenuating 
object between the two detectors. In other words, the attenuation factor is the same 
regardless if  the annihilation occurred inside the body (i.e. from the injected 
radiotracer) or outside the body, such as from an external source. In practice, this 
principle can be applied in order to compute attenuation factors for individual LORs 
from an external source o f radiation, which could be a single photon emitter (e.g. 
^^ C^s with Ti/2 = 30 years) or a positron emitter (e.g. ^^Ge with T1/2 = 271 days).
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Two scans are performed using the external source. First, a blank scan is acquired 
for which no object is present in the scanner. This scan is usually performed prior to 
the patients arriving for their examinations and does therefore not require any extra 
time. The second scan is a transmission scan during which the object is present and 
takes about 5-15 minutes. The ratio o f transmission to blank scan results in the 
attenuation correction factors for each individual LOR and can be applied during 
image reconstruction.
In principle, this method o f attenuation correction is exact. However, additional 
statistical noise is introduced into the PET data. The radioactivity in the transmission 
sources is limited to avoid excessive dead time in the adjacent PET detectors and to 
meet the limitations for patient radiation exposure. In addition, the transmission scan 
time lengthens the total scan duration and may represent 40 % or more o f the total 
scan duration, during which the patient is required not to move. The relative short 
half-life o f the isotope ^^Ge (271 days) requires replacing the transmission sources 
regularly, which is also moderately expensive. In order to keep the measurement 
statistics constant while the activity o f the transmission sources varies significantly 
after months, the scan duration needs to be adjusted to compensate for this effect.
D
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Figure 2.4 The detectors A and B record attenuated photons arising from a positron 
annihilation along an LOR at a distance x from detector A and (D-x) from detector 
B. For each positron annihilation the probability o f detecting both photons equals 
the product o f the individual photon detection probabilities. Therefore, the combined 
count rate observed is independent o f the location o f the positron emitter along the 
LOR. The total attenuation is determined by the total thickness (D) alone.
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In combined PET/CT scanners, the CT scan can, besides the anatomical information, 
provide attenuation information. However, in order to apply the attenuation o f x- 
rays to the PET emission data, an energy transformation o f the x-rays is required. 
This is usually performed by using a bilinear scale factor [20]. The very short 
imaging time o f a few seconds with a CT scan can be another complication for CT- 
based attenuation correction. While this is an advantage for the patient and increases 
throughput, there are potential differences in the respiratory phases o f the CT and 
PET scan and can cause attenuation correction errors if  unchecked. Similar errors 
may occur from patient or physiological motion between the scans.
2.4.4 Normalisation
Single detector crystals have different sensitivities and therefore the data need to be 
normalised. The measurement o f a homogenous phantom should result in a 
homogenous count contribution, assuming that all detectors register the same amount 
o f counts. The difference between this expected and the measured data leads to a 
correction factor for each LOR in the sinogram. This measurement is suggested to 
be repeated daily on most scanners since the detector characteristics may vary over 
time. With this method, not only variations in the crystals, but also variations in the 
photomultipliers and electronics are corrected [21].
2.5 PET Reconstruction
The principle steps that are involved in reconstructing PET data are illustrated in 
Figure 2.5. Following data acquisition, the uncorrected emission sinogram (A) is 
corrected for randoms (B) by applying either online or smoothed randoms correction 
(section 2.4.1). After randoms subtraction the emission sinogram is multiplied by the 
normalisation (C), which contains corrections for detector variations (section 2.4.4). 
The blank and transmission scans (section 2.4.3) are used to build an attenuation map 
or so called p-map (D), which is backward projected into an attenuation sinogram 
(E). The multiplication o f the attenuation sinogram (E) with the randoms corrected 
emission data (A) and the normalisation (C) produces a scatter image (F) after 
reconstruction. The back projection o f the combined scatter image (F) and p-map
15
(D) is a scatter sinogram (G). Finally, the randoms corrected (B) and normalised (C) 
emission sinogram (A) can be corrected for scatter by subtraction (G), and for 
attenuation by multiplication (E). The result produces a fully corrected sinogram 
(H). Applying a reconstruction algorithm, such as Filtered Backprojection (FBP), 
Direct Inverse Fourier Transformation (DIFT) or Ordered Subset Expectation 
Maximisation (OSEM), produces an image o f  the underlying activity distribution o f  
the acquired object.
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Figure 2.5. The basic steps involved in producing a PET image: The uncorrected 
emission sinogram (A) is corrected for randoms (B) and normalised for detector 
variations (C). A fully corrected emission sinogram (H) is produced after scatter 
(G) and attenuation (E) correction. A  reconstruction algorithm produces an image 
o f the underlying activity distribution o f the acquired object.
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3 A REVIEW OF RECENT ADVANCES IN PET
3.1 New Fast Scintillators
The most common and primary detectors for PET scanners are scintillator based 
designs because o f their good stopping efficiency and energy resolution for 511 keV  
photons. It is crucial for a PET detector to provide high stopping power, a fast signal 
decay time, high light output, and good energy resolution. The stopping power o f  a 
scintillator is characterized by its attenuation length for 511 keV photons, which 
depends upon its density (p) and the effective atomic number (Zeff). A short decay 
time o f  a scintillator reduces system dead time and improves the count rate 
performance, particularly at high activity levels in the FOV. More importantly, 
faster scintillators and improved electronics allow PET scanners to be operated with 
shorter coincidence timing windows (4.1-6 ns compared to 10-12 ns) and therefore 
reduce random coincidences. An increased light output o f a scintillator improves the 
energy resolution for the same size PET detector, allowing operating with higher 
energy thresholds (400-450 keV compared to 350 keV), thereby reducing scattered
Table 3.1. Physical properties o f  common scintillators used in PET. Note that some 
o f these specifications are subject to change as manufacturers vary dopants and trace 
elements in the scintillator growth [22-24].
Property Nal BGO LSO:Ce LYSO GSO:Ce LaBr3:Ce
Density (p) (g/cm^) 3.7 7.1 7.4 7.1 6.7 5.3
Effective atomic no. (Zeff) 51 74 66 60 61 47
Attenuation length (cm) 2.88 1.05 1.16 2.00 1.43 2.13
Decay constant (ns) 230 300 40-47 41 60 15
Light output (Photons/MeV) 38,000 8,500 31,000 32,000 10,000 65,000
Light yield (% Nal) 100 15 75 76 25 150
Hygroscopic Yes No No No No Yes
Nal: sodium iodide BGO: bismuth germanate
LSO: lutetium oxyorthosilicate LYSO : lutetium yttrium oxyorthosilicate
GSO: gadolinium oxyorthosilicate LaBrg: lanthanum bromide
Ce: cerium doped
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events. In addition, an increased light output permits more crystal elements to be 
decoded per photomultiplier tube (PMT) helping to improve spatial resolution by 
dividing blocks into a smaller grid o f  crystals. As an example, the decoding ratio in 
a modem block design between crystals and PMT is a 13 x 13 crystal array (each o f  
size 4 mm by 4 mm by 20 mm) on a 2 x 2 PMT block, resulting in a ratio o f  42:1
[25]. Table 3.1 compares the physical properties o f some scintillators applied in 
PET.
Early PET scanners used thallium-activated sodium iodide (Nal(Tl)) scintillators, 
which provide very high light output but suffer from lower stopping power because 
o f  the low density. The majority o f  PET scanners during the 1990s were based on 
bismuth germanate (BGO). While BGO has slightly worse timing properties and 
worse light output than Nal(Tl), its excellent stopping power gives it high sensitivity 
for photon detection. The introduction o f lutetium oxyorthosilicate (LSO) during the 
late 1990s appears as an ideal combination o f the high light output o f  Nal(Tl) and the 
high stopping power o f BGO [26] with the addition o f  a short decay time (40-47 ns), 
which makes this scintillator a candidate for use in time-of-flight (TOE) (section 
3.4.2). Although, the overall energy resolution o f  LSO is not as good as Na(Tl) 
based on intrinsic properties o f  the crystal. Gadolinium oxyorthosilicate (GSO) is 
another scintillator with useful properties for application in PET. While it suffers 
lower stopping power and light output than LSO, GSO benefits from better energy 
resolution and more uniform light output. Finally, lanthanum bromide (LaBrg) is a 
scintillator with an excellent short decay time (15 ns) and makes it therefore ideal for 
use in TOF applications. However, LaBrg suffers from low sensitivity due to 
reduced stopping power.
3.2 High Spatial Resolution Detectors
High spatial resolution detection in PET is important for image quality. While the 
size o f the crystals plays a predominant role in the design o f a high spatial resolution 
PET detector the spatial resolution that can be attained in positron emission is limited 
by well-known physical effects such as positron range and non-collinearity (or 
angular uncertainty) o f the annihilation photons. While the former effect is defined
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by the residual kinetic energy o f the ejected positron and depends on the positron- 
emitting isotope, the latter increases with the detector ring diameter. The achievable 
spatial resolution (T ) and the various physical and geometrical contributions are 
given by the expression [27]:
r = 1 .2 5 J (ÿ "  + (tan(0.25°)y)" + r ' +b^ (mmFWHM) eq. 3.1
where d is the size o f  the individual detector elements, D is the detector ring 
diameter, r is the effective positron range, and the factor b accounts for the block 
decoding scheme. The factor 1.25 accounts for the difference between system  
resolution and reconstructed image resolution due to insufficient sampling and use o f
the FBP algorithm. The expression (tan(0.25°)^) defines the spatial resolution loss
due to non-collinearity and is o f the order o f 1.76 mm for a detector ring diameter D  
o f 800 mm. The positron range r for positron emitters used in clinical practice, such 
as ^^ F and ^^ Rb may vary from 0.6 mm to 5.9 mm, respectively. The factor b is 
affected by the light output o f the scintillator and varies between block designs. 
Typically, b ranges between 0 mm fiill-width-at-half-maximum (FWHM) and 2 mm 
(FWHM) for individual PMT coupling and a block based detector design (see section 
3.2.1) and remains a fixed factor. Therefore, the crystal width, which ranges fi'om 4 
mm to 6.5 mm in clinical PET, is the dominating parameter and plays a very 
important role in the design o f high resolution PET.
3.2.1 Conventional Block and Quadrant Sharing Detectors
PMTs together with the scintillator material have the biggest impact on the total cost 
o f a PET scanner. Therefore, reducing the number o f PMTs or increasing the crystal 
elements per PMT is very important for cost-effectiveness. The most cost-effective 
solution may be the quadrant sharing design o f PMTs [28], which allows to increase 
the number o f crystals per PMT. This method reduces the number o f PMTs by a 
factor o f 4 compared to the conventional block design and therefore the cost factor. 
It must be pointed out that the price is about the same for any size PMT.
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Figure 3.1. Conventional and quadrant sharing detector designs. A  
scintillation block cut into 1 2 x 1 2  crystals is placed on a 2 x 2 PMT set in: (A) 
The conventional block design, where the scintillator block has an effective 
size o f four PMTs. (B) The quadrant sharing design, where the scintillator 
block has an effective size o f one PMT, and scintillator block comers 
(quadrants) are positioned above PMT comers (quadrants).
Figure 3.1 illustrates both design principles. Instead o f four PMTs decoding one 
scintillator block, one larger PMT with the effective size o f one block is shared 
among four crystal blocks. The decoding ratio for a 13 x 13 crystal block would be 
169:1 with the quadrant sharing design compared to 42:1 with the conventional block 
design. However, the quadrant sharing design has two disadvantages. The PMT 
sharing does not allow the single block detectors to be easily arranged with a 
cylindrical geometry. A resulting panel detector design with the crystal blocks
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arranged in a rectangle (Figure 3 .IB) enforces a lower geometry such as a hexagon 
or octagon. Image reconstruction for such designs is more complex than for scanners 
with cylindrical geometry. The other disadvantage is the detector dead time which is 
higher than for a single block with its “own” PMT set. When an event is indicated 
the electronics o f the quadrant sharing design have to determine which o f  the 
surrounding scintillator blocks was hit. Typically up to nine blocks are not able to 
detect other incidence photons for the entire signal processing cycle. Therefore, the 
system dead time is generally 9 times higher in a quadrant sharing design than in a 
conventional block design for the same block size.
3.3 Sensitivity and 3D Imaging
The system sensitivity o f  a PET scanner describes the ability to detect activity from a 
pre-defrned source inside the FOV. Usually, the system sensitivity is measured with 
either a line or a point source in air. Current PET scanners allow for an increase in 
system sensitivity to benefit whole-body patient exams. A  routine whole-body (eye 
to thigh) ^^FDG scan for an average size patient (70 kg, 180 cm) takes about 20 
minutes. This procedure involves multiple step-and-shoot bed positions, with each 
step covering a certain fraction o f  the axial extent o f  the patient in the imaging FOV 
o f the scanner. The greater this axial coverage, the more efficient use is made o f  the 
emitted radiation from the patient who receives a radiation dose from all annihilation 
photons, and not just those emitted within the imaging FOV o f the scanner. The 
axial imaging FOV for most whole-body PET scanners with conventional block 
design is about 16 cm, with one design having an axial extent o f 18 cm [29]. The 
most recent commercially available multi-ring PET scanner covers 21.8 cm axially in 
a single bed position with a measured sensitivity o f  0.8 % [30-32]. The only PET 
scanner with the highest sensitivity ever built was the ECAT EXACT 3D  
(CTI/Siemens) with an axial FOV coverage o f 23.4 cm and a line source sensitivity 
o f 5.8 % [33]. However, this research scanner was dedicated to high resolution and 
high sensitivity brain and cardiac imaging only and not suitable for clinical whole- 
body exams. Only one ECAT EXACT 3D scanner was built and is not employed for 
clinical use any more. An increase o f the sensitivity component to capture more o f  
the emitted radiation from the patient would allow for either decreased imaging times
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or an equivalent reduction o f the injected radiation for patients. The latter has 
recently gained increased interest as radiation safety requirements are more strongly 
limiting radiation exposure o f patients. It must be pointed out that the primary 
radiation dose in combined PET/CT scanners originates from the CT’s x-rays rather 
than from the photons o f the PET component.
3.3.1 2D versus 3D Acquisition
Initial steps to increase sensitivity were taken in the early 1990s when the first BGO- 
based PET scanners with retractable septa were introduced allowing coincidences to 
be formed between any pair o f detector rings in the PET scanner [34-37]. The 
purpose o f these lead or tungsten annular shields between adjacent detector rings was 
to absorb photons that scattered out o f the transverse plane (Figure 3.2).
septa
2D (septa)
3D (no septa)
Figure 3.2. The principle o f 2D (with septa) and 3D (without septa) imaging. 
Annular shield o f lead or tungsten were placed between adjacent detector rings to 
absorb photons that scattered out o f the transverse planes.
While this restriction in sensitivity makes inefficient use o f emitted radiation from 
the patient, scatter was limited and 2D image reconstruction algorithms were able to 
be used. The retraction o f septa encouraged the use o f 3D methodology with an
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immediate application in the brain where 5-fold sensitivity gains were experienced 
[38]. However, for the rest o f the body the acceptance o f  3D imaging was much 
slower due to high out o f FOV activity causing increases in scatter fractions and 
random coincidences so that significant benefits were not necessarily obtained. The 
slow decay time and low light output o f BGO leading to relatively poor timing and 
energy resolution were clearly the limiting factors in the performance o f  PET 
scanners operated in 3D mode. The development o f new and fast scintillators 
changed this situation in the late 1990s with the appearance o f  LSO- and GSO- based 
scanners. Since LSO- and GSO- based PET/CT scanners have no septa and operate 
in 3D mode only a limited number o f  LYSO-based PET/CT scanners with retractable 
septa have been evaluated in 2D and 3D mode suggesting the 3D operation over 2D  
[39,40].
3.3.2 Planar and Volume Sensitivity
The sensitivity o f a PET scanner can also be improved by increasing the amount o f  
detector material. As an example, the sensitivity o f  a 3D LSO-based system 
covering a 16.2 mm axial FOV with 20 mm long scintillators can be improved by 
either using longer scintillators or increasing the axial extent o f  the scanner using 
additional crystal blocks. An extension o f the 20 mm long scintillator by 50% results 
in a 40 % (70/50) increase in planar sensitivity, based on the coincidence detection 
efficiency for LSO [41]. Adding one more detector ring and therefore increasing the 
axial extent by 33 % results in a 78 % ((4/3)^) increase in volume sensitivity (Figure 
3.3). Although the extension o f the axial FOV makes more efficient use o f  the 
increased LSO volume additional PMTs will be necessary and thus raise the costs o f  
the scanner.
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A Planar sensitivity
20 mm ^  30 mm
• LSO volume increase: 50%
• sensitivity increase: 40%
y (511 keV)
B Volume sensitivity
16.2 cm ^  21.8 cm 
• LSO volume increase: 33% 
sensitivity increase: 78%
Figure 3.3. Two methods o f improving sensitivity in a PET scanner by: (A) 
increasing the thickness o f the scintillator (planar sensitivity) from 20 mm to 30 mm, 
and (B) by increasing the axial extent o f the scanner (volume sensitivity). The 
increase in axial length also implies an increase in the number o f PMTs. For a 
scanner operating in 3D, method (B) compared to (A) will result in a factor 2 
increase in sensitivity with 34% less LSO.
3.3.3 Increasing the Acceptance Angle
Another parameter that affects the sensitivity o f a PET scanner is the axial 
acceptance angle (O). The axial aceeptance angle describes the axial angle over 
which LORs are eollected, and depends on the maximum axial ring difference (mrd). 
The mrd is the maximum difference between two axial crystal-based detector rings 
(centre to centre) that accept coincidences. As shown in Figure 3.4A, for two 
different mrds (black and red lines), the acceptance angle can be computed by:
n  = 2 - t a n - ' ( H ± ^
D
eq. 3.2
where D is the diameter o f the detector ring, and As the axial slice thickness.
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Figure 3.4. The correlation between acceptance angle (O), mrd and sensitivity. (A) 
O is proportional to the mrd. (B) The mrd and Q are proportional to the planar and 
absolute (volume) sensitivity o f the scanner. (C) A larger mrd or Q requires an 
increased axial overlap in multi-bed PET studies in order to maintain uniform 
sensitivity along the central region o f the scanner. This may require additional bed 
positions for the same axial coverage, and in turn additional imaging time.
For example, the 4-Ring PET scanner investigated in this work consists o f 4 block- 
based detector rings with 1 3 x 1 3  crystals per block. Therefore, the total number o f  
crystal-based detector rings is 55 (4 blocks x 13 crystals + 3 gaps; gaps are treated as 
pseudo crystals). For a mrd o f 38, the acceptance angle Q  results in 10.3 degrees. If 
the mrd is increased to 49, the acceptance angle results in 13.2 degrees for the same 
D and As.
The correlation between the mrd and sensitivity is shown in Figure 3.4B. The 
triangular shape represents the axial sensitivity profile o f a 3D PET system. The 
width o f the triangle represents the number o f axial slices and the height represents 
the number o f crystal-based detector rings. For the 4-Ring PET system from the 
example above, the total number o f axial slices is 109 (with a 2 mm individual slice
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thickness). The peak o f  the triangle can be related to the sensitivity response o f a 
point source at the centre o f the PET scanner, which is proportional to the total 
number o f crystal based detector rings. Moreover, this peak value is proportional to 
the planar sensitivity at the centre o f the system and the area o f  the triangle is 
proportional to the absolute (volume) sensitivity. In practice, however, this peak 
value is purposely limited by the mrd in order to achieve a trapezoidal shape o f the 
axial sensitivity profile. This way, the sensitivity response in the central region 
becomes uniformly planar, as shown in Figure 3.4B for two different mrds. 
Although the sensitivity response with mrdi is larger than the sensitivity response 
with mrdi (vertical limit and area o f  the trapezium), the planar response o f the central 
region is axially shorter with mrdi than it is with mrdi. In consideration o f multiple 
bed acquisitions during a whole-body PET examination in clinical practice. Figure 
3.4C demonstrates that this effect (shorter planar sensitivity response) causes an 
increased overlap for two adjacent bed positions if  the uniform sensitivity in the 
central region is to be maintained. In other words, the bed step fi'om one bed 
position to another is shorter. Therefore, a significantly larger overlap (between bed 
positions) may require additional bed positions to be acquired in order to cover the 
same axial length. This may, in turn, lengthen the total time o f the PET examination, 
although, an increased sensitivity requires less time per bed position for the same 
count statistics.
3.4 Reconstruction Algorithms
The 3D FBP algorithm with reprojection (RP3D) was the earliest and most widely 
used 3D image reconstruction technique in PET [42]. While this algorithm works 
well in a lower noise environment o f  the brain, the results for whole-body imaging 
are less satisfactory. In the past few years, a lot o f effort has been devoted to 
developing iterative image reconstruction algorithms that weight the data according 
to their statistical quality. The introduction o f Fourier rebinning (FORE) in the late 
1990s by Defrise at al. [43] facilitated the use o f 2D iterative reconstruction methods. 
The development o f Ordered-Subset Expectation-Maximisation (OSEM) [44] in 
combination with FORE led to improved image quality in a routine clinical setting. 
The incorporation o f attenuation information directly into the reconstruction model
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in the form o f weighting factors through the Attenuation Weighted (AW) OSEM 
algorithm was originally suggested by Hudson and Larkin in 1994 as an additional 
advance to compensate for image degrading effects. This technique was further 
improved by eliminating the rebinning step and implementing OSEM fully in 3D, 
directly incorporating [45, 46] corrections for randoms, scatter, attenuation and 
detector efficiency variations.
3.4.1 Point Spread Function Modelling
In a recent development (2006) the spatial detector response function has also been
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Figure 3.5. Principle o f PSF modelling, showing: (A) the erroneous assignment o f  
LORs towards the periphery o f the FOV without PSF modelling, and (B) the correct 
assignment o f LORs when PSF modelling is employed.
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included in the reconstruction model [47]. As illustrated in Figure 3.5, the oblique 
penetration o f annihilation photons into the detectors causes the PSFs to vary 
throughout the FOV. Hence, the further the photon annihilation process occurs 
towards the periphery o f  the FOV the more erroneous LOR is assigned to this event 
and degrades image quality (Figure 3.5A). Measuring this variability and 
incorporating it into the reconstruction process improves spatial resolution to be 
nearly uniform throughout the entire FOV (Figure 3.5B).
3.4.2 Time of Flight
Further development in image reconstruction was achieved by incorporating TOF 
information about the positron annihilation point in addition to the PSF model. The 
potential for PET to measure the difference in arrival times o f  a pair o f  photons from 
the annihilation o f the positron was first explored during the early 1980s [48, 49], 
and an improvement in image SNR due to TOF information was expected. The 
scintillators that were available at that time were fast but had lower stopping power 
than BGO, the scintillator conventionally used for PET imaging because o f  its 
excellent stopping power for 511-keV photons. The low sensitivity o f these early 
TOF PET systems could not be offset by the SNR improvement due to TOF, and 
thus interest in this approach declined. The introduction o f  cerium-doped LSO(Ce)
[26] during the late 1990s, a scintillator that is both fast and has good stopping power 
as well as high light output for PET imaging, and the more recent development o f  
very fast scintillators such as LaBrg, has reawakened interest in TOF PET [29, 50, 
51]. The principle o f TOF is illustrated schematically in Figure 3.6.
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Figure 3.6. Principle o f time-of-flight (TOF) PET data acquisition and 
reconstruction: (A) without TOF information incorporated, and (B) using TOF
information to localise the annihilation site with an uncertainty that depends on the 
system time resolution Axtres-
For 511 keV photons travelling with the speed o f light ( c )  that originate from 
positron annihilation in an object with distance d  + Isd from detector A and distance 
d -b ^ d  from detector B, the differenee in detector arrival times t y ^ - tg  equals 
2 b d  /  c . The further the annihilation site originates from the point midway between 
the two detectors the greater the time difference. In conventional PET, the location 
o f the annihilation site is unknown and assigned equal probability along the line-of- 
response during image reeonstruetion (Figure 3.6A). In TOF PET, the time 
difference between the arrivals o f the two annihilation photons at the detectors is 
recorded within a known uncertainty. Thus, the most probable origin o f the
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annihilation site is located at the centre o f  this uncertainty distribution (Figure 3.6B). 
The width o f the distribution depends on the time resolution o f the system (Ar^g,).
For a scanner with a time resolution o f 500 ps (FWHM), the annihilation site can be 
localised to within a spatial uncertainty (A x) o f  7.5 cm (FWHM), given the 
relationship Ax = c A r /2  To pinpoint the annihilation site to within a 2 mm 
(FWHM) voxel and completely eliminate image reconstruction, the photon arrival 
times would need to be recorded with a precision o f  13 ps (FWHM). Current 
detectors and electronics have not yet achieved such a time resolution. However, 
while insufficient to place the annihilation within a single voxel, such an uncertainty 
is better than having no loealizing information and assigning equal probability to all 
voxels along the LOR. With TOF, LORs are subdivided into time bins or segments 
o f response, which are proportional to the system time resolution Ar (Figure 3.6B). 
According to Budinger, the direct incorporation o f TOF information into the 
reconstruction algorithm improves the image SNR ratio by a factor o f -JD / ( A x )
[48], where D  is the diameter o f  the activity distribution. While the first commercial 
TOF PET scanners have recently been introduced [52, 53], the clinical impact has yet 
to be established and is part o f this work.
The improvement in recovering the origin o f positron annihilation by incorporating 
additional information into the conventional image reconstruction process is 
illustrated in Figure 3.7 for an off-centre point source in the FOV. Conventional 
PET records the LORs for each angle and plane where this object is “visible” for the 
detectors limited by the spatial resolution, which decreases towards the periphery o f  
the FOV and introduces a blurring effect into the image o f  the object (Figure 3.1 A).  
With the incorporation o f the system’s PSFs into the reconstruction model the spatial 
resolution uniformity improves and eliminates the blurring effect (Figure 3.7B). 
When TOF information is incorporated, the LORs can be interpreted as segments o f  
response (proportional to the size o f the times bins) allowing to more accurately 
locate the object along the LORs. Without the incorporation o f PSFs, the object can 
be revealed more accurately over several segments (limited by the system time 
resolution) with some blurring towards the periphery (Figure 3.7C). When both TOF 
and PSF information are provided, the localisation o f the object is most likely limited 
by the time resolution along the LOR (Figure 3.7D).
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Figure 3.7. Illustration o f improvements in image reconstruction demonstrating: (A) 
conventional PET, (B) PSF, (C) TOP, and (D) PSF+TOF.
Figure 3.8A-D shows coronal images o f an obese patient using the previously 
described reconstruction techniques. Note the improvements for the lesion indicated 
(red arrow), as well as the liver uniformity.
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Figure 3.8. The same eoronal section o f a ^^FDG whole-body PET image o f one 
obese patient acquired in 3D mode without septa and reconstructed using: (A) FBP, 
(B) FORE + AW -0SEM 2D (3 iterations, 8 subsets, 5 mm Gaussian filter) [54]; (C) 
PSF 0P-0SEM 3D  (4 iterations, 14 subsets; no smoothing), and (D) PSF+TOF OP- 
0SEM 3D (2 iterations, 14 subsets; no smoothing filter).
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Chapter 4.
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4 PET SCANNERS
The technology advances described in the previous Chapter have been implemented 
into Siemens manufactured PET scanners based on two different architectures. 
Three multi-ring scanners and one panel based design were investigated. The axial 
FOV coverage o f  a multi-ring design with three rings o f  block detectors was 
extended with an additional ring o f block detectors with the intention to increase 
sensitivity and count rate performance. For further improvement, the axial 
acceptance angle was increased on the four ring design. Detector response functions 
and TOF information were incorporated into image reconstruction o f one o f  the four 
ring designs to improve spatial resolution uniformity and image signal-to-noise, 
respectively. A  rotating panel configuration with large area LSO detector heads was 
developed to build a cost efficient scanner with high sensitivity and good spatial 
resolution. The systems are described in the following.
4.1 3-Ring and 4-Ring Configurations
The multi-ring PET scanners are based on a cylindrical ring geometry with either 
three (3-Ring) or four (4-Ring) rings o f 48 LSO detector blocks. Both PET scanners 
are part o f a combined PET/CT configuration, manufactured by Siemens Medical 
Solutions USA, Inc. Commercially, the scanners are known as Biograph TruePoint 
(3-Ring) and Biograph TruePoint with TrueV (4-Ring). An isometric 3D drawing 
with a view inside the 3-Ring and 4-Ring PET gantries is shown in Figure 4.1. Both 
PET scanners have no septa and are operated in 3D-only mode. Each o f the 48 LSO 
detector blocks contain 13 by 13 crystals (4 x 4 x 20 mm^) coupled to four PMTs in 
the conventional block detector design. The 3-Ring configuration covers an axial 
FOV o f 16.2 cm resulting in 81 axial image planes with a 2 mm slice thickness. The 
additional block detector ring on the 4-Ring design increases the LSO volume by 33 
% (7,788 cm  ^ for the 3-Ring compared to 10,383 cm  ^ on the 4-Ring) and extends the 
axial FOV coverage to 21.8 cm with 109 image planes o f 2 mm thick slices. The 
mrds o f  27 and 38 correspond to axial acceptance angles o f  7.4 and 10.5 degrees on
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the 3-Ring and 4-Ring, respectively. Both systems operate with a 4.5 ns coincidence 
time window and an energy window of 425-650 keV.
Detector 
cassettes
Figure 4.1. Isometric 3D drawings o f the 3-Ring (A) and 4-Ring (B) PET gantries: 
The red arrows indicate the block detectors, which are housed inside detector 
cassettes (outside).
The 3-Ring PET scanner is combined with a 16 slice helical CT scanner (Somatom 
Sensation 16, Siemens Healthcare), and the 4-Ring PET scanner is coupled with a 6 
slice helical CT scanner (Somatom Sensation 6, Siemens Healthcare). The CT 
scanner is used to select the scanning range o f the object inside both the CT and PET 
FOVs through acquisition o f a low dose CT. Moreover, the CT scan provides 
anatomical infonnation o f the object in addition to the functional content from the 
PET scan. At the same time, the CT acquisition is also employed to correct the PET 
data for photon attenuation.
It must be pointed out that a previous 3-Ring system was based on a spherical or 
barrel shaped architecture rather than a cylindrical geometry. The main objective for
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a spherical or barrel shaped design was to achieve improved spatial resolution 
throughout the entire FOV. While advanced reconstruction algorithms are already 
developed for cylindrical data, instead o f  implementing new algorithms the spherical 
data set is converted into an equivalent cylindrical data set. As a result, the 
anticipated main objective o f  the barrel shape to improve spatial resolution is lost 
through conversion and interpolation. Comparisons between a spherical and a 
cylindrical 3-Ring PET scanner have shown no significant difference in performance. 
From a manufacturing point o f  view, it is easier to build a multi-ring PET gantry 
with cylindrical rather than spherical shape, which is also limited in the number o f  
axial detector blocks that can be added. All recent systems from Siemens Healthcare 
are now based on a cylindrical geometry.
4.2 4-Ring Configuration with Increased Acceptance Angle
The third multi-ring PET configuration that is part o f this work is the 4-Ring scanner 
with increased acceptance angle (4-Ring+). The 4-Ring+ PET scanner is also part o f  
a combined PET/CT configuration and commercially known as Siemens Biograph 
molecularCT (mCT). The geometry o f  the 4-Ring+ PET gantry is based on the 4- 
Ring scanner and comprises the same amount o f detectors. The patient bore on the 
4-Ring+ is 78 cm wide, compared to 70 cm on the 4-Ring and 3-Ring, and the axial 
footprint o f the combined PET and CT gantry was reduced by 20 cm to 136 cm on 
the 4-Ring+. The acceptance angle for incoming coincidence events was increased 
from 10.3 (4-Ring) to 13.2 degrees. Therefore, an increase in sensitivity and count 
rate performance were expected. An improved energy and time resolution allowed 
the increase o f the lower level energy discriminator (LED) from 425 keV to 435 keV, 
and to decrease the coincidence window from 4.5 ns to 4.1 ns, respectively. The 4- 
Ring+ scanner is equipped with TOF capability. The TOF information is encoded at 
the coincidence processor level with 78 ps wide time bins and then rebinned into 312 
ps time bins when sinograms are built. The sinograms comprise 400 radial bins, 168 
angular bins, 621 total slices, and 13 TOF bins (312 ps wide).
The 4-Ring+ PET scanner is combined with a 128-slice CT scanner (SOMATOM  
Definition AS+, Siemens Healthcare).
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4.3 The Panel Configuration
The fourth scanner that was investigated as part o f this work is based on a different 
architecture than the three multi-ring PET scanners. The PET gantry o f this scanner 
consists o f five large area panels (P5-Head) o f dimension 37 cm (transaxial) x 53 cm 
(axial) that are mounted in a hexagonal array, as shown in Figure 4.2.
Electronics
Transmission 
sources 
Detector
Figure 4.2. Schematic o f the panel detector PET scanner P5-Head with a hexagonal 
geometry. The five detector heads on the inside rotate with the electronics on the 
outside at a speed o f 30 rpm. The sixth facet o f the hexagon incorporates 
transmission sources to perform attenuation correction.
Each panel contains 7 x 1 0  LSO detector blocks. The individual blocks comprise a 
1 2 x 1 2  matrix o f 4 x 4 x 20 mm  ^ crystals, and are bonded to a 1.3 cm thick light 
guide. An array o f 8 x 11 PMTs in a quadrant sharing design is used for photon 
read-out (section 3.2.1). The concept o f the panel and the realisation o f the quadrant 
sharing design are shown in Figure 4.3.
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Figure 4.3. The panel detector concept for the P5-Head: (A) Photograph o f one 
detector panel. (B) Photographic section o f a detector panel illustrating the concept 
o f the quadrant sharing design for one scintillator block. (C) Sehematie o f  the PMT 
and crystal block arrays for one detector panel.
This scanner configuration covers an axial FOV o f 52.6 cm resulting in 239 image 
planes with a slice thickness o f 2.2 mm. The mrd to accept eoineidence data is 87, 
which corresponds to an acceptance angle o f 25.6 degrees. The P5-Head was 
operated with a coincidence window o f 5 ns and an energy window o f 400-650 keV. 
Such wider windows than on the multi-ring scanners were used due to employment 
of different detector electronics. The panels with the corresponding electronics [55] 
on the outside rotate with a speed o f 30 rpm to form a complete detector “ring” 
around the FOV. A slip-ring with copper contacts was used for data transmission 
between the rotating panels and the acquisition system through an optic fibre 
channel.
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Unlike the multi-ring scanners, this scanner is not part o f a combined PET/CT 
system. Therefore, in order to correct the PET data for photon attenuation, this PET- 
only scanner is equipped with ^^Ge transmission sources, which are mounted on the 
sixth facet o f  the scanner hexagon, as indicated in Figure 4.4.
Transmission
sources
Figure 4.4. Photograph o f the P5-Head scanner without covers. The red arrows 
indicate the location o f the transmission sources.
The transmission sources consist o f a set o f two axial rods, each containing ten 37 
MBq (ImCi) ^^Ge point sources (Ti/2 = 270.8 days, E = 1.9 MeV). Each point source 
is collimated axially and transaxially, providing an offset fan beam geometry. A  fast 
LSO crystal for each point source serves as a reference detector during the 
transmission coincidence acquisition [56, 57]. In order to perform attenuation 
correction, a transmission scan o f the object in the FOV is simultaneously acquired 
with the emission data. The transmission data are then referenced to a blank scan, 
which is acquired with no object in the FOV. The concept o f the transmission scan 
on the P5-Head scanner is illustrated in Figure 4.5.
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Transmission
Transmissi^ 
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Figure 4.5. Concept o f the transmission scan on the P5-Head scanner in the 
transaxial view with (A) an object in the FOV (transmission scan), and (B) no object 
in the FOV (blank scan).
The large FOV coverage and the small crystal size cause large data sets and very 
sparse data, which in turn translate into long computing times and challenges for 
image reconstruction with acceptable resolution. Therefore, a dedicated cluster o f  
eight dual CPU nodes and Ordinary Poisson (OP) 0SEM 3D, already developed for 
the HRRT, were used [58-60]. The CPU nodes are controlled by a data server/host 
with a 3 GHz Intel Xeon processor and a 1 Tbyte level-5 RAID is used for image 
reconstruction. Each CPU in the cluster is an Intel Xeon processor with 3 GHz and 2 
Gbyte DDR RAM. The nodes in the cluster communicate through a gigabit ethemet. 
The architecture uses a single program, multiple data (SPMD) model, where the 
same program runs on all nodes and communication between the nodes synchronizes 
the reconstruction.
While the multi-ring scanners are commercially available, the P5-Head scanner never 
became a product and remained a prototype during the course o f this work.
4.4 Summary and Conclusions
The main specifications for the four PET scanners are summarized in Table 4.1. One 
o f the main differences o f the scanner components is the axial coverage. The P5-
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Head has a factor 2.4 larger axial FOV than the 4-Ring and 4-Ring+ scanners. This 
extension corresponds to a 55 % increase in LSO volume (16,128 cm  ^ on the P5- 
Head compared to 10,383 cm  ^ on the 4-Ring). However, as a benefit o f  the quadrant 
sharing detector design, 43 % less PMTs are utilized for more than twice the 
extended coverage. Based on this increase in detector material, a corresponding 
increase in volume sensitivity and count rate capability can be expected.
For the multi-ring systems, the volume sensitivity o f  the 4-Ring increases by a factor 
o f (4/3)^ or 78 % compared to the 3-Ring since the volume sensitivity for an V-ring
system is proportional toN^  [61]. With the addition o f an increased acceptance 
angle on the 4-Ring+ scanner, the volume sensitivity is expected to be 29 % higher 
than on the 4-Ring and more than a factor 2 higher than on the 3-Ring. The 
improvements in sensitivity imply corresponding increases in count rates.
Table 4.1. Summary o f the PET scanner specifications for the 3-Ring, 4-Ring, 4- 
Ring+ and P5-Head scanners.
Parameter 3-Ring 4-Ring 4-Ring+ P5-Head
Detector material LSO LSO LSO LSO
Crystal size (mn?) 4 x 4  x 2 0 4 X 4 X 20 4 X 4 X 20 4 x 4  x 2 0
Detector elements per block 169 169 169 144
Detector blocks 144 192 192 350
Photo-mukplier-tubes (PMTs) 576 768 768 440
Crystal rings 41 55 55 120
Maximum ring difiference (mrd) 27 38 49 87
Acceptance angle 7.4 10.5 13.5 25.6
Lines o f response (LORs) 0.35 X 10^ 0.63 X 10^ 0.84x10^ 3.22 X 10^
Image planes 81 109 109 239
Plane spacing (mm) 2.0 (2.025) 2.0 (2.027) 2.0 (2.027) 2.2
Axial FOV (cm) 16.2 21.8 21.8 52.6
Transaxial FOV (cm) 60.5 60.5 70 60.5
Coincidence time window (ns) 4.5 4.5 4.1 6
Energy window (keV) 425-650 425-650 435-650 400-650
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Chapter 5.
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5 “PET SCANNER PERFORMANCE 
CHARACTERISATION
Performance evaluations o f  PET scanners require reproducible and reliable methods 
to allow intra system comparisons. Measurement methodologies have been 
developed and published by a task group o f  the Society o f  Nuclear Medicine (SNM) 
[65], the National Electrical Manufacturers Association (NEMA), and the 
International Electro-technical Commission (lEC) with input from the European 
Economic Community (EEC) Concerted Action o f Cellular Regeneration and 
Degeneration [66]. The original NEMA [67] and lEC [68] standards were primarily 
developed for PET cameras with 2D acquisition mode, but optionally applied in 
cameras with 3D mode without septa. While whole-body PET seanning in 3D 
increased during the late 1990’s and early 2000’s, those standard protocols proved to 
be rather limited in evaluating and comparing scanner performance in 3D. The 
advantage o f inereased sensitivity in 3D is accompanied by a considerable increase 
o f random and scattered events. The former arises primarily from activity located 
outside the PET scanner’s FOV. As a result, NEMA updated the standard protocol 
[69] in 2001 to specifically take into account the conditions o f 3D whole-body PET 
imaging. The recently updated protocol [70] incorporates Watson’s suggestions for 
scanners with intrinsic radioactivity [71].
While the standard protocols allow examination and comparison o f physical scanner 
performance, they do not address all aspects that are relevant for operating a PET 
scanner in a clinical environment. The following sections describe the measurements 
performed by the author on the different PET scanners.
A partial content of this Chapter has been published by the author et al. in [62-64].
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5.1 Methods
Before describing the methods that were followed to measure the performance o f the 
listed PET scanners, it must be pointed out that repeated measurements were 
performed on the multi-ring scanners (three repeats), while only one set o f  
measurements was completed on the rotating panel configuration P5-Head. Because 
the P5-Head scanner was a prototype, the device was constantly under experimental
Patient table
Pomt source S
Pomt source
\
Figure 5.1. Spatial resolution fixture for accurate positioning o f point sources within 
the PET scanner FOV. The point source can be moved in 1 cm steps laterally and 
vertically. (A) Isometric drawing o f the fixture. Photograph o f the mounted spatial 
resolution fixture with a point source in place: (B) along the axis o f the scanner; (C) 
from the side o f the scanner with a zoomed view.
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and therefore changing and unstable system conditions, so that it was challenging to 
complete multiple measurement series in one state o f  the scanner. While the 
statistical proof o f the reproducibility o f the measured results might be argued, the 
author however finds that the reported results are o f importance and o f interest for 
this work.
5.1.1 Spatial Resolution
The spatial resolution o f a PET scanner represents its ability to distinguish between 
two objects after image reconstruction. Empirically, it is a description o f the 
minimum distance at which two objects are recognized by the PET scanner. The 
measurement can be performed by imaging a radioactive point or line source inside 
the scanner’s FOV. The spatial resolution is then expressed as the (FWHM) o f the 
profile through the reconstructed images o f the point or line source. The profile is 
often referred to as point or line spread function (PSF or LSF), and can be 
approximated by a Gaussian function. The PSF represents a 3D profile through the 
point source, while the LSF is a 2D function. The following proeedures for the 
multi-ring scanners and the panel detector PET scanner were applied to evaluate the 
spatial resolution parameter.
Procedure for the Multi-Ring Scanners
Source Preparation and Acquisition Protocol
To obtain the spatial resolution for the multi-ring scanners, a point source was 
utilized. The point souree consisted o f 1 x 1 x 1 mm^ ^^ F absorbing anion exchange 
resin (Model peptide MP-1 ^^ F trap and release column. Oak Ridge Technology 
Group, Inc.) that is inserted into a 75 mm long glass capillary tube with a 1.1 mm 
inner diameter and a wall thickness o f 0.2 mm. A  high density polyethylene plug is 
placed behind the resin to prevent it from moving. The point source was prepared by 
flushing about 220 MBq ±  10 94 o f water solution with a concentration o f  0.1 ml 
± 5 % through the capillary until the residual within the resin resulted in about 14.8 
MBq ± 1 0  %. Thus, the activity was low enough to keep dead time losses and the 
ratio o f  randoms to total events below 5 % as suggested by Watson et al. [71]. The
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capillary with the resin inside was mounted onto a fixture that is secured on the 
patient bed, as shown in Figure 5.1. This fixture was developed in order to 
accurately move the point source 1 cm laterally and vertically within the FOV. As 
shown in Figure 5.2, data were acquired at 2 positions along the axial FOV (centre, 
% off-centre), at 3 (x,y) locations where x and y are the axes in the transverse plane, 
at: (0,1), (10,0), (0,10). To ensure adequate statistics, a total o f  2 M true coincidence 
counts were acquired at each position.
DDDDDDDDaaBa
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•  (»
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FOV
centre axial 
FOV
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■>X
DDDDUDU
A View into patient bore B Side view
Figure 5.2. Locations o f the point sources for the spatial resolution measurement. 
The three transverse point souree locations (A) are indicated for both axial positions 
(B).
Reconstruction and Data Analysis
The acquired sinogram data were reconstructed with FORE and FBP. The pixel size 
was 1 mm. The point source images were reconstructed without attenuation and 
scatter corrections (i.e. there should not be any attenuation or scatter for a point 
souree in air), and no post-smoothing filter was applied. Linear interpolation was 
used to determine the FWHM o f the reconstructed point sources at the locations 
shown in Figure 5.2. The axial and transverse spatial resolutions were extracted 
from the measurements at 1 cm radial distance from the FOV centre. The axial.
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tangential and radial spatial resolutions were extracted from the measurements at 10 
cm radial distance from the FOV centre. For all profiles through the isocenter o f  the 
reconstructed point sources, the averages over the two axial source locations (centre 
axial FOV, % off-centre axial FOV) were used. The complete formulas how the 
spatial resolution values were computed are listed in Table 5.1.
Table 5.1. Formulas for computing spatial resolution values. (RESx, RESy, RESz 
refer to the spatial resolution measured in x, y, and z directions) [70].
Description Formula
At 1 cm radius
Transverse Average x & y for both 
z positions (4 
numbers)
RES = ^^^^s»0,y=l,z-center x-O.y-l.z-center /
RESXx.o,y-l,2.1/4FOV +I^Syx.o,y-l,z-l/4FOV jj
Axial Average of 2 z 
positions (2 numbers)
RES (RESz,._Q 2-centK ^^^^x-0,y-l.z-l/4FOv)/^
At 10 cm radius
Transverse radial Average 2 transverse 
for both z positions (4 
numbers)
_ ( ^^^^s-10,y-0,z=center O.z-centtr 
[RESXx„10,y_0,2-l/4FOV + ^ Syx_o.y-10,z-l/4FOV^
Transverse
tangential
Average 2 transverse 
for both z positions (4 
numbers)
RES = RESyx«io,y-0.z»center f^SXx..o,y-10,z»center 
RESy^ l^O 2-1/4FCV + I^Sx,j.o,y-10.z-l/4FOV^
Axial resolution Average 2 transverse 
for both z positions (4 
numbers)
RES = ^^^^x-10,y-0.z-center ^^^^x-0,y-10,z-ceater L 
R^ESZs_io,y_o,2-l/4FOV +RESZx.o,y-10.z-l/4FOV J/
Procedure for the Panel Detector Scanner
Source Preparation and Acquisition Protocol
For the P5-Head scanner, the spatial resolution was measured according to a different 
procedure. The point source and the fixture that were used on the multi-ring 
scanners had not been developed at the time o f this measurement. Instead, a 3 MBq 
± 10 % ^^Ge point source was used to measure the spatial resolution o f the P5-Head 
system. The source was sealed inside a tungsten hollow cylinder with a 0.5 mm  
diameter cavity (0.5 mm deep, 0.5 mm wall thickness). It was assumed that all 
emitted positrons annihilated very close to the inner side o f the wall, given the high 
density o f tungsten (19.3 g/cm^). The point source was positioned in the axial centre 
with radial offsets o f 0 cm, 10 cm, and 20 cm. For each location, data were acquired 
in list mode for 5 minutes.
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Reconstruction and Data Analysis
The acquired list mode data were rebinned into sinograms, and reconstructed fully in 
3D using Unweighted Ordered Subset Expectation Maximisation (UW-OSEM3D), 
without corrections for normalisation, scatter and attenuation. The spatial resolution 
was extracted from orthogonal PSFs through the reconstructed point sources. A  
Gaussian fit was performed on each profile to determine the FWHMs. To estimate 
the transverse spatial resolution the profiles in x and y were averaged.
5.1.2 Sensitivity
The absolute or system sensitivity o f a PET scanner represents its efficiency o f  
detecting photons that originate from true coincidence positron annihilations. It is 
defined as the number o f counts per unit time detected by the PET scanner for each 
unit o f activity present in a source (cps/Bq). The measurement procedure is 
described in the following.
Source Preparation and Acquisition Protocol
In order to measure the absolute sensitivity o f  the different scanners, the method 
developed by Bailey et al. [72] was followed. A  70 cm polyethylene line source (ID: 
1 mm; CD: 3 mm) was filled with about 4 MBq ± 10 % o f ^^ F and placed inside five 
concentric aluminium sleeves o f the same length with known diameters, as shown in 
Figure 5.3. The sleeves cause attenuation for the annihilation photons inside the line 
source. The tube surrounded by the set o f sleeves was suspended in the radial centre 
o f the FOV, parallel to the axis o f the scanner. By removing sleeves, one at a time, 
the true coincidence count rate as a function o f attenuation was recorded with 2M  
total counts for each acquisition. An additional data set was acquired with the
; 12.5 10.0 7.5 5.0 2.5
Line source
Figure 5.3. Photograph o f the sensitivity sleeves with the line source indicating the 
outer diameters (CDs) in mm.
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sleeves positioned at 10 cm radial off-centre FOV. The average starting activities 
(defined as the average over three measurements) and uncertainties (defined as the 
standard deviation o f the average activity) which were used for the sensitivity 
measurements are listed in Table 5.2.
Table 5.2. Starting ^^ F activities with uncertainties for the sensitivity measurements.
Activity
Scanner mean SD
(MBq) (MBq)
3-Ring 4.8 0.5
4-Ring 4.6 0.7
4-Ring+ 6.2 0.5
*P5-Head 21.5 /
SD: standard deviation
* 1 measurement only
D ata Analysis
After correcting the true coincidence count rate for isotope decay, the attenuation 
curve was extrapolated to zero absorption. The ratio between the true count rate with 
no absorption and the starting activity represents the system sensitivity.
5.1.3 Scatter Fraction
The count rate performance o f a PET scanner characterizes the behaviour o f  a system  
as a function o f different activity levels. A  standard parameter which is derived from 
count rate data is the scatter fraction (SF) which is a measure for scatter counts 
relative to total true and scatter counts. While the final SF value is generally 
estimated at low count rates where random counts are negligible and refers to the 
minimum o f the scatter fraction curve, the entire SF response as a function o f  activity 
concentrations was recorded. The SFs o f the different systems were evaluated 
according to the following procedure.
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Source Preparation and Acquisition Protocol
In order to acquire count rate data a 70 ± 0.5 cm long and 20.3 ± 0.3 cm wide 
polyethylene cylinder (Volume: 22 1), also referred to as NEMA scatter phantom, 
was positioned so that the phantom isoeenter was aligned with the isocenter o f the 
PET FOV. A line souree (inner diameter: 3.2 ± 0.2 mm, outside diameter: 4.8 ± 0.2 
mm, length: 70 ± 0.5 cm) was filled with sufficient activity o f ^^ F to achieve count 
rates beyond the peak o f the curve (which is beyond the saturation point o f the 
detectors) and inserted 4.5 cm below the radial phantom centre, parallel to the central 
axis. A photograph o f the NEMA scatter phantom is shown in Figure 5.4. The 
average starting activities (defined as the average over three measurements) and 
uncertainties (defined as the standard deviation o f the average activity) which were 
used to acquire the count rate curves for the different scanners are listed in Figure
5.4. For all scanners, data were acquired in 35 frames, each with 600 second 
acquisition time and a 900 second delay prior to the next acquisition. A delayed 
coincidence window was used to collect random coincidences so that prompt and
Scatter phantom
\
Patient table
r, *
Line source
Figure 5.4. Photograph o f the NEMA scatter phantom on the patient table with the 
line source in place.
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random sinograms were generated for each frame.
Table 5.3. Starting activities for the count rate measurements.
Scanner
Activity
mean SD 
(MBq) (MBq)
3-Ring 1026.0 18.7
4-Ring 1000.2 67.4
4-Ring+ 979.8 53.2
*P5-Head 750.0 /
SD: standard deviation 
* 1 measurement only
D ata Analysis
The true, random and scatter events were extracted from sinogram data within a 24 
cm radial FOV around the centre o f  the 20 cm diameter phantom. This allowed 
capturing the count distribution close enough to the object. The true events including 
some scatter were assumed to lie within a centred 4 cm wide strip, elose enough to 
the location where the line source was situated during the acquisition. The scattered 
events around the 4 cm wide strip were extracted by linear interpolation and added to 
the scatter counts outside the 4 cm wide strip within the 24 cm radial FOV. The 
random counts for a 24 cm radial FOV around the centre o f the phantom were 
extracted from the separate randoms sinograms for each acquisition. From the 
extracted scattered and true events, the SF as a function o f  activity concentrations 
was computed according to:
=  eq.5.1
where S resemble the scatter and T the true coincidence count rates.
5.1.4 Noise Equivalent Count Rate
Noise Equivalent Count Rate (NECR) was first introduced by Strother et al. in 1990 
[73] and describes the equivalent trues count rate o f an ideal imaging system in the
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absence o f  randoms and scatter. Dahlbom et al. [74] showed that NECR is 
proportional to the square o f the image signal-to-noise. The resulting NECR 
response o f a PET system describes a count rate curve as a function o f  activity 
concentrations that reaches a peak value asymptotically and declines abruptly when 
the PET detectors are saturated. The NECR response curves o f  the different PET 
systems were derived by analyzing the acquired count rate data (see 5.1.3) according 
to the following method.
D ata Analysis
Once all events are separated as described previously (see 5.1.3), the NECR response 
for the different activity levels was computed according to:
where T, S, and R are the true, scatter and random eoineidence count rates, 
respectively. The factor k depends on how the randoms R are estimated. The factor 
k  takes a value o f 1 for smooth randoms correction, or a value o f  2 if  the randoms 
correction is performed via direct subtraction o f  the delayed coincidences (online 
randoms correction). For all scanners compared in this work, smoothed randoms 
correetion {k= l)  was applied. In the literature, the k==l case is usually referred to as 
IR, and in terms o f  the NECR with NECIR.
5.2 Results and Discussion: Multi-Ring Configurations
The performance results for the 3-Ring, 4-Ring and 4-Ring+ PET scanners are 
summarized in Table 5.4.
5.2.1 Spatial Resolution
The reconstructed image resolution for the multi-ring scanners was obtained for an 
^^ F point source in air at a radial distance o f 1 ± 0.5 cm and 10 ± 0.5 cm from the 
centre o f the transaxial FOV averaged over two axial positions. At 1 ± 0.5 cm radial 
distance from the transaxial centre o f  the FOV, the average spatial resolution
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(defined as the average over the transaxial and axial measurements) is essentially the 
same for all three scanners with 4.3 ± 0.2 mm (FWHM). The average spatial 
resolution at 10 ± 0.5 cm radial distance from the transaxial centre o f  the FOV 
(defined as the average over the transverse tangential, transverse radial and axial 
measurements) is similar for all three seanners and found to be 5.0 ± 0.5 mm 
(FWHM). A  small deviation o f 0.2 mm (FWHM) still remains when comparing the 
average results at 10 ±  0.5 cm radial distance for the 3-Ring (4.8 ± 0 .1  mm FWHM) 
and 4-Ring± (5.2 ± 0 .1  mm FWHM) scanners within the experimental uncertainties. 
This deviation could be attributable to additional blurring that is introduced into the 
PSF and may originate firom a combination o f acquiring the point source inside an 
axial gap and the increased acceptance angle for scattered events. However, within 
two standard deviations from the mean the results are comparable. Similar results 
are to be expected for all multi-ring systems with the same detector blocks o f 4 mm x 
4 mm X 20 mm elements, and the small deviation is within less than 5 % and 
therefore negligible.
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5.2.2 Sensitivity
The average volume system sensitivity (defined as the average over three 
measurements at the radial FOV centre and at 10 cm away from the radial FOV 
centre) increases by 82.7 ± 5.6 % from the 3-Ring to the 4-Ring scanner. It must be 
recalled that according to Watson [61], the volume sensitivity for an N-Ring system  
is proportional to N .^ Therefore, this performance gain in volume sensitivity o f  the 
4-Ring scanner by a factor o f  (4/3)^ or 78 % compared to the 3-Ring system is in 
good agreement (within experimental uncertainties) with expectations for an 
additional ring o f detector blocks. The average volume system sensitivity increases 
by an additional 19.3 ± 3.3 % from the 4-Ring to the 4-Ring+ scanner. This 
additional gain is attributable to the larger acceptance angle on the 4-Ring+. 
However, theoretically, a sensitivity increase by 29 % would be expected for 
increasing the mrd from 38 to 49. Here it is important to note that the lower level 
discriminator o f the energy window was raised from 425 keV (4-Ring) to 435 keV 
(4-Ring+) to decrease scatter, and the coincidence window was lowered fi*om 4.5 ns 
(4-Ring) to 4.1 ns (4-Ring+) to decrease randoms. However, the combination o f  
both will also affect the trues sensitivity and therefore the measured results for 
sensitivity do not match the expected increase when comparing the 4-Ring and 4- 
Ring+.
The corresponding plots for the system sensitivity measurements are shown in Figure
5.5. The trues count rates are plotted as a function o f sleeve thickness. The 
extrapolated y-intercepts for each individual measurement were used in order to 
compute the system sensitivity at the positions mentioned. The mean ± standard 
deviations over three measurements o f the computed system sensitivities are reported 
in Table 5.4. The deviations in the true count rates for the different measurements 
are caused by varying starting activities (see mean ± SD in Table 5.2). Higher 
activity increases the probability o f more annihilation photons passing through the 
attenuating material than lower activity. However, this does not affect the results 
since the ratio between the extrapolated trues rate without attenuation and the starting 
trues rate are computed in order to obtain the sensitivity.
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Figure 5.5. Trues rate as a function o f sleeve thickness for the sensitivity estimation 
on the 3-Ring (A), 4-Ring (B), and 4-Ring+ (C) scanners for three measurement 
repeats (A-C). The exponential model functions are indicated: centre (lower left), 
and 10 cm off-centre (upper right). R^=l for all model functions.
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Note the value o f the linear attenuation coefficient (0.02 mm" ) for aluminium in the 
exponent o f the exponential model functions.
5.2.3 Scatter Fraction
The SF as a function o f activity concentration is shown in Figure 5.6-5.8 for the 
different multi-ring systems. While a SF incline can be observed for an increasing 
activity concentration, there is also a slight increase at very low (< 4 kBq/mL) 
activity concentrations. The latter might be due to erroneous count contributions 
from the LSO crystals. Therefore, data below an activity concentration where the
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Figure 5.6. Scatter fraction (SF) as a function o f activity concentration for the 3- 
Ring scanner.
minimum SF occurs were neglected from the analysis. Above the minimum SF, a 
linear correlation between SF and activity concentration can be observed and is 
indicated by the model function for one measurement o f each system.
The effect o f inclining SF with increasing activity concentration is attributable to 
scatter pile-up due to the high singles count rate. It is possible that two scatter events
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Figure 5.7. Scatter fraction (SF) as a function o f activity concentration for the 4- 
Ring scanner.
have a greater probability to still have a pulse height within the set energy window  
(650 keV) than a true plus any additional event. The summed pulse height 
information in the latter case may end up above the upper energy threshold and result 
in a cancellation o f the event. With less accepted true events and more accepted 
scatter events the SF will increase. This has also been observed by Eriksson et al. 
[76].
The minimum SF values measured at low activity concentrations are reported in 
Table 5.4 and show similarity within two standard deviations from the mean. The 
average SF (defined as the mean over all multi-ring systems) results in 33.6 ± 0.9 % 
at 2.5 ± 0.6 kBq/mL. For an extended axial FOV and a larger acceptance angle an 
increase in scatter fraction might be expected for the same object. The scatter 
fractions o f two PET systems are the same if  the ratio o f true counts equals the ratio 
o f scatter counts. In other words, if  the true and scatter counts increase equally, the 
scatter fractions o f both systems are essentially the same. This is the case for the 70 
cm scatter phantom on the multi-ring systems. However, for a given patient the 
scatter fraction varies for different regions o f the body within the imaging FOV.
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This variation in scatter fraction has been demonstrated by Karp et al. for different 
sized phantoms [75] and is also shown for patients as part o f this work in Chapter 6.
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Figure 5.8. Scatter fraction (SF) as a function o f activity concentration for the 4- 
Ring+ seanner.
5.2.4 Noise Equivalent Count Rate
The NECR curves for the different multi-ring scanners are plotted in Figure 5.9-5.11. 
Figure 5.12 compares the NECR results for all three scanners. Polynomial funetions 
were applied to model the curves and are a good fit (R  ^= 1 ). However, it needs to be 
noted that the NECR is not a trivial function and its decrease with increasing aetivity 
concentration is mainly characterized by complex effects. The increase o f random 
events decreases the slope o f the curve and causes the curve to plateau. Pulse pile-up, 
dead time and multiplexing at the detector level finally bend the curve with a 
negative slope. Therefore, the maximum peak values that are reported in Table 5.4 
were estimated from both the derivatives o f the model functions and the actual 
maximum data points that were measured. Based on experimental experience, the 
maximum NECR peak values are reproducible within ± 5 %.
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Figure 5.9. NECR results as a function o f activity concentrations for the 3-Ring 
scanner.
The estimated (measured) peak NECR (Table 5.4) increase from the 3-Ring to the 4-
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Figure 5.10. NECR results as a function o f activity concentrations for the 4-Ring 
scanner.
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Ring scanner corresponds to a 65.0 ± 4.8 % (68.8 ± 6 .1  %) gain. An additional 15.5 
± 5.2 % (13.3 ± 5.9 %) peak NECR are obtained from the 4-Ring to the 4-Ring± 
seanner, which corresponds to a 90.6 ± 5.8 % (91.2 ± 6.9) increase from the 3-Ring 
to the 4-Ring± scanner. Improvements are expected for an extended axial FOV (4- 
Ring) and a larger acceptance angle (4-Ring±).
It is interesting to note that the average maximum NECR on the 3-Ring and 4-Ring 
occurs at the same activity concentrations within experimental uncertainties, while 
the NECR on the 4-Ring± scanner peaks at a slightly lower activity concentration; it 
is 5.4 ± 2.6 % below the estimated average o f 30.2 ± 0.5 kBq/mL. This slight 
difference seems to be an effect o f detector saturation. Both the 4-Ring± and 4-Ring 
scanners are composed o f the same amounts o f detectors and electronics, which can 
process incoming events. However, more incoming events are detected or “seen” on 
the 4-Ring± than on the 4-Ring scanner during the same period o f time for the same
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Figure 5.11. NECR results as a function o f activity concentrations for the 4-Ring± 
scanner.
amount o f activity in the FOV because o f the increased acceptance angle. In other 
words, the same amount o f incoming events are detected on the 4-Ring± than on the 
4-Ring scanner in either less time or with less activity in the FOV. Therefore, the
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detectors on the 4-Ring+ scanner are saturated earlier (at a lower activity 
concentration) than the detectors on the 4-Ring scanner.
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Figure 5.12. Noise Equivalent Count Rate (NECR) curves for the 3-Ring, 4-Ring, 
and 4-Ring+ scanners as a function o f activity concentrations. The results for three 
measurements (A-C) per scanner are indicated.
The increase in sensitivity with a corresponding improvement in NECR implies that 
the image signal-to-noise ratio improves for both an extended axial FOV and an 
increased acceptance angle. Moreover, from a clinical perspective this increase in 
statistics could be translated into either a lower injected radiation dose or a reduction 
in imaging time for comparable image quality. This subject will be part o f the 
investigations in sections 8.6.
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5.3 Results and Discussion: P5-Head
Table 5.5 summarizes the results for the system performance o f the P5-Head scanner.
Table 5.5. System performance results for the P5-Head panel detector scanner (one 
measurement).
Parameter ^Distance P5-Head
Spatial Resolution (mm FWHM)
Transverse 0 4.7
Axial 0 5.0
Transverse 10 5.4
Axial 10 6.0
Transverse 20 6.4
Axial 20 7.5
Sensitivity (kcps/MBq)
0 23.2
10 18.8
Scatter Fraction (%)
linear fit for scatter (NEMA) 46.0
polynomial fit for scatter 43.0
Noise Equivalent Count Rate
smoothed randoms correction
(kcps @ kBq/ml)
linear fit for scatter (NEMA) 127 @ 9.4
polynomial fit for scatter 178 @ 14.0
estimate from coincidence processor 215 @ 22.0
 ^radial distance in (cm) from center FOV
5.3.1 Spatial Resolution
An average spatial resolution o f 4.9 ±  0.2 mm (FWHM), 5.7 ± 0.4 mm (FWHM) and 
7.0 ± 0.8 mm (FWHM) was obtained at 0 cm, 10 cm, and 20 cm radial distance from 
the FOV centre, respectively. Compared to the multi-ring scanners, the average 
results are similar within two standard deviations from the mean for the 0 (1) and 10
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cm distance from the FOV centre. However, only one measurement was performed 
on the P5-Head scanner and therefore it is difficult to draw final conclusions. The 
degradation o f spatial resolution at large radial positions is primarily an effect o f  the 
depth o f  interaction, which can also be observed for the multi-ring scanners. While 
annihilation photons that originate from the centre o f  the FOV hit the detector 
crystals almost straight, photons towards the periphery o f  the scanner strike the 
crystals in an angle and may therefore spread the energy over several crystals rather 
than one. The resulting PSFs are broader towards the periphery o f the FOV than for 
photon interactions from the centre o f the FOV. One way o f  addressing this effect 
would be to measure the system PSFs throughout the FOV and implement a matrix 
or lookup table into image reconstruction. This method was explained in section 
3.4.1, and an implementation o f PSF reconstruction was explored as part o f  this work 
in Chapters 7 and 8Chapter 7. Another way o f addressing this effect would be to add 
an additional layer o f crystals with a decay time that is different from that o f the LSO 
crystals. This technique has been explored for the High Resolution Research 
Tomograph (HRRT) [60].
Another reason for spatial resolution degradation on the P5-Head scanner originates 
from the use o f image reconstruction algorithms that were available for cylindrical 
data. As a result, the hexagonal data had to be converted into an equivalent 
cylindrical data set prior to reconstruction. The interpolation error during this 
conversion contributes to a loss in spatial accuracy.
The axial data compression (maximum ring difference o f  87 and a span o f 7), which 
was necessary because o f computational limitations, degrades spatial resolution in 
the axial direction. However, a new improved rebinner algorithm and hardware 
which is capable o f correctly positioning the LORs using nearest-neighbour 
approximation, has demonstrated an axial spatial resolution o f  6.6 mm (FWHM) at 
the centre and at a 30 cm radial distance from the FOV centre [77]. This result 
corresponds to a 39 % improvement over the current method.
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5.3.2 Sensitivity
The sensitivity values for the P5-Head scanner are reported in Table 5.5, and the 
corresponding data are plotted in Figure 5.13. The average sensitivity over both 
positions (centre FOV and 10 cm off-centre FOV) results in 21.0 ± 3.1 kcps/MBq, 
which corresponds to more than a 2-fold difference from the 4-Ring+ scanner.
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Figure 5.13. Trues count rate as a function o f sleeve thickness for the sensitivity 
estimation on the P5-Head scanner. The exponential model functions are indicated 
for the two positions.
Figure 5.14 shows the axial sensitivity profiles for all multi-ring scanners and the P5- 
Head. One measurement sample from the centre o f the FOV is displayed for each 
scanner for comparison. The sensitivities are plotted for each axial plane. The sum 
of all plane sensitivities for each scanner corresponds to the system sensitivities that 
were reported. It is interesting to note that the plane sensitivity for the 4-Ring+ 
scanner reaches the highest peak value o f about 171 cps/MBq, while the P5-Head 
reaches a maximum value o f about 148 cps/MBq. However, the important point is 
that, although the sensitivity peaks higher for the 4-Ring+ than the P5-Head, the 
sensitivity o f the 4-Ring+ scanner drops below 90 % o f the maximum value after 14 
central planes (161.5 ± 4.2 cps/MBq), while the P5-Head maintains more than 90%
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of the maximum value for 83 planes (144.0 ± 3.4 cps/MBq). These observations 
translate into an axial coverage o f about 28 mm for the 4-Ring+ and 166 mm for the 
P5-Head with a sensitivity that maintains more than 90 % of the maximum value.
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Figure 5.14. Illustration o f the axial sensitivity profiles for the 3-Ring, 4-Ring, 4- 
Ring+, and P5-Head in centre o f the FOV for comparison.
5.3.3 Scatter Fraction
The scatter fraction and NECR were estimated according to NEMA [70]. However, 
in addition to estimating the scatter fraction with linear interpolation, it was also 
computed with a polynomial fit from the sinogram data. The reason for this 
additional estimate was based on the effect that individual PMTs “see” incoming 
light from not just one but four crystal blocks in a quadrant sharing detector design. 
This cross-talk effect becomes more evident at high count rates since the uncertainty 
in locating incoming events increases. The resulting misplacement o f events causes 
the spatial distribution o f true events to be blurred. Therefore, the radial profile
6 8
through the activity distribution o f the line source inside the scatter phantom is 
broader for a panel based design than for a multi-ring scanner. The differences o f the 
profiles are schematically shown in Figure 5.15.
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Figure 5.15. Radial profiles through the activity distribution o f the line source inside 
the scatter phantom for a panel based and multi-ring scanner. The difference o f  
linear and polynomial interpolation o f the true and scatter counts are indicated.
In the NEMA protocol, trues and some scatter counts are assumed to lie within a 
central strip ± 2 cm from the peak centre. Scatter counts are assumed to lie below  
the peak (trues) within the central 4 cm wide strip and under the “tails”, outside the 
central strip. Figure 5.15 demonstrates that linear interpolation o f scatter counts 
within the central 4 cm strip seems to work well for profiles from multi-ring 
scanners. However, when applying the same linear interpolation for a profile from 
this panel based design, it appears that the separation between true and scatter counts 
lies too far into the peak. Therefore, scatter from this panel based design was 
overestimated when applying linear interpolation. Based on this observation, results 
for both linear and polynomial interpolation were obtained.
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Figure 5.16. SF o f the F5-Head as a function o f activity concentration, estimated 
according to NEMA with linear interpolation (# )  and with polynomial interpolation 
(■).
Figure 5.16 shows the scatter fraction results with a measured minimum value o f 43 
% and 46 % when estimating scatter with and without polynomial interpolation, 
respectively. A linear incline o f the scatter fraction with increasing activity 
concentration can be observed. This effect originates from pulse pile-up. When a 
photon hits a scintillator on the panel detector head four PMTs are triggered to 
process the detection o f this event. During this time, a total o f 9 adjacent detector 
blocks are “dead” and incoming photons cannot be processed. The photons in the 
scintillator lose energy by undergoing additional Compton scattering. When the 
detection system becomes active again, the “piled up” events are registered as 
scattered events due to the energy loss during the dead time. The same effects apply 
for multi-ring scanners. However, the results do not seem as predominant. In order 
to really compare the scatter behaviour on a multi-ring scanner with the P5-Head, a 
multi-ring with the same or similar axial extent as the P5-Head would have to be 
built and investigated.
In order to decrease the cross-talk effect, the size o f PMTs could be reduced. While 
this would in turn also contribute to a potential improvement in spatial resolution.
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this solution however implies an increase in the number o f PMTs. The optimal 
trade-off between the benefit o f cross-talk reduction and cost efficiency would have 
to be determined.
5.3.4 Noise Equivalent Count Rate
In Figure 5.17, the estimated NECRs o f the P5-Head scanner are plotted as a 
function o f activity concentration. It can be observed that the measured NECR with 
linear scatter interpolation ( • )  declines when reaching a peak o f 125 kcps at 9.5 
kBq/mL. For polynomial scatter estimation (■), a measured peak o f 178 kcps can be 
observed at 14 kBq/mL. Using a scatter fraction o f 43 % (see section 5.3.3) and the 
prompt and random events occurring at the coincidence processor (CP) level, the 
measured NECR (^ )  reaches a peak o f 215 kcps at 22 kBq/mL.
The declining effect occurring at 9.5 kBq/mL (linear scatter interpolation) and 14
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Figure 5.17. NECR curves o f  the P5-Head for smoothed randoms correction 
(NECIR) as a function o f activity concentration. The NECR was computed from 
acquired sinogram data using: linear ( • )  and polynomial (■) scatter interpolation. 
An NECR estimate with data from the coincidence processor (CP) (-^) was obtained 
using a scatter fraction o f 43 % from the polynomial scatter interpolation.
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kBq/mL (polynomial scatter interpolation) is caused by the limited data transmission 
rate o f the acquisition system, as shown in Figure 5.18. The total events (prompts + 
randoms) rate o f the acquisition system is plotted as a function o f the total events rate 
that was registered at the eoincidence proeessor (Figure 5 .ISA). Data loss at the 
acquisition system in excess o f  about 5 Meps can be observed, which corresponds to 
14 kBq/mL in this case (Figure 5.1 SB).
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Figure 5. IS. Total (prompts + randoms) events rate o f  the acquisition system (# )  as 
(A) a function o f the total events rate that is registered at the coincidence proeessor 
( A ) ,  (B) as a function o f activity concentration.
However, in a elinical environment such high activity concentrations are not 
exeeeded for ^^FDG, which on average are below 7 kBq/mL and correspond to less 
than 2 Meps. For example, for a 75 kg patient who is injected with a 370 MBq dose 
of ^^FDG the aetivity concentration results in 2.S kBq/mL after an uptake period o f  
90 minutes. We have demonstrated in first ^^FDG patient studies that clinical 
imaging is possible with the P5-Head scanner [62]. However, further investigation is 
necessary to improve image quality and requires but is not limited to optimising the 
conventional imaging protocol for ^^FDG (370 MBq with an uptake period o f 90 
minutes) to accommodate the high sensitivity scanner. The imaging with short-lived 
isotopes such as ^^ Rb (T1/2 = 76 seconds) would cause clinieal relevant count rate
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problems as high doses (>1.5 GBq, >40 mCi) are administered. For example, a 1.5 
GBq injected dose for the same 75 kg patient results in an activity concentration o f  
20 kBq/mL, which is beyond the point o f  data loss (14 kBq/mL). Therefore, the P5- 
Head may be dedicated to applications, where the injected dose is restricted due to 
body weight or ethical reasons, such as in infants or small children. The successful 
application o f the P5-Head scanner for imaging low doses in canines has been 
explored as part o f  this work and is presented in Chapter 9.
5.4 Conclusions
The performance o f  four PET scanners based on two different architectures, multi­
ring and panel, has been assessed. In particular, the increase in sensitivity with 
corresponding NECR improvement from the 3-Ring to the 4-Ring [64] and from the 
4-Ring to the 4-Ring+ [63] have been quantified. Clinically, this improvement 
should allow either reducing the injected dose or decreasing the scan time for 
comparable image quality. The experimental and clinical image qualities are both 
investigated later (Chapters 7 and 8 ) as part o f this work. A  method to compare the 
clinical performance o f the 3-Ring and 4-Ring scanner is demonstrated in the 
following chapter based on the NECR results obtained here.
The prototype panel detector PET scanner showed good performance within a 
clinical count rate environment for ^^FDG. However, limitations apply when high 
activity concentrations are in the FOV causing the data transmission rate o f the 
acquisition system to be exceeded. Such issues would arise when patients that are 
injected with high doses (>1.5 GBq) o f  short-lived isotopes, sueh as ^^ Rb (T1/2 = 76 
seconds), are imaged. Therefore, the P5-Head scanner with particularly high 
sensitivity may be dedicated to specific low dose applications, such as imaging 
infants, small children or animals.
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The development o f the P5-Head scanner was discontinued. Re-oceurring hardware 
issues, such as damaged PMTs, slip-ring and bearing problems during rotation could 
have been addressed. However, a market driven development along with the 
application limitation influenced the decision o f the company to no longer devote 
any resourees to the development o f the P5-Head. As shown in Figure 5.19A, the
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Figure 5.19. Shipments o f PET and PET/CT scanners for the US markets as 
recorded by the Nuclear Equipment Manufacturers Association (NEMA): (A) Yearly 
from 2002 to the second quarter o f 2009; (B) Quarterly from the first quarter o f  2008 
to the second quarter o f  2009.
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sales o f  PET-only scanners declined from 2002 onwards until 2006 when the demand 
for PET-only scanners was entirely replaced by combined PET/CT scanners. 
Throughout this period, the overall market for PET or PET/CT remained fairly 
constant. Since January 2007 the sales o f PET/CT scanners started to decline as a 
result o f  the Deficit Reduction Act [78], which aimed to reduce costs for Medicare 
and therefore reimbursement for medical devices. As shown in Figure 5.19B, the 
sales for the first two quarters o f 2008 were well below the sales for the same two 
quarters o f 2007. However, the market seemed to have recovered thereafter, based 
on the sales in the first two quarters o f 2009, which indicate increased sales 
compared to the first two quarters o f 2008.
Prior to the P5-Head seanner starting to malfunction and becoming in-operational, it 
was successfully employed in collaboration with the School o f Veterinary Medicine, 
University o f  Tennessee (Knoxville, USA). Two series o f canine studies were 
performed. The description o f the studies and the results are reported in Chapter 9.
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Chapter 6.
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6 "PATIENT NOISE EQUIVALENT COUNT 
RATES
Patient NECRs attempt to reflect the clinical NECR response corresponding to a 
specific patient scan as if  a full count rate curve had been acquired for that patient. 
Watson et al. [79, 80] demonstrated that count rate response in a human subject can 
be accurately estimated by scaling the true and random coincidence rates measured 
in a phantom to the corresponding data points for an individual patient. This method 
not only permits the injected dose to be optimised and the variation o f the data 
quality with patient weight to be assessed, but it also allows the clinical performance 
o f different PET systems to be compared. An example o f a patient NECR as a 
function o f injected dose is given in Figure 6.1. The response curves for each 
individual bed position are indicated. The horizontal red arrow indicates the bed 
position which corresponds to the head and neck. Due to this high response (based 
on accumulated activity in the brain), the head and neck was omitted from this
70 kg phantom 
21.5 kg phantom 
■Patients
1000 15000 500 2500
W . m
Injected Dose (MBq), 90 minutes uptake
Figure 6.1. Example o f a Patient Noise Equivalent Count Rate response as a 
function o f injected dose for 6  bed positions in a clinical ^^FDG oncology scan 
performed on the 4-Ring. Each vertical arrow on the x-ray projection image on the 
right indicates one bed position to which the indicated response curve on the left 
corresponds. The dashed lines indicate the response curve from two phantom scans. 
The horizontal red arrow indicates the bed position which corresponds to the head 
and neck.
Partial content of this Chapter has been published by the author et al. in [64].
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analysis. In this work, the clinical performance o f the 3-Ring and 4-Ring scanners 
was compared. The patient population and the procedure as to how the patient 
NECRs were estimated are described in the following.
6.1 Patient Population
The de-identified patient data were selected from prior routine clinical ^^FDG 
oncology studies and also from prior research studies approved by the University o f  
Tennessee Medical Center Institutional Review Board. A  total o f 24 patients (mean 
± standard deviation (SD): 81.7 ± 28.9 kg, range: 42 - 154 kg) were analyzed: 15 
patients on the 3-Ring scanner (84.1 ± 28.0 kg), 9 on the 4-Ring scanner (77.7 ± 3 1 .6  
kg); 5 o f those 24 patients were scanned on both systems during separate visits, up to 
22 months apart. A  complete list o f  the injected dose, uptake time, weight, and the 
time between scans is given in Table 6.1 for those 5 patients. It must be pointed out 
that there is less variation in injected doses and uptake times during the exams on the 
4-Ring than on the 3-Ring scanner. The improved training and increased experience 
o f the attending PET/CT technologists explain this decreased variation. Note that for 
one patient (patient 5) a weight loss o f  more than 13 % occurred. While the number 
o f bed positions for all patients that were scanned (thigh to eye) on the 3-Ring 
scanner averaged to 6.0 ±  0.5, the number o f  bed positions on the 4-Ring scanner 
averaged to 4.2 ± 0.4 bed positions. This is based on the extended axial coverage 
(per bed position) on the 4-Ring compared to the 3-Ring scanner (21.8 cm on the 4- 
Ring, 16.8 cm on the 3-Ring). In this analysis, the last bed position (usually 
corresponding to the head and neck) from each study was excluded, because it 
typically has a much higher NECR than the rest o f the body. Therefore, the total 
number o f bed positions for all analyzed patients was 90 for the 3-Ring and 38 for 
the 4-Ring system. For the 5 same patients, the total number o f bed positions 
resulted in 26 on the 3-Ring and 17 on the 4-Ring.
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Table 6.1. Patient information for the examinations on the 3-Ring and 4-Ring 
scanners.
3-Ring 4-Ring Months
Patient Dose Uptake Weight Dose Uptake Weight between
(MBq) (minutes) (kg) (MBq) (minutes) (kg) Scans
1 370.0 1 0 0 53.5 399.6 96 55.3 5
2 307.1 1 1 1 153.8 429.2 8 6 151.0 1 2
3 407.0 8 8 87.5 373.7 90 88.5 7
4 432.9 76 6 6 . 2 388.5 90 62.1 2 2
5 432.9 8 8 64.0 395.9 90 55.3 6
Mean 390.0 93 85.0 397.4 90 82.4 1 0
SD 53.0 13 40.4 20.4 4 40.7 7
Min 307.1 76 53.5 373.7 8 6 55.3 5
Max 432.9 1 1 1 153.8 429.2 96 151.0 2 2
SD: Standard deviation
6.2 Estimation of Patient Noise Equivalent Count Rates
In order to compute the NECR o f individual patients an accurate estimate o f  true, 
random and scatter counts is required. Considering unavoidable counting losses due 
to both pulse-processing at the detector (dead time and pulse pile-up) and to 
multiplexing o f  the data channels from the detectors to the coincidence processor, it 
has been shown [79] that the trues and randoms rates are object-independent 
functions o f the singles event rate s, which is monotonically related to the incident 
photon flux, or the activity present, over the clinical range. As part o f  the 
implementation o f  the single scatter simulation algorithm by Watson et al. [15] the 
SF, the random (R) and true (T) counts are reported for each individual bed position 
o f a patient. With this information, the clinical count rate modelling can be 
performed by scaling the observed patient count rates during a scan to the count rate 
curves measured on a phantom. For this purpose, the count rate data that were 
acquired to compute system NECRs for the 3-Ring and 4-Ring scanners (section 
5.2.4) were utilized and implemented into the patient noise equivalent count rate 
model using the following formulas:
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Patient NECR =
Tpafe„,(s)"
Tp.üe„t(s) + Sp.,i„,(s) + kRp,„„,(s) eq. 6 . 1
where :
Yq
'^patient ( )^ ~ Z phantom( )^
 ^phantom \^0 )
^patient ( )^ ~  % Z phantom ( )^
^phantom \^0 )
SFq
^patient ( )^ ~  0 7 7  '^phantom ( )^
1 -  b t g
where  ^is the singles rate and so corresponds to the observed singles rate in a patient. 
Tpatient(s), Rpatient(s) and Spatient(s) are the modelled true, random and scatter rates, 
respectively, as a function o f singles rate in a patient. To and Rq are the observed true 
and random rates, and SFq is the scatter fraction, respectively for a patient. 
Tphantom(so) and Rphantom(so) are the corresponding true and random rates within the 
scatter phantom (section 5.2.4) at an observed singles rate sq in a patient. For a 
continuous trues and randoms function o f the phantom’s singles rate, quadratic and 
cubic polynomial models were applied, respectively.
The actual activity (a) within the patient is not known due to variation o f  the spatial 
distribution. Furthermore, the uptake periods and scan durations can vary from 
patient to patient. Therefore, the count rate response is characterized as a function o f
injected ^^FDG dose D-^j and standardized to an equivalent effective dose ,
which would give the same initial total activity in the patient after a 90 minute uptake 
as the actual average activity present during the scan:
Dfnj i.s) = ----------------- p^hantom (§) Cq. 6 .2
p^hantom V^ O/
where aphantom is the activity inside the phantom that was used to model the patient 
data as a function o f the singles rate s  and as a function o f the observed singles rate sq 
within the patient.
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It must be pointed out that the effective dose does not account for any redistribution 
o f  activity that might occur between the actual and standard uptake periods, nor the 
effect o f partial excretion o f the dose prior to scanning.
Once the different functional forms are determined from the phantom measurements 
and scaled to patient data the clinical count rate response is expressed as a fiinction 
o f the singles rate. In order to obtain the clinical response functions as a function o f
injected dose, Tpa t i e n t i n j )   ^ ^patient inj )  ^patient (^inj )  evaluated by
numerically transposing (s j  to get s(D^^j )  and substituting.
6.3 Results and Discussion
The estimated patient NECIR (IR  indicates smoothed randoms correction) curves 
are shown in Figure 6.2 for the 3-Ring (A) and 4-Ring (B) scanners as a function o f  
injected dose, normalized to an uptake period o f 90 minutes. The NECIR results 
reported in Figure 5.12 were used to model the patient response. The two highest 
activity points for both the 3-Ring and 4-Ring scanners were not used because o f  
detector saturation. Each curve in Figure 6.2 corresponds to one bed position o f a 
patient study. There are a total o f  26 bed positions for the 3-Ring (A) and 17 bed 
positions for the 4-Ring (B). The head and neck area was omitted for each scan due 
to higher NECR. The + symbols indicate the actual scan points for each patient and 
bed position. It is noticeable that the NECIR curves peak at a higher maximum on 
the 4-Ring than on the 3-Ring scanner. The remarkable long, flat peaks o f  the 
NECIR curves suggest at least for long lived isotopes such as ^^ F (T1/2 = ~110 
minutes) to more efficiently utilize the injected dose and image patients at doses 
below the peak o f  the response curve. For example, a 57.6 ± 0.02 % (average over 
all 15 patients) reduction in dose from its peak value reduces the maximum SNR  
(SNRmax) by only 1 0  % for the 3-Ring. The same operational point (90 % SNRmax) 
permits dose to be reduced by 59.1 ± 0.03 % (average over all 9 patients) for the 4- 
Ring system. Therefore, the patient data from the 3-Ring and 4-Ring scanners were 
analyzed at an operational point o f  90 % SNRmax, which corresponds to 81 % o f the
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Figure 6.2. Patient NECIR eurves (IR  - smoothed randoms eorrection) as a function 
o f injected dose after 90 minutes uptake for 5 patients. The same 5 patients are 
plotted for both (A) the 3-Ring and (B) the 4-Ring scanner. Each curve corresponds 
to one bed position. The + symbols indicate the actual scan point. The * symbols 
indicate 90 % SNRmax (corresponding to 81 % o f the peak NECIR).
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peak NECIR, based on SNR = si NECK . In Figure 6.2, the operating point o f 90 % 
SNRmax is indicated by * symbols.
For each patient scan, the NECIR at 90 % SNRmax and the optimal dose at this 
operating point were determined. As a comparison, the NECIR at a 370 MBq dose 
was also computed, which is the injected standard dose at the University o f  
Tennessee Medical Center (Knoxville, Tennessee, USA). For each computed 
parameter (NECIR, dose as functions o f weight) in all succeeding plots, the results 
were averaged over the total acquired bed positions per patient with the standard 
deviation as an indication for uncertainty. The small sample size o f  five patients that 
were scanned on both scanners was first analyzed separately from all patient data 
(including the five matching patients) and afterwards, all patient data were analyzed 
together.
6.3.1 Five Matching Patients
The optimal NECIR (at 90 % SNRmax) as a function o f patient weight for the five 
matching patients is plotted in Figure 6.3. The relative patient NECIR performance 
difference between the 3-Ring and 4-Ring scanner decreases with increasing weight. 
While this decrease seems to be more rapid on the 4-Ring than on the 3-Ring scanner 
(3-Ring: 1.0 %/kg, 4-Ring: 1.4 %/kg), the regression model is dominated by the large 
patient (-151 kg) and therefore, this hypothesis is inconclusive. The average patient 
NECIR at 90 % SNRmax for a 70 kg patient is 58 % higher on the 4-Ring in 
comparison to the 3-Ring. This difference increases to 6 6  % for an injected dose o f  
370 MBq with a 90 minute uptake period (Figure 6.4). Figure 6.5 indicates that 
larger patients require increased dose to maintain an operating point o f 90 % SNRmax, 
which is about 2 MBq/kg for both scanners. The slightly higher dose for the 3-Ring 
than for the 4-Ring scanner is attributable to the greater sensitivity o f  the 4-Ring 
scanner. The large error bars indicate variation o f  the optimal dose for different body 
positions. For example, the optimal dose for the head and neck area is lower than for 
an abdominal or thoracic position.
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Figure 6.3. Average (over total number o f bed positions) patient NEClRs at 90 % 
SNRmax as a function o f patient weight for the five matching patients on the 3-Ring 
and 4-Ring scanner.
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Figure 6.4. Average (over total number o f bed positions) Patient NEClRs for a 370 
MBq injected dose as a function o f patient weight for the five matching patients on 
the 3-Ring and 4-Ring scanners.
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Figure 6.5. Estimated average (over total number o f bed positions) dose for 90 % 
SNRmax as a function o f patient weight for the five matching patients on the 3-Ring 
and 4-Ring scanners.
The individual count rate components and randoms/trues ratios at a 90 % SNRmax 
operating point are shown in Figure 6 . 6  for the five matching patients. The trues 
count rates are higher for the 4-Ring scanner but so are the randoms and scatter rates 
and therefore the randoms to trues ratios. The average patient scatter fraction on 
both scanners increases only moderately with weight. The error bars indicate 
different scatter fractions for different body positions within the scanner.
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6.3.2 All Patient Data
The results for all patient data, including the five matching patients, are presented in 
the succeeding plots and underline the trend for the five matching patients. Figure 
6.7 presents the NECIR at the 90 % SNRmax operating point and indicates an average 
decrease o f 1.4 ± 0.1 %/kg on both scanners. For a 70 kg patient, the average 
NECIR at 90 % SNRmax is 36 % higher on the 4-Ring in comparison to the 3-Ring 
and increases to 52 % for a 370 MBq injected dose after an uptake period o f 90 
minutes (Figure 6 .8 ).
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Figure 6.7. Average (over total number o f bed positions) patient NEClRs at 90 % 
SNRmax as a function o f patient weight for all patient data from the 3-Ring (15 
patients) and 4-Ring (9 patients) scanner.
A comparable dose increase o f 2 MBq/kg for a 90 % SNR with a similar variation 
for different body positions can be observed for all patients (Figure 6.9) and for both 
scanners.
The individual count rate components and randoms/trues ratios at a 90 % SNRmax 
operating point are plotted in Figure 6.10. The results for all patient data underline 
the results o f the five matching patients.
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Figure 6.10. Average (over total number o f bed positions) patient count rate data for all 
patient data from the 3-Ring (15 patients) and 4-Ring (9 patients) scanners.
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6.4 Conclusions
Patient NECRs were assessed quantitatively for patients that were scanned on the 3- 
Ring and 4-Ring scanner. A  small sample size o f  five patients was scanned on both 
scanners and therefore the results could be directly compared. Although, it must be 
pointed out that this direct comparison is limited as the patients were scanned up to 
2 2  months apart.
It has been shown that for both scanners the injected ^^FDG dose can be reduced by 
more than 55 % when choosing an operational point o f 90 % SNRmax, which 
corresponds to 81 % o f the maximum NECIR. Therefore, all data were analyzed for 
an operational point o f 90 % SNRmax-
Overall, it has been demonstrated that patient NEClRs on the 4-Ring are higher than 
on the 3-Ring scanner. In particular, the differences are more evident for an injected 
standard ^^FDG dose o f 370 MBq. However, it has also been shown that the patient 
NEClRs decrease with increasing body weight on both scanners, which is to be 
expected for additional body attenuation. In order to compensate for this effect, 
larger patients would either have to be scanned longer or injected with a greater dose. 
For example, a 120 kg patient would have to be scanned about 2 times longer than a 
70 kg patient in order to achieve an equivalent SNR on the same scanner, or the 
injected dose would have to be increased by about 100 MBq (about 2 MBq/kg 
increase o f the mean optimal ^^FDG dose).
Based on a greater sensitivity o f the 4-Ring in comparison to the 3-Ring system, the 
mean optimal injected ^^FDG dose is slightly higher for the 3-Ring than for the 4- 
Ring scanner. However, for both scanners a large variation o f the optimal dose is 
indicated for different body regions.
The mean scatter fraction for a 70 kg patient was found to be 32 ± 0 % for both 
scanners and increases by 15 ± 1 % for a 120 kg person. A  variation o f the SF for 
different body positions can also be observed and confirms the findings for the 
NEMA scatter phantom in section 5.2.3
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For both scanners, the trues rate decreases more rapidly than the randoms rate with 
increasing weight. This loss o f trues is the dominating factor for the degradation o f  
NECIR with patient weight and is subsequently an indicator for loss o f  image 
quality.
While this Chapter investigated a clinical impact o f PET instrumentation and 
performance advances, which were quantified in the previous Chapter, the following 
Chapter assesses a methodology to improve PET image quality.
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Chapter 7.
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7 'IMAGE QUALITY ANALYSIS WITH POINT 
SPREAD FUNCTION MODELLING
PET image quality is a complex function o f  scanner resolution and the statistical 
quality o f the acquired data. The limitation o f image quality in most studies depends 
on the signal-to-noise characteristics o f the data. While the PET signal is defined by 
the true coincidence counts, noise originates fi"om the combined Poisson statistics o f  
true, scatter and random coincidences. An improvement in image quality can be 
achieved by removing more o f the approximations in reconstruction algorithms. 
Incorporating recorded spatial response functions (detector PSFs) o f a system into 
image reconstruction implies an improvement o f the spatial resolution and 
uniformity throughout the FOV. This chapter assesses the performance o f a 
prototype version o f  the PSF reconstruction after introducing a method to optimise 
reconstruction parameters.
7.1 Optimisation of PSF Reconstruction for Lesion SNR
One way o f assessing the performance o f  a reconstruction algorithm is the ability to 
detect a signal in a noisy background, which corresponds to a lesion in a noisy 
background in cancer imaging. A  concept o f measuring signal-to-noise ratio (SNR) 
or lesion detectability is simplified in Figure 7.1. The differences between lesions 
(LI and L2) and the background are compared to the noise level in the background. 
For a large signal-to-noise ratio, the lesion is detectable (LI). If the signal-to-noise 
ratio is lower than the detection limit o f  the imaging system, the noise becomes 
predominant and the lesion might not be detectable (L2).
Partial content of this Chapter has been published by the author et al. in [64].
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Figure 7.1. A profile through a phantom with two hot lesions showing the 
parameters for a concept o f measuring lesion detectability.
From a general SNR definition, a measure o f  lesion SNR can be derived from Figure 
7.1 as:
SNR = S'Snal -  Background ^
B^ackground
Lesion
Lesion -  Background 
Noise eq. 7.1
where the signal is defined as the mean voxel value in a volume o f interest (VOX) 
inside the lesion, and the background is defined as the mean voxel value in a fairly 
uniform area in the background, and the noise in this formula is defined as the 
standard deviation (SD) o f the voxel value in the background VOL
In order to optimise reconstruction parameters for lesion SNR, the following 
phantom experiment was performed.
7.1.1 Methods
Source Preparation and Acquisition Protocol
The NEMA image quality phantom was used for this measurement. This torso 
shaped phantom (volume o f -1 0  L) contains 6  coaxial spheres with inner diameters
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of 10, 13, 17, 22, 28 and 37 mm to simulate different sized lesions. A cylindrical 
insert with a diameter o f 5 cm containing styrofoam pellets with an average density 
of 30 g/mL is positioned in the transverse centre to simulate lung tissue and provide a 
non-uniform attenuation distribution. A conceptual drawing o f the image quality 
phantom is shown in Figure 7.2.
cold m  background
Figure 7.2. Conceptual drawing o f the image quality phantom in the transverse view. 
The different sized spheres and the lung insert are shown.
The phantom was filled with a solution o f water and ^^ F containing an initial 
background activity concentration o f 5.3 kBq/mL ± 10 % ( at the start o f the scan) to 
simulate a typical injected patient dose o f 370 MBq in a 70 kg patient. The 4 
smallest spheres were filled with a sphere-to-background activity ratio o f 4:1. The 
remaining two largest spheres were “cold” and were filled with water. The phantom 
was positioned with the isocenter o f the spheres in the isocenter o f the PET FOV. 
Following a CT scan, PET data were acquired for 10 minutes on the 4-Ring scanner.
Reconstruction
Images were reconstructed using a standard algorithm (Siemens Molecular Imaging) 
used at University o f Tennessee Medical Center: FORE followed by 2D Attenuation-
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Weighted Ordered-Subset-Expectation-Maximisation (AW -0SEM 2D) [45, 46]. In 
addition, a prototype implementation o f the PSF 0P-0SE M 3D  algorithm was used 
[47]. For both algorithms, 1-6 iterations were selected with 14 subsets for the AW- 
0SEM 2D algorithm and 21 subsets for the PSF algorithm. No post-smoothing filter 
was applied for both reconstruction methods. The data were reconstructed in a 168 x 
168 matrix with a 4 mm transverse pixel size and 2 mm axial slice thickness.
Analysis
v o i s  were drawn on each sphere matching the size o f the inner diameters 
isometrically as shown in Figure 7.3. For the background, a cylindrical VOI was 
drawn (50 mm diameter x 100 mm length).
o
e
#  ® o
Figure 7.3. Reconstructed NEMA Image Quality phantom with the VOIs used for 
the signal-to-noise analysis (left: transverse view through the axial centre o f the 
spheres; right: coronal view through the plane indicated by the arrow on the left).
Prior to computation o f the SNR or detectability as defined in eq. 7.1, the following 
quantitative figures o f merit were calculated from the images as part o f the analysis.
Contrast is a measure o f the convergence o f  an iterative reconstruction algorithm and 
tends to increase and converge asymptotically towards a “true” value. Optimally, 
this is the input contrast, which is known a priori (in phantom experiments). The 
contrast was defined as:
_  . . Signal
Contrast = —  ---------   eq. 7.2
Background
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where the signal is defined as the mean voxel value o f the sphere VOIs, the 
background is the mean voxel value o f the background VOI.
The undesired effect o f  convergence is noise since the noise increases monotonically
with each iteration. The noise in this section was computed as percent noise o f the 
background, which is the background variability (BV):
Background Background eq. 7.3
where gb is the SD o f  the mean voxel value inside the background VOI, the
background is the mean voxel value o f the background VOI.
The noise in the image here is expressed as a percentage o f the background, which is 
also referred to as background variability.
7.1.2 Results and Discussion
Figure 7.4 shows the computed contrast values for the different sized “hot” spheres 
reconstructed with both the standard AW -0SEM 2D and the prototype PSF 
algorithms as a function o f  background variability. Each data point corresponds to 
one iteration starting with one on the left. For all spheres, the mean VOI values seem  
to increase asymptotically towards a final value for each iteration. At the same time, 
the background variability increases. Optimally, the final value corresponds to the 
initial sphere-to-background ratio, which was 4:1 for this experiment. However, 
since the VOIs were drawn the same size as the physical size o f the glass spheres and 
therefore included “cold” pixels the mean VOI value is below 4. For both the AW- 
OSEM and the PSF reconstruction algorithms, it can be observed that the larger 
spheres approach a final value in fewer iterations than the smaller spheres. This 
behaviour demonstrates the effect o f limitation in spatial resolution and the pixel size 
o f 4 mm, which is used to reconstruct most clinical studies.
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Figure 7.4. The contrast values as a function o f background variability for the 
different sized spheres. Each data point corresponds to one iteration (left to right: 1 
to 6 ). Error bars are indicated for the smallest spheres.
In order to find the optimised reconstruction parameters for maximized SNR or 
detectability, Figure 7.5 shows the SNR as a function o f iteration number. For the 
same size spheres, SNR is higher for PSF reconstruction than for the AW-OSEM  
algorithm. The decreasing SNR for the larger spheres is an effect o f image 
convergence. Larger structures converge faster to their final image while the noise 
continues to increase, and therefore SNR decreases. Smaller structures take longer to 
converge to their final image. In Figure 7.5, it can be observed that the SNR 
decreases for the larger spheres with PSF reconstruction and for all spheres with the 
AW-OSEM algorithm. The SNR for the 10 and 13 mm spheres reaches a maximum 
with PSF reconstruction after 3 iterations. If the maximum SNR value for the 
smallest sphere was to be found with the AW-OSEM algorithm, the number o f  
subsets would have to be reduced for this method in order to lower the noise for the 
benefit o f increasing SNR. In this experiment, the number o f subsets for the AW- 
OSEM algorithm was increased in order to bring the higher noise level o f the AW-
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OSEM algorithm in line with the PSF algorithm for comparison. However, three 
iterations and 8 subsets with a 5 mm Gaussian post-smoothing filter were obtained as 
optimal lesion SNR parameters for the AW-OSEM algorithm.
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Figure 7.5. SNR values as a function o f iteration for the different sized spheres. 
Error bars are indicated for the smallest spheres.
7.1.3 Conclusions
In order to find reconstruction parameters with optimised lesion SNR for the PSF 
algorithm, image SNR, contrast and noise were defined as figures o f merit.
The number o f iterations for the prototype PSF algorithm with the highest lesion 
SNR for small lesions (<  13) in this experiment was three. Therefore, these 
parameters (3 iterations, 21 subsets) were used in the following phantom experiment.
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7.2 Experimental Image Quality
There are several ways o f assessing image quality in PET, while the term image 
quality remains poorly defined. However, in order to assess and compare image 
quality o f different scanners, standard phantom measurements can be performed. For 
the multi-ring scanners, a similar method to that given in [70] was followed. This 
procedure attempts to experimentally simulate a whole-body study in a clinical 
environment. To assess the performance o f  the PSF algorithm, the following 
experiment was performed on the 3-Ring and 4-Ring scanners.
7.2.1 Methods
Source Preparation and Acquisition Protocol
The same image quality phantom that was used for optimising the reconstruction 
parameters was filled with a solution o f  water and 18F, also containing an initial 
background activity concentration o f B = 5.3 kBq/mL ± 1 0  %. In addition to the 4:1 
sphere-to-background ratio, the phantom was filled with 8:1 sphere-to-background 
ratio in a second measurement. In order to minimize the phantom filling error and 
make the method reproducible, the initial activity was mixed into the total volume o f  
the hot spheres (10 to 22 mm IDs) plus the volume o f the background divided by the 
hot sphere-to-background ratio. First, the hot spheres were filled fi-om this mixture, 
followed by the background, which was then filled entirely with water.
A  second phantom, the 70 cm long NEMA scatter phantom, which was used to 
acquire the count rate data (section 5.1.3), was positioned axially behind the image 
quality phantom as shown in Figure 7.6. The purpose o f  this phantom was to 
simulate activity fi-om outside the FOV, as found in a real patient situation. The 
initial activity in the line source simulated a typical background o f  about 116 MBq ±  
10 % o f ^^ F for both acquisitions on both scanners. Following a CT scan, the 
isocenter o f  the spheres was positioned in the isocentre o f the PET FOV.
1 0 0
Centre of axial FOV
70 cm
Lung insert Scatter phantom
Line source
Patient table
B
Image Quality phantom
Scatter phantom
Patient table
Lme source
Figure 7.6. Setup for the image quality measurement: (A) Drawing o f  both the 
NEMA image quality (left) and scatter (right) phantoms. (B) Photograph o f the 
phantom setup on the patient table outside the PET/CT scanner.
The acquisition protocol was based on simulating a whole body scan (emission and 
transmission) o f 100 cm axial imaging distance in 60 minutes. Because the 
transmission scan was performed with the CT scanner its contribution to the total 
imaging time was negligible. The imaging times AT for the 3-Ring and 4-Ring 
scanners were computed according to:
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AT = — A<5? eq. 7.4
D  ^
where T is the total imaging time (60 minutes), D  the total imaging distance (100 cm) 
and M  the effective axial scanning distance (imaging planes without overlap planes) 
between consecutive bed positions. The acquisition times were determined by 
considering the values listed in Table 7.1.
The 3-Ring image comprised total prompts o f 73 x 10  ^ with 16 x 10  ^ delayed 
randoms. The 4-Ring image comprised 146 x 10  ^ prompts with 40 x 10  ^ delayed 
random counts.
Table 7.1. Parameters for Computation o f the Imaging Times for the Experimental 
Image Quality Measurement.
Parameter 3-Ring 4-Ring
Imaging planes 81 109
Overlap planes 23 35
Plane spacing (mm) 2 2
Effective axial imaging distance (mm) 116 148
Imaging time (seconds) 418 533
Reconstruction
All data were corrected for random coincidences (smoothed randoms correction), 
normalisation, dead time losses, scatter [81, 82] and attenuation. The data from both 
systems were reconstructed with the AW -0SEM 2D algorithm [45, 46] with 3 
iterations, 8 subsets and a 5 mm (FWHM) Gaussian post-smoothing filter (axial and 
transaxial). For the 4-Ring system, the PSF 0P-0SE M 3D  reconstruction algorithm 
[47] was performed in addition to AW -0SEM 2D with 3 iterations, 21 subsets and no 
post-smoothing filter. The data were reconstructed in a 168 x 168 matrix with a 4 
mm pixel size and 2 mm axial slice thickness.
Data Analysis
For all reconstructed images, circular regions-of-interest (ROls) were drawn on each 
o f the six spheres in the central axial slice. The diameter o f  the ROls matched the 
size o f the inner diameters o f the spheres. Each ROl was then reproduced at 12
1 0 2
background locations, with each size ROI concentric to each other resulting in a total 
o f 60 ROls. The background ROls were reproduced on the axial slices ±  1 cm and ±  
2 cm adjacent to the central slice. The ROls were positioned at the same locations 
for all images.
From the ROls, the percent contrast recovery values were computed for all spheres 
(hot and cold) to measure the contrast that was recovered from the known sphere-to- 
background activity ratios:
^ - 1
Contrast Recovery^ot (%) =  x 100% eq 7 5
^ - 1
As
B — S
Contrast Recovery^ i^d (%) = ^ x 100% eq. 7.6
where S and B are the average counts o f the pixels inside the sphere and background 
ROls, respectively, in the PET image As and Ag are the known activity 
concentrations in the spheres and background, respectively, as determined externally.
In order to assess the noise in the images relative to the background, the background 
variability was computed according to equation eq. 7.3).
For all reconstructed images, circular ROls were also drawn inside the lung insert in 
order to asses the scatter and attenuation correction performance. Only the axial 
planes within +/- 2 cm from the isocentre o f  the spheres (0 cm) were included. The 
percent residual signal inside the lung relative to the background was computed 
according to:
g
^ I m g  (%) = X100% eq. 7.7
where Simg and B are the average counts o f the pixels inside the lung and 
background ROls, respectively.
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7.2.2 Results
The reconstructions o f the transverse section through the axial centre o f the spheres 
within the image quality phantom are shown in Figure 7.7 for sphere-to-background 
ratios o f both 4:1 and 8:1. A visual inspection confirms an increased sphere-to- 
background contrast for the 8:1 ratio compared to the 4:1 ratio as one would expect. 
In order to quantify the effect o f the PSF algorithm, horizontal profiles were drawn 
through the central section o f the phantom images from the 4-Ring acquisition as 
indicated in Figure 7.7. The results o f the profiles in Figure 7.8 show increased peak 
values for the PSF algorithm implying improved contrast.
4-Ring3-Ring
AW-OSEM2D PSFOP-OSEM3D
Figure 7.7. Transverse images o f the reconstructed image quality phantom on both 
the 3-Ring and 4-Ring system, for a sphere-to-background ratio o f 4:1 (top row) and 
8:1 (bottom row). The images are the transverse section through the axial centre o f  
the spheres with the lung insert in the middle for (left) 3-Ring and (middle, right) 4- 
Ring reconstructed with: (left, middle) AW -0SEM 2D, 3 iterations, 8 subsets, 5 mm 
Gaussian filter; (right) PSF 0P-0SEM 3D , 3 iterations, 21 subsets, no smoothing 
filter. (Note the spheres in the 4-Ring image series are rotated anti-clockwise in 
reference to the position in the 3-Ring image series).
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Figure 7.8. Plot o f the profiles through the transverse phantom images o f the 4-Ring 
scanner in Figure 7.7 comparing the results o f the AW -0SEM 2D and PSF OP- 
OSEM3D algorithms. The 10 and 17 mm spheres and lung insert are indicated.
The contrast recovery and background variability values are reported in Table 7.2 for 
both the 4:1 and 8:1 sphere-to-background ratios. Both the contrast and background 
variability results fall into ± 10 % o f experimental repetitive measurements. 
Comparing the 4-Ring to the 3-Ring for hot (10 mm to 22 mm spheres) and cold (28 
mm and 37 mm spheres) contrast recovery, the results for the same algorithms (AW- 
0SEM 2D) and for both sphere-to-background ratios are comparable within the 
experimental error o f ± 10 %. Figure 7.9 illustrates this comparison for the hot 
spheres. The PSF 0P-0SEM 3D  algorithm on the 4-Ring scanner however increases 
both the hot and cold contrast recovery, up to a factor o f 2 for the 10 mm sphere. 
The results obtained for background variability are similar for both scanners when 
comparing the same reconstruction algorithms.
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Table 7.2. Percentage contrast recovery, background variability, and average lung 
residual for 4:1 and 8:1 sphere-to-background ratios
Sphere
size
Contrast Recovery (%) Background Variability (%)
non-PSF PSF non-PSF PSF
3-Ring 4-Ring 4-Ring 3-Ring 4-Ring 4-Ring
4:1 Sphere--to-Background Ratio
10 mm 24 27 48 4.2 4.5 7.1
13 mm 37 37 71 4.0 3.9 6.1
17 mm 54 62 87 3.8 3.5 5.2
22 mm 67 75 90 3.4 3.1 4.4
28 mm 56 60 69 3.2 2.7 3.6
37 mm 63 60 70 2.9 2.3 2.8
Lung residual (mean ±  SD (%)) 25.9 ± 0 .8 26.9 ± 1 .4 17.7 ± 0 .9
8:1 Sphere--to-Background Ratio
10 mm 31 30 63 4.9 4.6 6.2
13 mm 46 47 84 4.4 4.3 5.4
17 mm 60 67 94 3.9 3.9 4.5
22 mm 74 75 93 3.4 3.5 3.6
28 mm 56 59 67 3.0 3.1 3.0
37 mm 64 62 74 2.7 2.7 2.8
Lung residual (mean ±  SD (%)) 25.4 ± 1 .5 25.7 ± 2 .9 16.7 ± 1.6
The 28 and 37 mm spheres are filled with water.
non-PSF: AW -0SEM 2D, 3 iterations, 8 subsets, 5 mm Gaussian filter.
PSF: PSF 0P-0SEM 3D , 3 iterations, 21 subsets, no filter.
SD: Standard deviation
Figure 7.10 shows the contrast recovery for the 13 mm sphere as a function o f  
background variability for the PSF 0P-0SE M 3D  and AW -0SEM 2D algorithms, 
with different numbers o f iterations (14 subsets for both), on the 4-Ring. At a similar 
contrast recovery level, the background variability is lower for the PSF OP- 
0SEM 3D reconstruction by a factor o f  about 1.5. In other words, for similar 
background variability, the contrast is higher for PSF 0P-0SEM 3D .
106
3-Ring (non-PSF) ■ 4-Ring (non-PSF) ■ 4-Ring (PSF)
>o0
1o
U
10 mm 13 mm 17 mm
Sphere size
22 mm
Figure 7.9. Contrast recovery o f the hot spheres for a spheres-to-background ratio 
o f 4:1 on the 3-Ring and 4-Ring scanners for non-PSF (AW -0SEM 2D) and PSF 
(0P-0SEM 3D ).
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Figure 7.10. Contrast recovery as a function o f background variability for the 13 mm 
sphere on the 4-Ring. The data set for a sphere-to-background ratio o f 4:1 was 
reconstructed with non-PSF (AW -0SEM 2D (■)) and PSF (PSF 0P-0SE M 3D  ( A) )  
using 1-6 iterations and 14 subsets. Each data point corresponds to one iteration 
starting with iteration 1 on the left.
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The average count residuals in the lung region, which are interpreted as the 
attenuation and scatter correction errors, for both contrast ratios are also listed in 
Table 7.2. While the average residual is similar for the two scanners for the same 
reconstruction algorithm and the same sphere-to-background ratios within 
uncertainties, the average residual improves with PSF 0P-0SE M 3D  reconstruction. 
Recall that the active region o f the phantom was limited to the axial planes where the 
spheres were located. Therefore, the mean values o f the residual counts in the lung 
over the axial planes (-2, -1, 0, +1, +2 cm) ± 2 cm from the axial isocentre (0 cm) o f  
the spheres were reported (Table 7.2).
7.2.3 Discussion
The overall highest image contrast recovery values were achieved with PSF OP- 
0SEM 3D reconstruction for the 4-Ring scanner. For the same contrast recovery, the 
PSF 0P-0SE M 3D  algorithm achieved decreased background variability compared to 
AW -0SEM 2D (Figure 7.10). As demonstrated by Panin et al. [47] the incorporation 
o f the PSF system model into image reconstruction results in a more uniform spatial 
resolution throughout the FOV. This improvement in spatial resolution leads to an 
increase in image contrast, which is what was shown here.
It is noteworthy to point out that the acquisition times for this image quality 
measurement was based on the same total whole body scan time (60 min per 100 cm  
axial extent) as recommended by the NEMA NU  2-2007 standard. Therefore, the 
increased counts from the 4-Ring acquisition (about a factor o f  2) contributed to 
lower background variability when comparing the same contrast recovery values 
(Figure 7.10). To acquire the same counts on both scanners, the sensitivity increase 
o f a factor o f 1.78 on the 4-Ring in comparison to the 3-Ring would allow a 
reduction o f either scan time or dose by 44 %. A 4  minute acquisition per bed 
position on the 3-Ring corresponds to about 2 minutes per bed position on the 4-Ring 
for comparable count statistics.
While hot sphere-to-background ratios o f  8:1 and 4:1 are acceptable values for a 
visual inspection o f images, more realistic ratios could be applied as they appear in a
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clinical environment. Lesions in the lung or liver for example can reflect a lesion-to- 
background ratio o f 3:1 and less.
It also needs to be pointed that the total volume o f both the NEMA image quality and 
scatter phantom equal about 30 kg, which is more representative for a child rather 
than an adolescent. However, i f  comparative measurements are to be performed on 
different systems, it is more practical to keep the phantom as light as possible.
7.2.4 Conclusions
An experimental method to optimise lesion SNR for the PSF algorithm was 
introduced and figures o f  merit to compute image SNR, contrast and noise have been 
defined.
The experimental image quality assessment o f the 4-Ring and 3-Ring scanners 
demonstrated that the contrast recovery for the same non-PSF standard algorithms 
(AW -0SEM 2D) is comparable within experimental uncertainties. An improved 
contrast recovery was achieved when the PSF algorithm was applied on the 4-Ring 
scanner.
Experimental phantom studies are advantageous in assessing the performance o f  
reconstruction algorithms for a known imaging situation in a reproducible manner. 
However, it is the objective to use the algorithms in a clinical environment. 
Therefore, it is important to evaluate reconstruction performance clinically. Such a 
clinical investigation o f the PSF algorithm is performed in the following chapter, 
where TOF is investigated to further improve image quality.
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Chapter 8.
1 1 0
8 “PHYSICAL AND CLINICAL ASSESSMENT OF 
TIME OF FLIGHT
While PSF modelling improves the spatial resolution uniformity throughout the 
FOV, TOF information about the photons o f the positron annihilation process 
implies an improvement in image SNR [48,49]. It must be recalled that the expected
gain in SNR due to TOF can be estimated from the expression V 5 7 A x  , where D is 
the diameter o f the positron-emitting distribution and Ax the spatial uncertainty, 
which is a function o f the system time resolution (A t )  in the form: Ax = c A t /2  , 
where c is the speed o f light. Thus, for a 40 cm diameter uniform distribution o f  
radioactivity and a timing resolution o f  600 ps, the SNR improvement is a factor o f  
2.1. The gain is greater for larger diameter distributions (bigger values o f  D), 
implying that in clinical practice the benefits o f  TOF will be more evident for larger 
patients than smaller ones. In an effort to verify this assumption and assess the 
clinical impact o f TOF, the performance SNR was estimated for some challenging 
imaging conditions o f the NEMA image quality phantom without and with TOF. 
These experimental studies helped to define the appropriate reconstruction 
parameters that would result in the optimal image. A  series o f 103 cancer patients 
was acquired on the 4-Ring PET/CT scanner with TOF capability and the studies 
reconstructed both without and with the timing information. Image quality was 
assessed subjectively by two nuclear medicine physicians, who reviewed all studies 
without knowing which o f the pair o f images for each patient was reconstructed with 
TOF. Quantitative analysis was performed by estimating SNR as a function o f the 
number o f iterations in the reconstruction, and contrast as a function o f  noise for 
different numbers o f  iterations. The SNR gain due to TOF was measured for 
tumours in the abdomen, lungs, and head and neck, and the gain was evaluated as a 
function o f  body mass index (BMI) for each body region. Based on the clinical 
results, the impact o f  TOF on large patients was studied in a separate section. In a
 ^Partial content of this Chapter has been published by the author et al. in [83].
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final investigation, the effect o f TOF for lower injected doses was explored with 
clinical patients.
Prior to investigating the clinical impact o f TOF on the 4-Ring system, the stability 
o f the TOF performance was assessed with the following experiment.
8.1 Time, Energy and Spatial Resolution Stability for TOF 
Imaging
PET scanners can be exposed to a wide range o f count rate conditions based on the 
imaging isotope, the amount o f the administered dose and the size o f the patient or 
object. As a result, significant and unavoidable counting losses may be experienced 
due to both pulse-processing o f  the detectors (dead time and pile-up) and to 
multiplexing o f the data channels firom the detectors to the coincidence processor. 
While it has been shown that energy and spatial resolutions can be affected by pulse 
pile-up at high count rates [84], there is a potential impact on time resolution. 
Because time resolution is used in TOF reconstruction, it is important to characterize 
the time resolution o f TOF PET scanners as a function o f count rate. For this 
purpose, the following experiment was performed in order to assess the stability o f  
time, energy and spatial resolutions on the 4-Ring scanner with TOF capability under 
different count rate conditions.
8.1.1 Methods
Source Preparation and Acquisition Protocol
A 40 cm long plastic line source with an inner diameter o f 1.1 mm was filled with 
370 MBq ±  10 % o f ^^ F (at start o f  acquisition) mixed in water and suspended axially 
in the radial centre o f the FOV. Data were acquired in list mode for several half- 
lives and rebinned into 40 frames, each 5 minutes long and separated from the 
previous by a 30 minute delay to obtain 4 frames per half-life.
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D ata Analysis -  Time Resolution
From the list mode data, the time resolution was extracted by combining all prompt 
coincidence events in the 435-650 keV energy window from all crystals in a system 
TOF spectrum. The random events, which were acquired separately, were then 
subtracted from the spectrum and a Gaussian fit was applied o f the resulting true 
timing peaks, for each count rate frame.
D ata Analysis -  Energy Resolution
The energy resolution was computed by extracting a system energy spectrum that 
combined single photon detection o f all 32,448 crystals in the scanner, and 
performing a Gaussian fit on the 511 keV peak, for each count rate frame.
D ata Analysis -  Spatial Resolution
The spatial resolution was computed from line-spread-frinctions (LSFs) by obtaining 
mean transverse profiles over 10 transverse planes (defined as the mean profiles o f  
the FWHM in the horizontal and vertical direction through the reconstructed line 
source). For this purpose, images for each frame were reconstructed using FORE 
and filtered backprojection with a voxel size o f  2 mm. Reconstruction was 
performed without attenuation and scatter corrections, and no post-smoothing filter 
was applied.
8.1.2 Results and Discussion
Table 8.1. Results for energy, time, and spatial resolutions as a function o f singles 
count rate (up to 55 Mcps) o f the 4-Ring scanner.
Parameter
Mean ± SD 
(FWHM) R^
Slope
Max. deviation 
from mean
Time Resolution 
0-55 Mcps (singles) 527.5 ± 4.9 ps 1 30% 2%
Energy Resolution 
3.7-55 Mcps (singles) 11.5 ± 0 .2 % 0.9 1 % 3%
Spatial Resolution (line source) 
0-55 Mcps (singles) 4.1 ± 0.0 mm 0.4 0.1 % 2%
SD: Standard deviation
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The mean time, energy and spatial resolution results for total singles count rates up to 
55 Mcps on the 4-Ring scanner are listed in Table 8.1. Figure 8.1 shows the time 
(A), energy (B) and spatial (C) resolutions as a function o f total singles count rates. 
All data are fitted by linear regression. For all plots, the typical clinical oncology 
count rate o f 7-15 Mcps for ^^FDG on the 4-Ring scanner is indicated in grey.
The results indicate stable time, energy and spatial resolutions for a singles count rate 
of up to 55 Mcps if  the maximum deviations from the mean with up to 3 % are
A 550
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535
y = 0.3x+  524
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Figure 8.1. Time (A), Energy (B), and Spatial (C) resolutions (FWHMs) as a 
function o f singles count rate o f 1.1-55 Mcps for a '^F-water filled line source, 
correlated with a linear regression. The grey shaded areas indicate the clinical 
scanning range (7-15 Mcps) based on a 370 MBq ± 10 % (10 mCi 4  10% ) injected 
^^FDG dose and a 90 minute uptake period.
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considered. While linear regression fits well for time and energy resolutions (R  ^
values o f  1 and 0.9, respectively), the spatial resolution seems to be more variable 
(R  ^ value o f 0.4), as shown in Figure 8.1. However, the spatial resolution varies 
within insignificant decimals, which dominates the linear regression causing a low  
R  ^value. The mean spatial resolution o f 4.1 ±  0.0 mm matches the transverse value 
obtained from the performance assessments (Table 5.4).
8.1.3 Conclusions
The stability o f time, energy and spatial resolution over a wide range o f singles count 
rate in excess o f the clinical range imply good conditions for TOF measurements. 
After finding TOF reconstruction parameters optimised for SNR, the potential 
benefit o f TOF will be explored experimentally and clinically in the following 
sections.
8.2 Optimisation of TOF Reconstruction for Lesion SNR
8.2.1 Methods
The same phantom study was performed as for the PSF reconstruction optimisation 
(see section 7.1) in order to assess how many iterations are required (using 14 
subsets) to optimise lesion SNR. The results o f  this study were later confirmed with 
real lesions identified in patient images. The NEMA image quality phantom was 
filled with ^^ F mixed in water. The four smaller spheres (inner diameters o f  10, 13, 
17, and 22 mm) were filled with a sphere-to-background ratio o f 8:1. The two 
largest spheres, 28 mm and 37 mm, were filled with water. The central lung insert 
was left with no activity. The total activity in the FOV was about 37 MBq ± 10 % (1 
mCi ± 1 0  %). A 30 minute list mode scan was acquired that comprised 461 x 10  ^
prompt counts and 63 x 10  ^ randoms. Data reconstruction was performed using a 
conventional version o f the PSF 0P-0SEM 3D  algorithm without TOF (referred to as 
non-TOF in the following) and with TOF (referred to as TOF in the following) 
implementation. For both methods, 14 subsets were used and the results o f  up to 8 
iterations were analyzed. The image matrix size was 168 x 168 x 109 voxels, and no
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post-smoothing filter was applied for both algorithms. SNR (eq. 7.1), contrast (eq. 
7.2) and percent noise/background variability (eq. 7.3) were studied as a function o f  
iteration number for the 10, 13, and 17 mm spheres (i.e. spheres smaller than 2 cm).
In order to compare noise levels between PSF without and with TOF the number o f  
subsets was matched for both algorithms and differs from the number previously 
assessed for optimised SNR (section 7.1).
8.2.2 Results and Discussion
The SNR variation for lesions o f sizes less than 2 cm was studied and the results are 
shown in Figure 8.2, where lesion SNR is plotted as a function o f iteration number. 
The maximum SNR was reached earlier for the larger spheres, because larger 
structures converge quickly while noise continues to increase. The smaller structures
-A --TOF - 17 mm -A -- nonTOF - 17 mm
-TOF - 13 mm -B - - nonTOF - 10 mm
-T O F - 10 mm —©-- nonTOF - 13 mm
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Figure 8.2. Lesion SNR as a function o f number o f iterations, for TOF and non- 
TOF. Results for the 10 mm, 13 mm and 17 mm diameter spheres are plotted.
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take longer to reach a value consistent v i^th convergence. In fact, as mentioned 
before, the choice o f iteration number should ideally be matched to the statistics o f  
the data and diagnostic task, and theoretically each small lesion in each patient has a 
different optimal number o f iterations, although this cannot be implemented 
clinically. The iteration number that maximized lesion SNR for the smallest (10 
mm) sphere was selected as a practical standard for all reconstructions. As can be 
seen in Figure 8.2, the maximum SNR for the 10 mm sphere using non-TOF 
reconstruction occurred at iteration 4. When TOF is used, the maximum occurred at 
iteration 2.
In Table 8.2, the contrast and noise are listed as a function o f iteration number for the 
10 mm, 13 mm, and 17 mm spheres, for non-TOF and TOF reconstruction. It can be 
observed that for a given iteration number, both contrast and noise level are higher 
for TOF compared with non-TOF, a consequence o f  the faster convergence o f  TOF 
reconstruction. When the optimal number o f iterations for lesion SNR is selected, a 
similar value for contrast is reached with the two methods within an experimental 
error o f ±  10 %. For example, the 10 mm sphere had a measured contrast o f 4.4:1 for 
4 iterations non-TOF and 4.3:1 for 2 iterations TOF, whereas the noise level was 
lower in TOF reconstruction: the non-TOF image at iteration 4 shows a background
Table 8.2. Contrast and background variability for each iteration.
Iter.
Contrast
10 mm 13 mm 17 mm
BV
nonTOF TOF nonTOF TOF nonTOF TOF nonTOF TOF
1 1.9 3.0 2.8 3.9 3.8 5.2 2.5 2.1
2 2.9 [ 4 .3 / 4.2 1 i 3 5.5 [ 6 2 3.4 ["3.3
3 3.8 5iÔ 5.1 5.8 6.1 " 63; 4.2 4.4
4 5.3 5.6 ' 6.0 } 6.4 6.6 [ " 5 . 0 " 5.4
5 4.8 5.6 5.8' 6.1 6.6 6.7 5.8 6.3
6 5.1 5.8 6.0 6.2 6.7 6.8 6.5 7.1
7 5.3 5.9 6.2 6.3 6.7 6.8 7.2 7.8
8 5.4 6.0 6.3 6.3 6.8 6.9 7.9 8.6
BV: Background variability (equivalent to percent noise).
Iter.: Iteration
Schaded cells correspond to optimal iter, number for a given reconstruction method.
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variability o f 5.0 % while the TOF image at 2 iterations shows a background noise o f
3.3 %. The cells o f  the table that are shaded correspond to the optimal iteration 
number for a given reconstruction method.
8.2.3 Conclusions
For iterative reconstruction algorithms, it is well known that a trade-off has to be 
found between image contrast and noise. It is arbitrary to choose an iteration number 
or stopping criterion since it depends on the acceptable level o f noise. For this work, 
the image SNR was the chosen parameter to be optimised. As a result, it was found 
that two iterations were required for the PSF 0P-0SE M 3D  algorithm with TOF and 
4 iterations without TOF in order to achieve this criterion for lesions smaller than 2 
cm. This is to be expected owing to the faster convergence o f the reconstruction 
algorithm with TOF, which in turn is an effect o f  the better localisation o f the 
annihilation events when TOF information is used.
8.3 The Ability of TOF to Recover Low Input Contrast
The NEMA standard requires the assessment o f  the image quality o f  a PET scanner 
using phantoms with high contrast o f 4:1 and 8:1. Clinical practice has to face more 
challenging situations o f  lower contrast. Therefore, the following experiment was 
carried out.
8.3.1 Methods
In this experiment, the same image quality phantom described previously was used 
with all six spheres filled with a ^^F-water solution resulting in a 2:1 sphere-to- 
background ratio. The central lung insert was left with no activity. A one hour list 
mode scan was performed acquiring 623 x 106 prompt counts and 72 x 106 delayed 
randoms on the 4-Ring scanner. The first five minutes o f  data were extracted from 
the list mode file in order to have also a low statistics sample. The purpose o f  this 
study was to assess the recovery o f small lesions (< 2cm) when lesion-to-background 
contrast was very low (2:1). Data were reconstructed for several iterations (14
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subsets) with non-TOF and TOF in a 168 x 168 matrix with 4 mm pixels, and with a 
high resolution mode, 336 x 336 matrix with 2 mm pixels. No post-smoothing filter 
was applied to any o f the reconstruction methods.
8.3.2 Results and Discussion
The 2:1 image quality phantom was used to evaluate the small lesion detection 
capability o f the TOF PET scanner in two different conditions: high statistics, low  
noise, medium spatial resolution; and low statistics, high noise, high spatial 
resolution situation.
It should be recalled that the former situation corresponded to a one hour scan 
duration, reconstructed into an image matrix o f 168 x 168 (4 mm pixels); the latter 
situation corresponded to a five minute scan duration, reconstructed into a 336 x 336 
matrix (2 mm pixel size). In Figure 8.3, a central slice passing through the hot 
spheres is shown, for the high statistics scan: one can compare the first 5 iterations o f  
non-TOF and TOF reconstructions, 168 x 168 pixels. Even though the high count 
statistics present in the one hour scan are not realistic o f a typical oncology study, 
they nevertheless allow a clear assessment o f the superior imaging performance o f  
TOF reconstruction in terms o f lesion visualisation. O f the six hot spheres, the 
smallest (10 mm) sphere cannot be identified over the noise in any o f the five non-
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Figure 8.3. Reconstructed images o f the high statistics (1 hour scan) image quality 
phantom with a sphere-to-background ratio o f 2:1. The first five iterations (1 to 5 
from left to right) are shown (A) for non-TOF and (B) TOF reconstruction in a 168 x 
168 matrix with 4 mm pixels.
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TOF images, but it is visible after the first iteration o f  TOF reconstruction. The 13 
mm sphere can be easily localised in all TOF images but becomes clearly visible 
with non-TOF reconstruction only at higher iterations.
The five minute scan is a more realistic simulation o f an oncology study. This data 
set was reconstructed at the best spatial resolution possible, using a 336 x 336 image 
matrix that gives a 2 mm pixel size. A 4 mm pixel size is generally used in PET 
oncology studies because o f the lower noise level, but at the cost o f reducing spatial 
resolution and contrast. The intrinsic noise reduction in TOF images allows higher 
spatial resolution to be exploited. For high resolution (2 mm pixels), the 10 mm 
sphere is not visible in either TOF or non-TOF images, whereas the 13 mm sphere is 
visible only in TOF images, and the 17 mm sphere is visible with both reconstruction 
methods (images not shown).
8.3.3 Conclusions
This experiment assessed the recovery o f small lesions (< 2 mm) when the lesion-to- 
background contrast was very low (2:1) for high (1 hour scan) and low statistics (5 
minute scan). As expected, shorter scans suggest reduced detectability o f  small 
lesions, particularly when the contrast is low. Shorter scans have higher noise levels 
and larger pixels correspond to degraded spatial resolution. Nevertheless, the TOF 
reconstruction consistently offered better detection capability than non-TOF: 
particularly remarkable is the ability o f TOF reconstruction to recover, in conditions 
o f high noise, a 13 mm lesion with a low contrast (2:1). This is a more challenging 
situation and potentially more relevant for oncology imaging, which will be the topic 
o f  the following section.
8.4 Impact of TOF on Clinical Image Quality
8.4.1 Methods
103 clinical oncology studies were acquired with TOF information. For each study 
data acquisition began approximately 91 ± 6 minutes after intravenous injection o f
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377 ± 36 MBq (10 ± 1 mCi) o f ^^FDG. Data were acquired at 4 or 5 bed positions 
(depending on the patient) for 2 minutes per bed position; for larger patients, in 
excess o f 110 kg (250 lb), data were acquired 3 minutes per bed position. All studies 
were reconstructed with PSF 0P-0SEM 3D . A  conventional version o f  the algorithm 
without TOF information was used to reconstruct non-TOF images, and a version 
incorporating a 590 ps (FWHM) TOF time resolution kernel was used to reconstruct 
the TOF images. The image matrix for the patient studies was 168 x 168 
corresponding to a 4 mm in-plane pixel size, with a plane thickness o f  2 mm. No 
smoothing filter was applied to the images after reconstruction and hence all 
reconstructed images are unsmoothed.
Optimisation was performed using both phantoms, as described in the previous 
chapter, and patient studies. For the patient studies, optimisation o f  the 
reconstruction methodology was achieved by using two separate approaches. The 
first approach was a subjective assessment o f image quality by two experts, including 
a physicist and a nuclear medicine physician. The experts examined a series o f  four 
patient studies reconstructed with 14 subsets and with 1-8 iterations for both non­
TOF and TOF; the experts were blinded as to whether or not TOF information had 
been incorporated. After a careful review it was agreed that a choice o f 2 iterations 
for TOF and 4 iterations for non-TOF gave near-optimal image quality in each case. 
It is important to realize that these conclusions apply only to the whole-body 
oncology studies that are subject o f  this work; different conclusions may apply to 
other types o f studies.
A  second approach consisted o f  reviewing a small series o f five patients, randomly 
selected, for which both non-TOF and TOF reconstructions were performed for 1-8 
iterations and 14 subsets. For each patient, a lesion less than 2 cm in diameter was 
identified and a VOX o f diameter between 4 mm and 10 mm was drawn, located 
within the lesion; the mean counts within the VOX was taken as a measure o f the 
signal (S). The noise was estimated from a VOX drawn in the liver with a diameter 
greater than 2 cm; the standard deviation (<%) was taken as a measure o f  the noise. 
The background (B) was estimated as the mean counts in the liver VOX. The liver 
was selected for this purpose because it is an organ o f large size, moderate uptake
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and good uniformity. The signal-to-noise was then defined by eq. 7.1. In addition, 
contrast and noise were defined according to eq. 7.2 and eq. 7.3, respectively. For 
each patient, SNR was plotted as a function o f iteration number, and contrast as a 
function o f noise for different numbers o f iterations. Once the optimal reconstruction 
parameters were identified, the basis o f this work consisted o f a quantitative and a 
qualitative evaluation o f the TOF and non-TOF images in terms o f SNR and other 
image quality features. The TOF information is known to reduce image noise by 
better localisation o f the annihilation point for each event. There is, therefore, a gain 
in SNR ( G s n r )  due to TOF compared with non-TOF that can be computed as the 
ratio SNRTOF/SNRnonTOF
A first quantitative study was performed on 103 patients. For each patient, a lesion 
(or lesions) was identified o f size less than 2 cm in diameter from the PET. For each 
patient, the Body Mass Index (BMI) was calculated and then G s n r  plotted as a 
function o f BMI. Since in general a large patient diameter is likely to correspond to 
a patient o f large BMI, the G s n r  is expected to increase with BMI. Also, since the 
gain will be different for different body regions, the lesions were grouped according 
to their location in the upper and lower abdomen, lungs, and head and neck. Linear 
regression analysis was applied to the data points for each group separately.
A final subjective assessment was performed on a different subset o f  about 50 
patients by two physicians, one an experienced nuclear medicine physician and the 
other a radiologist board-certified in nuclear medicine. The pairs o f non-TOF and 
TOF reconstructions were randomized and the physicians were blinded to the 
reconstruction method. Each image set was evaluated in terms o f a number o f  
independent criteria including uniformity o f liver uptake, definition o f detail in the 
mediastinum, spine, kidneys, and in the lesion. The resolution o f small lesions was 
also assessed along with the overall subjective image quality. A score from 1-5 (1 = 
worst; 5 = best) was assigned to each o f the criteria mentioned above, allowing the 
quality o f the non-TOF and TOF reconstructions to be compared. The results were 
then compiled as the number o f images for which non-TOF was considered superior 
to TOF, and vice versa. When it was not possible to assess whether one method 
outperformed the other, the score was randomly assigned to one o f the two.
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8.4.2 Results
The result o f a preliminary visual inspection o f TOF and non-TOF patient images, by 
an experienced physicist and a nuclear medicine physician, subjectively confirmed 
that the best image quality, in terms o f the trade-off between noise level and contrast, 
was obtained (in most o f the cases) for 4 iterations o f non-TOF and 2 iterations o f  
TOF reconstruction. This result was further confirmed by the quantitative study o f  
small lesions in a selected set o f 5 patient studies. The plot o f SNR as a function o f
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Figure 8.4. SNR (A) and contrast (B) analysis for a patient with a small lesion (<2 
cm) in the liver comparing TOF (red solid symbols) and non-TOF (blue empty 
symbols) reconstructions. Each data point corresponds to one iteration. The arrows 
indicate the selected iteration number for TOF and non-TOF. Errors are insignificant 
and therefore not indicated for this analysis.
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iteration number is shown in Figure 8.4A as an illustration. The TOF reconstruction 
reaches a maximum at 2 iterations compared with 4 iterations for the non-TOF. In 
addition, a greater SNR is achieved with TOF than with non-TOF, reflecting an 
improved image quality.
With the exception o f  lesions in the head and neck, similar behaviour was observed 
regardless o f the location o f  the lesion within the body. A plot o f  contrast as a 
function o f  noise is shown in Figure 8.4B for the same lesion as in Figure 8.4A; the 
TOF images demonstrate better contrast with a more rapid increase. For TOF, 2 
iterations (also with 14 subsets) show the same contrast as 4 iterations, 14 subsets 
with non-TOF, but at a lower noise level. This behaviour is again typical for most 
lesions.
While 2 iterations with TOF and 4 iterations with non-TOF seem to optimise SNR 
for most lesions in the thorax and abdomen, lesions in the head and neck exhibit a 
different behaviour. In general, TOF and non-TOF curves, for both SNR and 
contrast, are comparable and the improvement due to TOF is somewhat reduced. 
Also, the maximum SNR seems to be reached at an earlier number o f  iterations in 
these cases. Nevertheless, 4 iterations o f  non-TOF and 2 iterations for TOF 
reconstructions were chosen as the default reconstruction parameters.
Once the patient data were reconstructed with the established parameters, the 
selected TOF and non-TOF images were analyzed in terms o f TOF SNR gain for 
small lesions in 103 patients. The SNR gain due to TOF was plotted as a function o f  
the BMI for different body regions, as shown in Figure 8.5A-C. Each plot includes a 
linear regression line showing the trend o f the data points; the plots in Figure 8.5 are 
for lesions in (A) upper and lower abdomen, (B) lungs and (C) head and neck. 
Figure 8.5A shows a total o f 141 abdominal lesions with an increase in SNR gain as 
a function o f  increasing BMI. This is to be expected as the diameter o f the patients 
increase. The gain factor varies from about 1.1 at low BMI values up to 2.3 at high 
BMI values (BMI = 43). The same plot for 64 lesions in the lungs, Figure 8.5B, 
shows no correlation with BMI and an average SNR gain o f  about 1.4 ± 0.2 (SD).
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Figure 8.5. Measured SNR gain factor as a function o f BMI, for small lesions (<2 
cm) located in different parts o f the body for a group o f 103 patients: (A) 141 lesion 
located in the upper and lower abdomen, (B) 64 lesions located in the lungs, and (C) 
30 lesions located in the head and neck.
125
In the head and neck region, Figure 8.5C, where little gain is to be expected for the 
reasons discussed previously, a total o f 30 lesions show a slight trend from a gain 
factor o f 1.0 at low BMI up to 1.4 at high BMI values. The small increase in SNR 
with BMI for head and neck lesions may be due to the fact that the patients were 
imaged with arms up; the size o f neck and arms in the FOV increase the effective 
diameter o f the region, and can be correlated with BMI. As long as the patient does 
not move between the CT and PET scans, the attenuation correction and scatter 
correction can be accurately estimated.
The final assessment o f the data required two experienced physicians, blinded to the 
reconstruction methods, to review a pair o f images for each patient study, one o f the 
pair reconstructed without TOF and the other with TOF. The results for this 
assessment o f TOF image quality compared to non-TOF are summarized in Figure
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Figure 8.6. Evaluation o f TOF and non-TOF images according to different criteria: 
uniformity in liver, clarity o f and definition o f detail in mediastinum, spine, and 
kidney, lesion contrast, resolution o f small lesions, overall image quality. The bars 
indicate the number o f patients with combined criteria score that is superior for either 
o f the two methods.
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8.6 which shows that TOF image quality is superior to non-TOF for the liver and 
mediastinum in 4 % o f cases, in 12% for details o f the spine, and in 8 % for details of 
the kidneys. TOF is superior in image contrast in 12 % o f cases and for small lesion 
resolution in 8 % o f cases.
Finally, a few patient cases are presented that illustrate some o f the image quality 
improvements due to incorporating TOF information into the reconstruction. In 
Figure 8.7, images o f a 79 kg patient (BMI 34.2) with lung cancer were reconstructed 
without (A) and with (B) TOF information. This study had an average o f 41 x 10  ^
prompt counts per bed and 17 x 10  ^random counts per bed, for a total o f 5 beds. It 
is evident that Figure 8.7B demonstrates lower noise and better defined details than 
the non-TOF image in Figure 8.7A. This study is typical o f the improvement in 
image quality achieved by lowering the noise through incorporating TOF 
information. In addition to an overall improvement in image quality with TOF, there 
is evidence that certain artefacts due to inconsistent projection data can be reduced, 
using the additional localisation capability intrinsic to the TOF information. In 
particular, the photopenic artefact that can appear above the liver and spleen due to
B
Figure 8.7. A 79 kg patient (BMI: 34.2) with lung cancer reconstructed (A) without 
TOF and (B) with TOF. The red arrow indicates the banana-shaped artefact.
127
the CT and PET respiration mismatch is less visible on a TOF image, as shown again 
in Figure 8.7. The obvious, banana-shaped artefact above the spleen seen in Figure 
8.7A is much less evident in Figure 8.7B where TOF information has been used: the 
respiration artefact and resulting incorrect attenuation correction factors have been 
partially mitigated by the TOF information. This effect has been observed in a 
number o f other patient studies.
As a final illustration o f the potential image quality and diagnostic improvements due 
to TOF, Figure 8.8 shows two examples o f possible liver lesions, in two different 
slices, which can be seen on the non-TOF images. Figure 8.8A (upper and lower). 
Both slices are from the same, 107 kg patient (BMI 30.2). This study had an average 
o f 22 X 10  ^ prompt counts per bed and 10 x 10  ^ random counts per bed, for 5 beds 
total. Both non-TOF images appear to be positive for liver disease.
B
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Figure 8.8. The upper row indicates a true positive liver lesion (red arrow) that was 
see on both the non-TOF (A) and TOF (B) reconstructions in a 107 kg (BMI: 30.2) 
patient. The lesion was subsequently verified as positive from the corresponding CT 
scan (C). The lower row shows an apparent liver lesion on the non-TOF (A) image, 
which is not visible on the TOF (B) image. The corresponding CT scan (C) showed 
no evidence o f a lesion, demonstrating that this was a false positive finding from the 
non-TOF image, which became a true negative finding with incorporation o f TOF 
information.
However, in the TOF reconstruction, the lesion in the upper row is visible (Figure 
8.8B, upper) whereas the lesion in the lower study is no longer visible (Figure 8.8B, 
lower). The accuracy o f the TOF reconstruction was verified from the corresponding
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CT scans (Figure 8.8C) confirming that the upper image is a true positive, whereas 
the lower image is a false positive, probably a noise artefact, fi*om the non-TOF 
reconstruction, and it becomes a true negative fi*om the TOF reconstruction. Thus, 
the reduction in noise level due to the TOF information can result in the reduction or 
elimination o f such artefacts.
8.4.3 Discussion
This study, performed on a prototype Siemens TOF PET scanner with a 590 ps TOF 
time resolution kernel, focused on the assessment o f image quality obtained with 
TOF incorporated into the reconstruction, with particular attention to oncology and 
small lesions (<2 cm). The reconstruction method was PSF 0P-0SE M 3D  without 
and with the incorporation o f TOF.
It is well known that, for iterative algorithms, a trade-off must be found between 
contrast recoveiy and the acceptable level o f  noise. Choosing an iteration number or 
stopping criterion for an iterative algorithm is arbitrary, since it depends on the 
acceptable level o f noise. We decided to select an iteration number that optimises 
the SNR. This is dependent on several factors, including the lesion size and the scan 
statistics, and in theory each patient and each lesion may need an individual 
assessment o f the appropriate number o f iterations. Thus, for the 0P-0SE M 3D  
reconstruction algorithm, it was found that the number o f  iterations required to 
achieve optimal SNR differed between non-TOF and TOF reconstructions. This is to 
be expected owing to the better localisation o f  the annihilation events when TOF is 
included. The appropriate number o f iterations that offer a good trade-off between 
contrast recoveiy and noise was explored with both phantom and patient data. TOF 
reconstruction converged faster and resulted in lower image noise. The iteration 
number which maximized the SNR for small lesions was identified to be two for 
TOF and four for non-TOF reconstruction when fourteen subsets were used. It is 
interesting to note that this criterion provided images which reached similar contrast 
recovery, but the TOF image had the advantage o f  a lower noise level. As a result o f  
this investigation, patient studies obtained using 2 iterations o f  TOF and 4 iterations 
o f non-TOF reconstruction were compared.
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The gain in SNR due to incorporation o f TOF was measured and assessed as a 
function o f the BMI o f  the patients. As expected, for lesions in the abdomen where 
the effect o f high BMI is most evident, the SNR gain due to TOF was the most 
significant. Even at low BMI values (< 17), an SNR gain o f 1.1 was observed, 
whereas at a BMI o f 40 or above the gain approached a factor o f  2.3. This agrees
well with the estimated gain given by y i D / A x  [48] which, for a 40 cm diameter 
disk o f uniform activity and a TOF resolution o f 590 ps, predicts an SNR gain o f  2.1. 
It is worth noting the large dispersion (R  ^ value o f 0.4) o f the SNR gain for 
abdominal lesions. This may be due to two reasons: First, a high BMI does not 
necessarily imply a large abdomen. A  patient with a high BMI can have large thighs 
or be very muscular in the upper abdomen, arms and legs. Therefore, a lesion in the 
lower abdomen may not experience a large gain in SNR. A  second reason for this 
dispersed SNR gain with increasing BMI could be that not all lesions were 
reconstructed with parameters optimised for lesion SNR. Nevertheless, this study 
confirms that the greatest benefits o f  TOF will be for the larger patients. For lesions 
in other parts o f the body than the abdomen or thorax, the benefit is less. In the lung, 
where low background activity results in good contrast, the increased gain due to 
TOF was a factor o f 1.4, irrespective o f the BMI o f the patient. For the head and 
neck the increase was less, around 1.2, again more or less independent o f  BMI as 
would be expected. These results are consistent with other studies, recently 
published, which also measured improved SNR and detection capability in TOF 
images [85, 86].
These quantitative findings were confirmed by a careful but subjective assessment o f  
image quality by two experienced nuclear medicine readers. The TOF reconstruction 
consistently resulted in improved image quality in most o f the parameters used for 
the assessment, particularly resolution o f image detail, definition o f  small lesions, 
and image uniformity. Finally, some specific illustrative patient studies 
demonstrated a reduced level o f noise and artefacts that could have significant 
diagnostic implications.
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8.4.4 Conclusions
This section has validated in clinical studies that the incorporation o f  TOF 
information into image reconstruction results in more rapid convergence o f  the 
algorithm, better image contrast, and lower noise. Moreover, it has been quantified 
that the SNR gain due to TOF has the greatest effect in patients with higher BMI. A  
qualitative assessment by experienced physicians identified improved resolution o f  
image detail, definition o f  small lesions, and image uniformity in studies 
incorporating TOF information.
While the effect o f  TOF was found to be more evident with increasing BMI in this 
study, there appears to be still a large dispersion when a linear model is applied. 
Therefore, the effect o f TOF on obese patients (BMI > 3 0 ) was exclusively explored 
in further detail in the following section.
8.5 The Impact of TOF on Large Objects
Obesity (BMI > 30) has been increasing world-wide. Figure 8.9 shows the increase 
o f  obesity in young adults in the USA over the past 20 years. More than 30 states 
have a prevalence o f more than 25 % obesity. Therefore, imaging with PET has 
become more challenging for such larger patients. While the implementation o f  TOF 
into PET reconstruction has demonstrated an improvement o f  image SNR for 
increasing BMIs in the previous section, the impact o f TOF on explicitly large 
objects is explored experimentally and clinically in this section.
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Figure 8.9. Obesity trends among young adults in the USA from 1990 to 2009 
(Behavioural Risk Factor Surveillance System, CDC).
8.5.1 Methods 
Experimental Setup
A large (50 cm diameter, 20 cm long) high density polyethylene cylinder phantom 
with different sized cylindrical inserts was used, as shown in Figure 8.10. The 
inserts at the periphery were 13 mm, 25 mm, 51 mm, and 51 mm in diameter. A 101 
mm diameter cylinder was located in the center o f the phantom. All cylinders were 
filled with ^^ F mixed in water, with the largest 50 cm diameter compartment serving 
as the background. The hot-to-background activity ratio was different for each 
cylinder; 5.4:1 (13 mm), 3.2:1 (25 mm), 2:1 (51 mm), 1:1 (51 mm), 0.7:1 (101 mm). 
PET data were acquired for 1 hour with the phantom positioned in the isocenter o f 
the FOV. Images with a 168 x 168 matrix and a pixel size o f 4 mm were
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reconstructed using PSF 0P-0SE M 3D  with and without TOP for up to 50 iterations, 
14 subsets, and no post-smoothing filter.
Patient Population
19 obese patients (BMP 35.1 ± 5.6, range: 30.1-55.6) with different sized lesions 
(14.8 ± 6.3 mm diameter, range: 7-30 mm) were selected for this work. Images were 
reconstructed with the same parameters as in the previous section: 2 and 4 iterations 
for TOP and non-TOP, respectively, with 14 subsets and no post-smoothing filter.
A quantitative image analysis was performed using ROIs for the different sized 
cylinders/lesions and computing SNR, contrast and noise. Por patients, an ROI in 
the liver was used as the background.
51 mm
Background
25 mm
3 .2  O
101 mm
2.00.7
13 mm
5.4 51 mm
Figure 8.10. 50 cm diameter phantom with the different sized inserts and hot-to- 
background ratios (0.7 - 5.4).
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8.5.2 Results and Discussion 
Experimental Results
The reconstructed phantom images are shown in Figure 8.11 for different numbers o f  
iterations. Because the phantom and inserts are cylindrical, all 109 planes were 
added in order to enhance potential artifacts and differences between TOF and non- 
TOF images. The large phantom size and resulting attenuation is more challenging 
for image reconstruction. Therefore, the complete recovery o f the internal structures 
o f the phantom requires more iterations (than e.g. the smaller image quality phantom 
in section 8.2). The advantage o f TOF is obvious from a visual comparison: TOF 
converges faster to a "correct" image and the structured noise is increasingly visible 
with non-TOF at high number o f iterations. Moreover, the recovery o f the circular 
shape o f the inserts is already complete after 10 iterations with TOF, while much 
slower without TOF. Also, notice the bright spot at the top o f the cylinder in the 
non-TOF images. This is an air bubble inside the large cylinder, which appears as a 
hot spot because o f an incorrect attenuation correction. In the TOF image however, 
this attenuation correction artifact is eliminated and the correct distribution o f fluid is 
reflected.
The quantitative results o f the phantom images are presented in Figure 8.12. It can
^ ^  '
Figure 8.11. Reconstructed images o f the phantom for different iterations. Non-TOF 
images (top) and TOF images (bottom).
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be observed that SNR and contrast with TOF are consistently superior to non-TOF, 
as a function o f iterations and noise. Although, SNR results (Figure 8.12A) are 
plotted for the smallest inserts only, the trend is consistent for all size structures.
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Figure 8.12. Quantitative results for the large cylinder phantom: (A) SNR as a 
function o f iteration for the smallest inserts (13, 25 mm); (B) Contrast as a function 
of noise for different iterations.
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It can also be observed that the larger structures reach the maximum SNR and 
contrast value faster than the smaller structures due to faster convergence. The 
performance gain with TOF reconstruction is however greater for smaller structures: 
at any given noise level, the TOF image exhibits a much higher contrast value, and 
the maximum is obtained with a lower number o f iterations or, in other words, for the 
same contrast, the TOF image has a much lower noise level and is obtained with a 
lower number o f iterations (Figure 8.12B).
Clinical Results
Figure 8.13 shows the SNR gain o f TOF to non-TOF for lesions in the 19 obese 
patients. All lesions are located in the abdomen. For the majority o f the lesions, an 
SNR gain o f more than 1.4 can be observed. However, four lesions (red label) 
indicate an SNR gain o f 1.1 or less even though the BMIs o f the corresponding 
patients are in the range o f 30.1 to 37.7. The largest SNR gain o f 2.2 corresponds to 
a patient with a BMI o f 31.0, whereas the lesion o f the largest patient (BMI: 55.6)
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Figure 8.13. SNR gain with TOF as a function o f BMI for lesions from 19 patients.
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indicates an SNR gain o f 1.3.
One might argue that the reconstruction parameters o f these lesions are not all 
optimised for lesion SNR and therefore the highest SNR gain is not obtained with the 
largest BMI. However, a careful investigation o f the extreme cases (BMIs o f 31.0 
and 55.6) confirmed the chosen reconstruction parameters for optimal lesion SNR. 
Therefore, an SNR gain with TOF cannot always be expected for lesions in patients 
with a high BMI as the lesion might be located in a low attenuation body region.
8.5.3 Conclusions
It has been demonstrated that TOF has an impact on structures/lesions inside large 
objects. TOF exhibits a consistently higher SNR and contrast as a function o f  
iteration and noise than non-TOF. While larger structures converge faster and reach 
maximum SNR more rapidly, the performance gain with TOF is greater for smaller 
structures than it is for larger structures.
For the majority o f lesions in obese patients an SNR gain with TOF can be 
experienced. However, the highest SNR gain is not necessarily obtained for the 
largest BMI because the lesion might be located in a low attenuation body region.
So far, TOF has shown to reduce image noise while maintaining contrast. The 
following section explores the impact o f TOF on reducing injected dose, which is in 
other words an increase o f image noise.
8.6 The Potential of TOF to Reduce Injected Dose
This TOF section explores the effect o f TOF on reducing the injected activity on 
image quality, which is equivalent to lowering the scan time. As demonstrated in 
previous sections, when using TOF information to reconstruct images, the image 
noise is decreased without sacrificing image contrast. Therefore, the scan time can 
be shortened or the injected activity reduced when TOF reconstruction is used and
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the image quality should remain the same as can be achieved with a longer scan or 
higher injected activity without incorporation o f  TOF information.
8.6.1 Methods
Reducing Counts
In order to investigate the actual reduction in counts, which is equivalent to either 
reducing scan time or injected dose, the following experiment was conducted.
A 68 kg and 178 cm tall patient (BMI: 21.7) was injected with 405 MBq ±  10 % (11 
mCi ± 10 %) o f ^^FDG 90 minutes prior to undergoing a PET/CT examination on the 
4-Ring scanner with TOF capabilities. A  whole-body scan containing five bed 
positions o f  2 minutes per bed was acquired in list mode. Simultaneously, 
conventional sinogram data were also acquired by rebinning the list mode data.
For each bed position, a list mode file containing half the number o f counts 
(prompts) was built by deleting every other count in the original file. This method o f  
reducing the counts is preferable to scanning the patient a second time in that the 
physiology is comparable for both the long and the “short” scan. This “short” scan is 
equivalent to either an injected dose o f 203 MBq ± 10 % (6 mCi ± 10 %) with a scan 
time o f 2 minutes per bed or a 405 MBq ±  10 % (11 mCi ± 10 %) injection with a 
scan time o f 1 minute per bed.
For both list mode scans, the images were reconstructed with three algorithms: AW- 
0SEM 3D, PSF 0P-0SEM 3D  and PSF+TOF 0P-0SEM 3D . Since each 
reconstruction algorithm converges at a different rate as demonstrated previously, a 
different combination o f iterations and subsets was used to obtain the optimum 
image (in terms o f SNR) from each algorithm. Table 8.3 below summarizes the 
reconstruction parameters.
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Table 8.3. Reconstruction parameters for the 2 and 1 minute scans.
Algorithm Iterations Subsets
Gaussian filter 
(mm FWHM)
AW -0SEM 3D 3 8 5
PSF 0P-0SEM 3D 4 14 none
PSF+TOF 0P-0SEM 3D 2 14 none
The same assumptions were made in this experiment as for the analysis o f  the 103 
patients in section 8.4. Uptake o f  ^^FDG in the liver was assumed to be reasonably 
uniform and was therefore used to compute the noise by placing a liver VOI and 
applying eq. 7.3. The contrast was computed by placing a VOI on a small lesion and 
applying eq. 7.2. The SNR was computed according to eq. 7.1.
Reducing Injected Patient Dose
The previous method o f reducing the counts is preferable to scanning the patient a 
second time as it would be unethical to expose the patient to unnecessary radiation, 
even with a lower dose for the PET scan. It is also practical that the physiology is 
comparable for both the long and the “short” scan. In the previous method, the same 
count distribution is assumed for the regular and reduced dose. In an effort to 
investigate whether or not the regular dose images are comparable to the reduced 
dose images when reconstructed with TOF an existing research protocol for 
oncology cancer patients at the University o f Tennessee Medical Center was adapted. 
Following approval by the Internal Review Board o f the hospital, patients were 
recruited to participate in the following protocol.
A total o f 16 patients were scanned on the 4-Ring scanner with prototype TOF 
capabilities, first with 379 ± 17 MBq (regular dose) o f ^^FDG injected, followed 
within 5 days (3.4 ± 1 .7  days) by a second scan with 203 ± 9 MBq (reduced dose) 
injected. The patient weight averaged to 76 ± 22 kg (47 -  106 kg, BMI: 27.8 ±  5.7) 
during the first visit and 77 ±  22 kg (47 -  106 kg, BMI: 27.4 ± 5.4). Therefore, no 
significant weight change was observed during the two scans. The protocol was 
standardized to control start o f imaging post injection, imaging time per bed position
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and patient glucose level. All patients were scanned with two minutes per bed 
position for the first visit and for four minutes per bed position during the second 
visit. The data set with regular dose was reconstructed with PSF 0P-0SEM 3D . For 
the reduced dose, only the first two minutes o f the data sets were reconstructed with 
PSF+TOF 0P-0SEM 3D . The image SNR, contrast and noise were compared for the 
two sets o f  images acquired for each patient and for specific lesions according to the 
equations introduced in section 7.1. As the scans were acquired within 5 days o f  
each other, the reproducibility o f  SUVs could also be assessed.
8.6.2 Results and Discussion
Reducing Counts
Table 8.4. Results o f  the VOI analysis for the 2 and 1 minute scans.
Scan
Time
Algorithm
Liver
Uptake
(mean)
(Bq/mL)
Liver Lesion 
Uptake Uptake 
(SD) (mean) 
(Bq/mL) (Bq/mL)
Contrast
Noise
ro/
2 min
1 min
AW -0SEM 3D 6798 705 28847 3.2 10.4
PSF 0P-0SEM 3D 6705 1093 42758 1 16.3
PSF+TOF 0P-0SEM 3D 7222 839 46687 5.5 .........1L6
AW -0SEM 3D 3406 461 13071 2.8 13.5
PSF 0P-0SEM 3D 3298 744 20637 5.3 22.6
PSF+TOF 0P-0SEM 3D 3567 571 22342 [  .5 -3 [ 16.0
SD: Standard deviation.
The results o f the VOI analyses are shown in Table 8.4 and Figure 8.14 indicates the 
locations o f the VOIs. The 2 minute scan corresponds to the original list mode file 
while the 1 minute scan corresponds to the shortened file. An examination o f the 
contrast and noise values for the one minute PSF+TOF results reveals approximately 
the same values as the 2 minute PSF reconstruction (grey shaded cells). For this 
particular patient, the improvement o f the shorter 1 minute scan by incorporating 
TOF information could be termed as equivalent to an increase in counts by a factor 
o f  two. Visual inspections o f the images confirm these quantitative results.
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Figure 8.14. Images o f the 2 minute (upper row) and 1 minute (lower row) scans 
reconstructed with PSF+TOF (left), PSF (middle), and AW -0SEM 3D. The 
location o f the liver VOI is also indicated.
Reducing Injected Patient Dose
Eight patients were included in the data analysis and a total o f 17 lesions were 
compared for the two data sets o f each patient.
Figure 8.15 illustrates the results from the lesion analysis. The lesion SNR (A), 
contrast (B) and noise (C) values from the PSF images o f the regular dose scans are 
displayed as a function o f the same lesion values from the PSF+TOF images o f the
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Figure 8.15. Results for the 17 lesions from 8 patients comparing image (A) SNR, 
(B) contrast, and (C) noise for the same lesions reconstructed with PSF (regular dose 
scan) and PSF+TOF (reduced dose scan). Colours in A distinguish patients; shapes 
distinguish lesions o f the same patient.
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reduced dose scans. In the SNR plot (A), lesions from the same patient are indicated 
with the same colours, while different lesions for the same patient are distinguished 
by different shapes o f  the data points.
The linear regression for lesion SNR indicates good correlation between the results 
from the PSF and PSF+TOF images. For the 17 lesions, the factor S N R to f/ SNRpsf 
averages to 1.1 ± 0.1. This implies comparable lesion SNR between the PSF and 
PSF+TOF images. The linear regression for the contrast (B) with a y-intercept o f 1.9 
implies that the contrast o f the PSF images is increased. The factor ContrastroF /  
Contrast PSF for the 17 lesions averages to 0.8 ±  0.4 and shows a slightly higher mean 
contrast for the lesions from the PSF images (with more statistics). However, within 
1 SD, the contrast values are comparable. The linear regression o f  the noise (C) 
implies similar noise for both the PSF and PSF+TOF images. The average noise 
factor NoiseTOF /  NoisepsF results in 0.9 ± 0 .1  and is therefore comparable for both 
image sets.
8.6.3 Conclusions
The results o f  the analysis for the same lesions demonstrate that incorporation o f  
TOF information into the PSF reconstruction process can compensate for the 
increased noise due to reduced injected dose when imaging with the same scan time. 
No significant difference in the image SNR between the regular and reduced dose 
scans for the same lesions were observed.
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9 TET FOR PETS: IMAGING LOW DOSES 
WITH HIGH SENSITIVITY
PET is commonly used in humans in order to diagnose, stage and monitor neoplastic 
disease [3, 4] or in small animals, such as mice or rats to study functions or perform 
research on novel pharmaceuticals. In veterinary medicine, however, access to PET 
facilities for larger and companion animals, such as dogs and cats is limited. 
Therefore, only a few studies exist, which evaluate this imaging modality.
In an effort to assess PET for applications in the veterinary field, two series o f canine 
studies were acquired with low doses o f ^^FDG on the P5-Head. It must be recalled 
that this scanner demonstrated high sensitivity and was therefore particularly suitable 
for low dose injections (~100 MBq). The first series o f canine patients had no 
indication o f tumours (referred to as normal dogs herein and after), while the second 
canine series was diagnosed with naturally occurring tumours. The details and 
outcome o f the studies are explored in the following sections.
9.1 ^^FDG Imaging in Normal Dogs
According to Cook at al. [89], in humans without tumour indication (referred to as 
normal humans herein and after), there is typically high ^^FDG uptake within the 
brain, and low to moderate uptake within the liver, spleen, and bone marrow. 
Normal lymphatic tissue and thymus, particularly in children and young adults, may 
have moderate to marked ^^FDG uptake. Lung uptake is usually low, while cardiac 
uptake is variable and dependent on the patient’s insulin levels, as the predominant 
myocardial energy substrates are fatty acids in the fasted state. Gastrointestinal tract 
uptake can be variable, but small bowel uptake is typically low grade, whereas 
colonic activity may be marked and affect all parts o f this intestinal segment. Unlike 
glucose, ^^FDG is not reabsorbed by the renal tubules and so renal cortices may have
The content of this Chapter has been published by the author et al. in [87, 88].
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significant uptake in a normal subject. ^^FDG is excreted through the urine and 
therefore intense activity within the renal collecting systems, ureters, and bladder is 
an expected finding. The most common area o f interpretive pitfalls in human PET is 
skeletal muscle uptake, which is minimized by avoidance o f  talking, chewing, or any 
physical activity principally for the first 20-30 minutes after ^^FDG administration 
[9 ,89].
In order to compare these finding in the canine studies, SUVs have been computed 
for a patient series o f osteosarcoma, pheochromocytoma, lymphoma, blastomycosis, 
pulmonary carcinoma and soft tissue sarcoma [90-96]. To the author’s knowledge 
there were no data describing normal SUVs o f  the various parenchymal organs o f the 
thorax and abdomen in dogs to guide in study interpretation at the time o f this work.
Normal uptake data are critical to interpretation o f PET scans that use ^^FDG in dogs 
with suspected or confirmed disease. The primary goal o f this study was to establish 
an imaging protocol using the P5-Head scanner with a large FOV and high 
sensitivity that allows documentation o f radiopharmaceutical uptake data 
simultaneously from the entire thorax and abdomen cavities in dogs. With this 
imaging protocol in place, an assessment o f  normal distribution o f ^^FDG uptake and 
SUVs o f  the major parenchymal organs o f  the normal dog could be made.
9.1.1 Methods
Seven young (mean age 5.0 ± 0.5 months) female, purpose-bred mixed breed dogs 
weighing 10.8 ±  0.8 kg (mean ± SD) were acquired through the Laboratory Animal 
Facilities at the University o f  Tennessee College o f  Veterinary Medicine. The dogs 
were housed in Office o f Laboratory Animal Care approved facilities at the 
University o f Tennessee and all protocols were approved by the University o f  
Tennessee Institutional Animal Care and Use Committee. The dogs were considered 
normal based during physical exam, results o f laboratory testing, thoracic and 
abdominal radiography, abdominal ultrasound examination, and thin-slice computed 
tomographic exam o f thorax and abdomen. The mean plasma glucose concentration 
before ^^FDG injection was 95 ±  10 mg/dl. The dogs were pre-medicated with
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acepromazine maleate (0.8 mg intravenous (IV)), butorphanol tartarate (1 mg IV), 
and atropine (0.1 mg intramuscular (IM)). Anaesthesia was induced with propofol 
(30 mg IV), the dogs were intubated and anaesthesia was maintained with isoflurane. 
The dogs were placed in ventral recumbancy, and positioned within the gantry o f the 
P 5-Head scanner so that the entire thorax and abdomen was included within the 
FOV. The dogs were injected intravenously with 96.2 ± 6.6 MBq (2.6 ± 0.2 mCi) o f  
human-grade ^^FDG and a 2 hour dynamic list mode acquisition was initiated 
simultaneously with the injection.
Following acquisition, the list mode data were rebinned into 24 five-minute frames 
and reconstructed using 0P-0SEM 3D  with four iterations, 16 subsets and a 4 mm 
Gaussian post-smoothing filter. All dynamic frames were decay corrected to the start 
of the scan. An objective assessment o f ^^FDG uptake within parenchymal organs
»
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Figure 9.1. Depiction o f representative ROIs manually drawn for image analysis 
and calculation o f standardized uptake values over a 2 hour time period for the 
thoracic and abdominal organs o f seven normal dogs; (A) blood pool ROI drawn 
in frontal plane, (B) liver ROI drawn in coronal plane, (C) kidney ROIs drawn in 
coronal plane, (D) thymic ROI drawn in coronal plane, (E) splenic ROI drawn in 
transverse plane, (F) myocardial ROI drawn in coronal plane.
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was carried out by drawing an ROI around the target organ or a representative 
portion thereof. The ROIs were manually drawn over liver, spleen, left and right 
renal cortices, and left ventricular free wall (Figure 9.1). For the kidneys, care was 
taken not to include the renal pelvises in the ROI due to accumulation o f ^^FDG for 
urinary excretion. Because o f  the dogs’ immaturity, an ROI was also placed over the 
thymus. SUVs o f these organs were calculated with a standard formula for all seven 
dogs for all 24 time points [97]. In general, SUV is defined as the average tissue 
concentration o f  a radiopharmaceutical. Here, the ^^FDG dose was decay corrected 
to the time o f  injection, in the region delineated by the ROIs divided by the 
radioactivity injected per kilogram o f  the body weight.
9.1.2 Results
Table 9.1 contains the average SUV and associated SD for each parenchymal organ 
studied, along with an assessment o f  blood pool radioactivity obtained by drawing an 
ROI over the left ventricular lumen o f the heart.
Mild to moderate uptake o f ^^FDG was readily recognized in all major visceral 
organs with the exception o f  the lung. Figure 9.1 depicts how representative ROIs 
were manually drawn in the coronal plane (liver, left ventricular lumen, myocardium, 
kidneys, thymus) or transverse plane (spleen) o f  the obtained images.
Figure 9.2 contains time activity curves (TAG) generated for all studied organs and 
blood pool activities. Uptake o f ^^FDG within the liver was high at beginning o f the 
study (SUV: 5.7 ± 1.5) due to high levels o f  radiopharmaceutical within the blood 
pool, as the liver receives a large portion o f cardiac output. After blood pool 
clearance, a steady decline in SUV with values at 1 and 2 hours being quite similar 
was noted (1-hour SUV: 2.7 ±  0.4; 2-hour SUV: 2.4 ± 0.4). The gall bladder was 
recognized as a consistently photopenic region within the liver, representing lack o f  
gall bladder radiopharmaceutical uptake and/or accumulation within bile. Intestinal 
uptake o f  ^^FDG was intense in some dogs and increased over time. Peristaltic 
activity precluded accurate measurement o f  this uptake over the entire study period.
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splenic uptake o f ^^FDG was consistent among dogs and a slight decrease in uptake 
was noted over the 2-hour scan time (Injection SUV: 1.7 ± 0.2; 1-hour SUV: 1.7 ±  
0.1; 2-hour SUV: 1.5 ± 0 .1 ).
Thymic uptake o f ^^FDG was consistently visualized in all dogs due to their young 
age (< 1 year). Over time, thymic uptake steadily increased (injection SUV: 2.0 ±  
0.2; 1-hour SUV: 3.1 ± 0.4; 2-hour SUV: 3.4 ±  0.4), likely due to active metabolic 
activity o f the expanding resident lymphoid population.
Table 9.1. Average Standard Uptake Value and corresponding standard deviation for 
each parenchymal organ studied.
Right Kidney Left Kidney Spleen Liver Blood Pool Left Ventricle Thymus
Time (s) SUV SD SUV SD SUV SD SUV SD SUV SD SUV SD SUV SD
0 6.7 2.0 6.2 2.1 1.7 0.2 5.7 1.5 4.3 1.0 3.1 0.8 2.0 0.2
300 5.0 1.1 4.6 1.1 1.7 0.1 4.3 0.7 3.2 0.4 2.4 0.3 2.1 0.2
600 4.2 0.6 3.9 0.6 1.7 0.1 3.8 0.5 2.9 0.3 2.2 0.2 2.2 0.2
900 3.9 0.3 3.6 0.3 1.8 0.1 3.5 0.5 2.7 0.2 2.1 0.1 2.3 0.2
1200 3.7 0.3 3.4 0.4 1.8 0.1 3.3 0.4 2.6 0.2 2.1 0.1 2.4 0.2
1500 3.5 0.3 3.3 0.4 1.8 0.1 3.2 0.4 2.5 0.2 2.0 0.1 2.5 0.2
1800 3.5 0.3 3.2 0.4 1.8 0.1 3.1 0.4 2.4 0.2 2.0 0.1 2.6 0.3
2100 3.3 0.3 3.1 0.5 1.8 0.1 3.1 0.4 2.3 0.2 1.9 0.2 2.7 0.3
2400 3.2 0.4 2.9 0.5 1.8 0.1 3.0 0.4 2.2 0.2 1.9 0.2 2.8 0.3
2700 3.1 0.4 2.8 0.5 1.8 0.1 2.9 0.4 2.1 0.2 1.9 0.2 2.9 0.3
3000 3.0 0.4 2.7 0.5 1.7 0.1 2.8 0.4 2.0 0.2 1.9 0.2 3.0 0.3
3300 3.0 0.4 2.6 0.5 1.7 0.1 2.8 0.4 2.0 0.2 1.8 0.2 3.0 0.3
3600 2.9 0.3 2.6 0.4 1.7 0.1 2.7 0.4 1.9 0.2 1.8 0.2 3.1 0.4
3900 2.8 0.3 2.5 0.4 1.7 0.1 2.7 0.4 1.9 0.3 1.8 0.2 3.2 0.4
4200 2.8 0.3 2.5 0.4 1.7 0.1 2.7 0.4 1.8 0.2 1.8 0.2 3.2 0.4
4500 2.7 0.3 2.5 0.5 1.6 0.1 2.6 0.4 1.8 0.3 1.8 0.2 3.3 0.4
4800 2.6 0.4 2.4 0.5 1.6 0.1 2.6 0.4 1.7 0.3 1.7 0.2 3.3 0.4
5100 2.6 0.4 2.4 0.5 1.6 0.1 2.5 0.4 1.7 0.3 1.7 0.2 3.3 0.4
5400 2.6 0.4 2.4 0.5 1.6 0.1 2.5 0.4 1.7 0.3 1.7 0.2 3.4 0.4
5700 2.5 0.4 2.4 0.5 1.5 0.1 2.5 0.4 1.6 0.3 1.7 0.2 3.4 0.4
6000 2.5 0.4 2.3 0.5 1.5 0.1 2.5 0.4 1.6 0.3 1.6 0.3 3.4 0.4
6300 2.5 0.4 2.3 0.5 1.5 0.1 2.4 0.4 1.5 0.3 1.6 0.3 3.4 0.4
6600 2.5 0.4 2.3 0.5 1.5 0.1 2.4 0.4 1.5 0.3 1.6 0.3 3.4 0.4
6900 2.4 0.4 
SD: Standard deviation
2.3 0.5 1.5 0.1 2.4 0.3 1.5 0.3 1.6 0.3 3.4 0.4
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Figure 9.2. Time activity curves (TACs) for ^^FDG uptake represented by mean SUVs ± 
SD within thoracic and abdominal parenchymal organs and blood pool o f seven normal 
dogs; (A) blood pool, (B) liver, (C) kidneys, (D) thymus, (E) spleen, (F) myocardium.
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uptake o f ^^FDG was readily noted within both kidneys, which decreased with time 
from the initial blood pool blush o f radiopharmaceutical that occurs after IV 
injection. The decrease in SUV was rapid after injection with a plateau occurring 
after 1 hour similar to that seen within the liver (right kidney: injection SUV: 6.7 ±  
2.0, 1-hour SUV: 2.9 ±  0.4, 2-hour SUV: 2.4 ± 0.4; left kidney: injection SUV: 6.2 ±  
2.1; 1-hour SUV: 2.6 ±  0.4; 2-hour SUV: 2.3 ±  0.5).
Progressive ^^FDG accumulation within the renal pelvises, ureters and urinary 
bladder indicative o f radiopharmaceutical excretion was noted over the span o f  the 2- 
hour scan.
Uptake o f ^^FDG within the myocardium was minimal, consistent with the fasted 
state in which cardiac muscle switches from glycolysis to fatty acid metabolism to 
satisfy energy requirements. Myocardial ^^FDG uptake may be absent in humans 
following a fast o f  18-24 hours, due to this shift in metabolism [12]. Poor 
myocardial uptake o f  ^^FDG in this study is consistent with typical findings in 
humans after an 18 hour fast. Fasting is important in veterinary patients that require 
general anaesthesia for this type o f whole-body imaging, but it does serve an 
important function in obtaining quality PET data. Glucose competes with ^^FDG for 
cellular uptake, and elevated serum glucose levels will lower observed ^^FDG uptake 
in malignant neoplasms or other hypermetabolic disease states. Human patients are 
routinely fasted for 12-18 hours to ensure glucose levels and insulin levels are low at 
the time o f ^^FDG administration.
The head and neck regions were not included in the FOV, as the focus o f this study 
was ^^FDG uptake within thoracie and abdominal organs. Mild but consistent ^^FDG 
uptake within the visible dorsal cervical musculature, the significance o f  which is 
unknown, was noted.
9.1.3 Discussion and Conclusions
The SUVs determined in this study are a practical and semi-quantitative measure o f  
radiopharmaceutical uptake, which can be related to the absolute metabolic rate o f
151
glucose [98, 99]. Though founded on the general kinetic principles and biochemical 
behaviour o f ^^FDG, the SUV is calculated without regard to radiopharmaceutical 
distribution in a volume o f tissue, which may not be homogenous with respect to 
variables that affect tracer transport and metabolism [100]. The usefulness o f  SUV is 
currently subject to intense debate, as factors other than lesion metabolie activity 
may influence the calculated SUV: size and placement o f ROI, lesion size, scanner 
specifications and imaging protocol, blood glucose concentration, time o f  
measurement after radiopharmaceutical injection, and patient body composition [8]. 
Further, reconstruction parameters such as chosen algorithm (analytical in 
comparison to iterative reconstruction), choice o f smoothing filter for the 
transmission scan, variation in ROI isocontours, and number o f iterations performed 
may significantly impact measured SUVs leading to variation in quantification o f  up 
to 30 % [97, 101]. If the patient undergoes serial PET imaging with the same 
scanner and imaging protocol to assess changes in radiopharmaceutical uptake 
during or after therapy, SUV can he a helpful adjunct to visual interpretation, but 
strict standardisation is necessary for acquisition, reconstruction and processing 
parameters when SUVs are compared between different PET imaging centres. While 
many potentially confounding variables impact the true diagnostic value o f  SUV, it is 
a clinically useful and widespread parameter to objectively describe areas o f  
abnormal ^^FDG uptake detected with PET. It is especially important to recognize 
the limitations o f  SUVs when using this parameter to evaluate suspected or known 
neoplastic diseases. Although an SUV o f >2.5 is generally considered characteristic 
for malignancy, the SUV cannot be relied upon as an absolute criterion o f  
malignancy as SUVs reported in publications have been obtained using varying 
methods and do not represent a standardized parameter [8, 9]. ^^FDG uptake, and 
therefore SUVs, is not only subject to glucose transport systems but also is 
dependent on a series o f processes common in inflammation, necrosis, and 
alterations in tissue perfusion and oxygenation.
The SUVs calculated for canine parenchymal organs in the current study were very 
similar to a report o f  20 “normal” humans in which whole-body PET scans were 
performed to assess ^^FDG uptake in a variety o f normal tissues [97]. In that study, 
SUVs were calculated 45-60 minutes after ^^FDG injection using iterative
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reconstruction. The mean SUVs o f  kidney, spleen and liver were 2.3 ± 0.5, 1.7 ±  
0.3, and 2.2 ±  0.3, respectively. These values compare with the SUVs reported 
herein for dogs that were scanned 60 minutes after injection.
The SUVs reported for human myocardium in this study were significantly higher 
than in the current canine study (5.0 ±  2.9 compared with 1.8 ±  0.2), but these human 
patients only fasted for 6 hours before their scans. Myocardial uptake is considered 
extremely variable among human patients and the same may be observed as larger 
groups o f dogs are imaged with ^^FDG PET in future studies. Potential reasons for 
differences in glucose metabolism between species include differences in expression 
and activity o f  glucose transporters responsible for intracellular movement o f  ^^FDG. 
It is currently unknown if  dogs have different numbers o f  glucose transporter 
proteins compared with humans, which may alter the avidity o f  their tissues for 
^^FDG. Similarly, it is unknown if  the immaturity o f the studied dogs had an impact 
on the results. The dogs in this study were on average 5 months old. Young age o f  
human patients has been connected with physiologic alterations in ^^FDG uptake 
[89]. It is currently unknown whether this phenomenon occurs in dogs but it is 
possible that younger canine patients may have higher metabolic rates overall and 
thus may have higher normal organ SUVs than adult dogs.
In the current study, a group o f dogs within a controlled age frame was used and 
provides a homogenous data set from this particular population o f dogs. This is 
advantageous over a single study o f  patients with widely varying ages wherein 
dilution o f data may not provide a clear picture o f expected normal canine organ 
SUVs. This study should be repeated in a group o f  older dogs for comparison to 
define differences in organ SUVs that may be directly attributable to patient age.
The imaging protocol employed in this study entails use o f general anaesthesia, and 
this may also be a confounding variable. One could reason that the use o f  general 
anaesthesia would dampen endogenous metabolic pathways thus falsely lowering the 
^^FDG uptake o f most organs, but the true impact o f general anaesthesia on ^^FDG 
uptake in the dog is unknown. In rodent tumour model studies, use o f  isoflurane 
anaesthesia did not have any effect on xenograft tumour ^^FDG uptake, but the
153
impact o f  other anaesthetic protocols, such as those that contain ketamine or 
xylazine, is not yet defined [102]. It is advised that a single anaesthetic protocol be 
employed across studies such as this to minimize variations in ^^FDG uptake 
influenced by general anaesthesia.
A final limitation o f  this study is the use o f  a prototype large axial FOV PET scanner 
that is not commercially available. This may have generated SUVs that may not be 
reproducible with smaller axial FOV scanners that are commonly used for whole- 
body PET in human facilities. However, the use o f this scanner represents a major 
advantage over commercially available systems in that SUVs can be calculated 
simultaneously for different parenchymal organs in one FOV.
9.2 ^^FDG Imaging in Tumour Bearing Dogs
There is minimal information characterizing the use o f PET in tumour bearing dogs. 
Therefore, six dogs with naturally occurring blastomycosis and three dogs with 
lymphoma were imaged with ^^FDG on the P5-Head scanner. For these diseases, 
avidity was demonstrated for ^^FDG [95, 103, 104]. ^^FDG PET in canine cancer 
imaging has potential to advance the current standard o f care in veterinary oncology 
practice, but more data are needed. Canine lymphoma (ESA) is common, affecting 
30 per 100,000 at risk annually [105]. Comprehensive tumour staging is important 
for assessing tumour burden, identification o f paraneoplastic syndromes, and 
characterisation o f concurrent illness. Veterinary oncologists currently rely on 
radiographic and ultrasonographic imaging studies, coupled with cytological 
assessment o f  lymph nodes, internal organs, and bone marrow, for tumour staging. 
Canine ESA is also a valid model for human non-Hodgkin’s lymphoma (NHL), 
where ^^FDG PET is considered the best non-invasive imaging technique for staging, 
assessment o f response to chemotherapy, and detection o f recurrence [3, 106-108]. 
A sensitivity o f 76 %, specificity o f 94 %, positive predictive value o f  82 %, negative 
predictive value o f 92 %, and accuracy o f 89 % were found for PET in lymphoma 
[30, 107, 109, 110]. ^^FDG PET also often leads to alterations in lymphoma staging 
and treatment. Clinical management o f human NHL patients was altered in 34 % o f  
patients in which PET and CT were compared as staging tools, and o f 22 discordant
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lesions in which true disease status was determined with biopsy, PET findings were 
correct in 21 [106]. In a comparison o f PET with CT using surgical staging as the 
gold standard in humans with Hodgkin’s disease, PET correctly upstaged 21 patients, 
equally staged 16 patients, and downstaged one patient compared with CT. Overall, 
PET imaging resulted in a change o f  stage in 59 % o f  the population [111].
Mast cell tumour (MCT) is the most common malignant skin tumour o f  the dog 
[105]. While most dogs develop solitary MCT, many will have multiple cutaneous 
MCT at the time o f diagnosis. Appropriate MCT treatment relies on careful tumour 
staging by systematically evaluating each patient for metastasis to regional lymph 
nodes and internal organs. Physical examination, radiographs and ultrasound, 
coupled with cytology o f lymph nodes, spleen, and liver, may not accurately identify 
all sites o f  metastatic MCT [110]. The whole-body ^^FDG PET scan is uniquely 
suited for staging MCT with evaluation o f skin, lymph nodes, and visceral organs 
such as spleen and liver for signs o f metastatic spread. If canine MCT is 
characterized by increased glucose metabolism, patients could be staged in one non- 
invasive procedure.
The aims o f the current study were to evaluate multicentric LSA and cutaneous MCT 
using ^^FDG PET scans and to compare the results with traditional staging 
techniques. Further, as there are no previous reports o f canine MCT being imaged 
with PET, this study aims to document the avidity o f this tumour for ^^FDG.
9.2.1 Methods
The uptake o f ^^FDG in nine tumour-hearing dogs were evaluated, three with LSA 
and six with MCT. Clinical patients with a cytological or histopathological diagnosis 
o f multicentric LSA (Dogs one-three) or cutaneous MCT (Dogs four-nine) and no 
prior treatment were studied. All dogs were fully staged using complete blood count, 
serum biochemistry panel with electrolytes, urinalysis, thoracic, and abdominal 
radiography and abdominal ultrasound examination with liver and spleen cytology 
obtained fi*om ultrasound guided fine needle aspirates. Bone marrow aspirates were 
performed on all dogs with LSA and one dog with MCT. All protocols were
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approved by the University o f Tennessee Institutional Animal Care and Use 
Committee. Whole-body PET scans were performed under general anaesthesia 
within 48 hours o f  routine tumour staging and the results o f  both staging protocols 
compared. Dogs with LSA had both a baseline PET scan and a repeat scan after 
achieving clinical remission after several weeks o f chemotherapy. When possible, 
areas o f ^^FDG uptake, which did not correlate with results o f standard imaging were 
sampled with fine needle aspiration cytology and/or biopsy to verify PET findings.
For PET imaging, dogs were sedated and then anesthetized with propofol induction 
followed by isoflurane maintenance. A blood glucose measurement was made 
immediately before ^^FDG injection. Dogs were positioned in ventral recumbency in 
the PET scanner gantry so that the majority o f the body was within the FOV. For 
very large dogs, two bed positions were acquired to include area o f known tumour 
and associated regional lymph nodes and major visceral organs. The dogs were 
injected intravenously with a mean dose o f 117.7 MBq (3.18 mCi) o f human-grade 
^^FDG (range 75.1-153.2 MBq or 2.01-4.14 mCi). Whole body images acquired 1 
hour after injection were reviewed in coronal, sagittal, and transverse planes, and 
areas o f  increased ^^FDG uptake were noted. Images acquired with all modalities 
were compiled and reviewed by a single radiologist (G.B.D) and potential artefacts 
and areas o f physiologic radiopharmaceutical uptake taken into consideration. Any 
focus o f  visually elevated ^^FDG uptake relative to the background, not located in 
areas o f physiologically increased uptake or where the clinical data did not suggest 
the presence o f a non-malignant hypermetabolic lesion, was regarded as positive for 
malignant disease (MCT or LSA). In organs with physiologic ^^FDG uptake (e.g. 
spleen and liver), focal or heterogeneous uptake patterns are considered to be 
indicative o f malignant infiltration [112].
9.2.2 Results
Three dogs with previously untreated multicentric LSA were clinically staged and 
enrolled in this study. Dog 1 (Figure 9.3) had stage 5a high-grade T-cell lymphoma, 
with cytological confirmation o f peripheral blood, liver and spleen involvement. 
There was inhomogeneous increased ^^FDG uptake within the spleen, consistent with
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Figure 9.3. Whole-body ^^FDG PET scan o f a dog with stage 5a high-grade T-cell 
lymphoma. The top images are pretreatment images and the bottom images are o f 
the same image planes after clinical remission. The images from left to right are 
coronal, transverse, and sagittal images, acquired 1 h after injection o f ^^FDG. Note 
the foeal areas o f uptake within the spleen (top middle image) and the inereased 
uptake by the superficial cervical and axillary lymph nodes (top left image). These 
abnormal areas o f ^^FDG uptake are not seen in following treatment.
nodular parenchymal changes noted with ultrasonography. Several intra-abdominal 
lymph nodes also had intense ^^FDG uptake. A follow-up PET scan performed after 
8 weeks o f chemotherapy confirmed the clinical findings o f complete remission.
Dog 2 (Figure 9.4) had Stage 5a low-grade T-cell lymphoma, with palpable 
enlargement o f cervieal lymph nodes. Spleen, liver, and bone marrow cytology was 
normal but there was a homogenous intermediate-size lymphoeytosis (7700 
cells/mL). The ^^FDG PET scan confirmed increased radiopharmaceutical uptake in 
the cervical lymph nodes, but also identified inereased uptake in the axillary lymph 
nodes, which were not palpable, possibly due to body condition.
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Figure 9.4. Whole-body ^^FDG PET scan o f a dog with stage 5a low-grade T-cell 
lymphoma. The top images are pretreatment images and the bottom images are the 
same image planes after clinical remission. The images from left to right are 
coronal, transverse, and sagittal planes, acquired 1 h after injection o f ^^FDG. Note 
the focal areas o f uptake in the left and right superficial cervical and axillary lymph 
nodes (top left and middle images). The focal high intensity region o f the right distal 
antebraehium (top left image) is the radiopharmaceutical injection site. These 
abnormal areas o f ^^FDG uptake are not seen following treatment.
The patient was treated with chemotherapy and in a repeat PET scan performed 4 
months later there was resolution o f ^^FDG uptake in the mandibular and prescapular 
lymph nodes, but persistent uptake in the axillary lymph nodes. Physical 
examination confirmed normalisation o f the mandibular and prescapular lymph 
nodes. Cytology o f the axillary lymph nodes was not performed.
Dog 3 (Figure 9.5) had Stage 4a high-grade B cell lymphoma, with generalized 
peripheral lymphadenopathy. Spleen and liver were radiographically and 
ultrasonographically normal, yet cytology from these organs was consistent with 
lymphoma. Intra-abdominal lymphadenopathy was seen radiographically and 
sonographically. These lymph nodes were characterized by '^FDG uptake. Liver 
and spleen appeared normal in PET images. Marked myocardial uptake was noted 
although the patient was fasted overnight before the scan to limit 
radiopharmaceutical uptake in the heart.
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Figure 9.5. Whole-body ^^FDG PET scan o f a dog with stage 4a high-grade B-cell 
lymphoma. The top images are pretreatment images and the bottom images are the 
same image planes after clinical remission. The images from left to right are 
coronal, transverse, and sagittal planes, acquired 1 h after injection o f ^^FDG. Note 
the focal areas o f uptake within intra-abdominal lymph nodes (top left and middle 
images). These abnormal areas o f ^^FDG uptake are not seen following treatment.
There were no clinical or radiographic signs o f cardiac disease. Intestinal uptake o f  
'^FDG was intense in this patient. After 4 weeks o f chemotherapy there was 
resolution o f the intra-abdominal lymph node and myocardial uptake, consistent with 
the clinical diagnosis o f complete remission [113].
All dogs with MCT had measurable disease at the time o f enrolment. Four dogs 
(Dogs 4, 6, 7, and 9) had a single Grade 2 MCT, one dog (Dog 5) had multiple 
MCTs (Grades 1 and 2), and one dog (Dog 8) had multiple MCTs (Grades 2 and 3). 
Gross primary MCT were easily visible in all dogs with ^^FDG PET, exhibiting 
intense ^^FDG uptake corresponding to the cytological or histological confirmed skin 
lesion(s). No dogs with MCT had spleen or liver metastasis based on radiographs, 
ultrasound, and ultrasound-guided fine needle aspirates o f these organs, but mild 
generalized splenomegaly was noted in Dogs 5 and 6. This could be attributable to 
the effects o f premedicant drugs and general anaesthesia, but large-scale studies on 
the effects o f general anaesthesia on '^FDG PET findings are lacking. In rodents 
there is no effect o f anaesthesia on xenograft tumour '^FDG uptake [102].
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Dogs 4 and 5 had no clinical or PET evidence o f regional lymph node metastasis, but 
both had gross MCT easily visible with PET. Figure 9.6 depicts Dog 4, a small 
breed dog with a large axillary MCT imaged with ^^FDG PET, then treated with 
chemotherapy. Three weeks later the blood glucose was elevated due to diabetic 
ketoacidosis.
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Figure 9.6. Whole-body ^^FDG PET scan o f a dog with Grade 2 mast cell tumour in 
the right axillary region. The top images are pretreatment images and the bottom 
images are the same image planes 3 weeks after chemotherapy. The images from left 
to right are coronal, transverse, and sagittal planes, acquired 1 h after injection o f  
^^FDG. Note the large area o f  radiopharmaceutical uptake within the left axillary 
region. Although the size and uptake o f ^^FDG within the tumour is visibly reduced 
after chemotherapy, the patient’s elevated blood glucose level precludes accurate 
interpretation o f these images as response to therapy.
Although the MCT was measurably reduced in size, the amount o f  ^^FDG uptake is 
not an accurate reflection o f the tumour’s glucose metabolism. Glucose competes 
with ^^FDG for cellular uptake, and elevated serum glucose levels will lower the 
observed ^^FDG uptake in some malignancies [12].
Three dogs (Dogs 6, 8, 9) had clinical evidence o f regional lymph node metastasis 
based on pre-PET cytology; these findings were confinned with PET as the lymph 
nodes in question had increased FDG uptake consistent with malignant infiltration.
160
An additional dog (Dog 7) (Figure 9.7) with a Grade 2 MCT on the right carpus had 
an enlarged prescapular lymph node with a cytological diagnosis o f lymphoid 
hyperplasia. This lymph node and the ipsilateral axillary lymph node that was not 
deemed abnormal during physical examination had increased ^^FDG uptake on PET. 
These lymph nodes were subsequently removed as a part o f a forequarter amputation 
and found to contain metastatic MCT.
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Figure 9.7. Whole-body ^^FDG PET scan o f a dog with Grade 2 mast cell tumour o f  
the right carpus. The images from left to right are coronal, transverse, and sagittal 
planes, acquired 1 h after injection o f ^^FDG. The bottom images show coronal 
planes. Note the large areas o f uptake associated with the right carpus. There is also 
abnormal uptake by the right superficial cervical lymph node. The axillary lymph 
node is seen on the coronal plane images below.
Dog 6 (Figure 9.8) had a Grade 2 MCT o f the left lower lip and palpably enlarged 
bilateral mandibular and left prescapular lymph nodes. Cytology o f these lymph 
nodes was consistent with metastatic MCT, which was confirmed with PET
demonstrating increased ^^FDG uptake in these areas.
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Figure 9.8. Whole-body ^^FDG PET scan o f a dog with Grade 2 mast cell tumour in 
the left lower lip region. The images from left to right are coronal, transverse, and 
sagittal planes, acquired 1 h after injection o f ^^FDG. Note the large areas o f uptake 
within the left caudal mandibular region. There is also abnormal uptake by the left 
superficial cervical lymph node. The focal high intensity region on the right 
antebraehium (left image) is the radiopharmaceutical injection site
Dog 8 (Figure 9.9) had a history o f multifocal Grade 2 and 3 MCT o f the head and 
neck, and had gross MCT on the ventral neck and metastasis to a superficial cervical 
lymph node. ^^FDG PET revealed a large, symmetrical sub-muscular mass in the 
dorsal aspect o f the cervical region that was not noted during physical examination. 
Biopsy and computed tomography o f this mass confirmed a diagnosis o f an 
additional Grade 2 MCT.
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Figure 9.9. Whole-body ^^FDG PET scan o f a dog with Grade 2 and Grade 3 mast 
cell tumour o f the head and neck. The images at the top from left to right are 
coronal, transverse, and sagittal planes, acquired 1 h after injection o f ^^FDG. The 
images at the bottom are 8 mm thick transverse CT images aequired after intravenous 
contrast administration. Note the large areas o f ^^FDG uptake in the dorsal cervical 
region. There were also focal areas o f increased ^^FDG uptake in the ventral cervical 
region and head but are outside these image planes. This large area o f ^^FDG uptake 
in the dorsal cervical region corresponds to the hi lobed contrast enhancing mass 
seen dorsal to the cervical spine on the CT images. A tissue biopsy confirmed this as 
Grade 2 MCT.
Dog 9 (Figure 9.10) had two focal areas o f increased '^FDG uptake that were not 
noted during physical examination in the interseapular area, in addition to uptake 
associated with a Grade 2 MCT on the antebraehium and ipsilateral prescapular 
lymph node. During surgery to remove the MCT and prescapular lymph node, which 
cytologically demonstrated MCT metastasis, these nodules were removed. 
Histopathologically, these interseapular nodules were injection site granulomas.
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Figure 9.10. Whole-body ^^FDG PET scan o f a dog with Grade 2 mast cell tumour 
in the left antebrachial region. The images from left to right are coronal, transverse, 
and sagittal planes, acquired 1 h after injection o f ^^FDG. Note the focal superficial 
area o f uptake within the left antebrachial region near the elbow, which is the site o f  
known Grade 2 MCT. There are also two abnormal areas o f uptake (middle and 
right images) in the dorsal cervical region, which were diagnosed via tissue biopsy as 
injection site granulomas.
9.2.3 Discussion and Conclusions
The ^^FDG PET scans in three dogs with multicentric lymphoma demonstrated its 
utility for pre-treatment staging o f untreated lymphoma and for evaluation o f  
treatment response. ^^FDG PET was able to identify lymph nodes and organs known 
to be affected with ESA and show resolution o f these lesions after chemotherapy. In 
Dog 2, additional involvement o f the axillary lymph nodes was suggested by PET 
but was not confirmed with cytology or biopsy. Based on increased ^^FDG uptake 
by inflammatory cells in hyperplastic or reactive lymph nodes [114], it is difficult to 
confirm infiltration o f these lymph nodes with malignancy. It is interesting that these 
lymph nodes had persistent uptake o f ^^FDG; if  these lymph nodes did contain 
lymphoid malignancy, the persistent radiopharmaceutical uptake would indicate 
residual disease after other sites o f disease had responded favourably to treatment. In 
human studies o f Hodgkin’s disease (HD) and NHL, this is a poor prognostic 
indicator for survival [115, 116]. However, due to the low-grade histology in this 
dog, the persistent uptake o f ^^FDG in these lymph nodes may simply reflect the 
relatively slow response to chemotherapy often observed with indolent ESA in dogs.
In Dog 1, '^FDG PET identified increased ’^FDG uptake and thus presumed 
malignant infiltration within liver and spleen, which was confirmed with cytologic 
evidence o f ESA within these organs.
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Dog 2 did not have increased hepatic or splenic uptake o f ^^FDG, which matched the 
cytologic findings. However, Dog 3 did have cytological evidence o f both hepatic 
and splenic lymphoma but did not have increased uptake o f ^^FDG in these organs. 
In this dog, neither routine radiography nor ultrasonography was suggestive o f  
malignant infiltration. The sensitivity o f ^^FDG PET for detection o f diffuse 
infiltrative disease is unknown in the dog and it is possible that a certain threshold o f  
disease infiltration is needed for detection o f  disease in these organs. If PET/CT 
were performed, we may have detected subtle changes within the architecture o f  the 
spleen and liver to suggest malignant infiltration.
Dog 3 also had intense ^^FDG uptake in the myocardium at the pre-treatment PET 
scan, which was not present when this patient was re-scanned after 4 weeks o f  
chemotherapy. In the previous study o f  normal dogs, uptake o f ^^FDG within the 
myocardium was minimal, consistent with the fasted state in which cardiac muscle 
switches from glycolysis to fatty acid metabolism to satisfy energy requirements. 
Myocardial ^^FDG uptake may be absent in humans following a fast o f  18-24 hours 
due to this shift in metabolism, but in practice a wide range o f uptake is seen [12, 
89]. Increased *^FDG uptake in Dog 3 may be a normal variant or represent 
infiltration o f the myocardium with lymphoma, which has been reported rarely [117, 
118].
This study also demonstrates that both canine ESA and cutaneous MCT can be 
imaged successfully with ^^FDG PET and that PET is a useful tool for detection o f  
lymph node involvement in both diseases. ^^FDG PET scans in Dogs 8 and 9 with 
MCT allowed detection o f additional sites o f  disease, which were not detected during 
physical examination and led to alteration in treatment. The PET scan from Dog 9 
also demonstrates a shortcoming o f ^^FDG PET, in which benign inflammatory 
disease can exhibit intense ^^FDG uptake and must be differentiated from true 
malignancy with a tissue biopsy and/or cytological examination. In Dog 7, the PET 
scan identified an additional site o f regional lymph node metastasis, which was not 
detected during physical examination. In all three dogs (Dogs 6, 8, 9) with positive 
lymph node cytology for MCT metastasis before PET, the PET scan confirmed these
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findings. Additional studies in these and other common malignancies are needed to 
more fully evaluate the potential role PET has in the future o f  veterinary oncology.
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Chapter 10.
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10 CONCLUSIONS AND FUTURE PROSPECTS
This thesis has assessed a variety o f  recent advances in the field o f  PET. Basic 
physics investigations have been combined with clinical assessments o f state-of-the- 
art PET methodologies.
The thesis started out with an introduction into the basic principles o f PET (Chapters 
1 and 2), followed by a historical review o f advances in the field until recent 
developments (Chapter 3), which were the main driver for this work. The PET 
scanners that have been investigated in light o f the advances were introduced in 
Chapter 4. The systems were based on three multi-ring configurations and one 
rotating panel configuration.
The main investigational part o f the research began with Chapter 5, which described 
the techniques and phantom experiments that were carried out to assess the physical 
performance o f the scanners. Spatial resolution, sensitivity, scatter fraction and 
count rate results were examined. For the multi-ring scanners, the physical 
improvements o f  the 3-Ring to the 4-Ring scanner were quantified, as well as the 
improvements for an increased acceptance angle (4-Ring+). A  comparison o f the 
system sensitivity with theoretical expectations for an additional ring o f  block 
detectors and an extended axial acceptance angle confirmed the experimentally 
obtained findings within reasonable tolerances. To further extend this part o f  the 
work, the performance results could be utilized to validate currently existing Monte 
Carlo based simulation codes, such as GATE [119] or PeneloPET [120], which is 
based on PENELOPE [121, 122]. Furthermore, the performance o f  multi-ring 
scaimers with additional rings could be explored through simulations. For instance, 
the effect o f  changing the scanner geometry or materials as well as basic parameters, 
such as the coincidence time and energy windows, on the system performance could 
be studied.
The performance o f the prototype panel detector scanner (P5-Head) was also 
evaluated. While the results indicated drawbacks for high injected doses (> 1.5
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GBq), the P5-Head might be limited to specific clinical applications where low doses 
are preferably administered, such as for infants, small children or animals. The 
successful application o f  this scanner has been demonstrated as part o f  this work in 
veterinary medicine for quantitative as well as for diagnostic tasks in dogs (Chapter 
9). The large axial coverage allowed studying the biokinetics o f  multiple organs 
simultaneously. In a few cases, malignancy was diagnosed with the P5-Head 
scaimer where it had not been observed with conventional procedures and imaging 
techniques. The employment o f  511 keV transmission sources for attenuation 
correction with the P5-Head instead o f using a CT may be a non state-of-the-art 
procedure. While it may add extra time to the PET examination and produce noisy 
and therefore potentially inaccurate results, in comparison to a CT scan the total 
radiation exposure might be decreased. Also, no additional transformation (and loss 
o f information) o f  the acquired attenuation map to 511 keV is necessary. The latter 
might be a useful application in material science where the attenuation o f  different 
materials can be investigated prior to employment in PET. With the recent 
development o f MR/PET scanners, for example, such 511 keV transmission scans 
could be utilized as a tool to acquire attenuation maps for hardware and appliances 
that are to be used during MR/PET examinations.
The clinical impact o f the experimentally obtained performance improvements o f the 
multi-ring scanners was investigated in Chapter 6. In particular, the improvement in 
system sensitivity with corresponding signal-to-noise increase from the 3-Ring to the 
4-Ring scanner was explored further. Patient noise equivalent count-rates, which 
essentially correspond to a measure o f signal-to-noise, were computed and results 
indicated better performance o f the 4-Ring scanner for both a 90 % maximum signal- 
to-noise ratio and a standard injected dose o f 370 MBq with a 90 minute uptake 
period. However, the results also showed a decrease in performance with increasing 
weight. While part o f  this investigation was limited to comparing the same patients 
that were scanned on the 3-Ring and 4-Ring scanners up to 22 months apart, a future 
analysis could include patient data sets that have been acquired within a few days on 
both scanners. In another investigation, this work could be applied on the 4-Ring+ 
scanner. The results could be utilized to guide physicians and researchers in
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optimizing injected patient dose and uptake periods. The behaviour o f different 
isotopes could also be investigated clinically.
The effect o f employing point spread function modelling in image reconstruction on 
PET image quality was exploited in Chapter 7. Prior to this investigation, figures o f  
merit were defined to analyze PET image quality and used to optimise the PSF OP- 
0SEM 3D algorithm for small (< 2 cm) lesion signal-to-noise. Based on those 
optimised parameters, the enhanced image contrast recovery o f the 4-Ring with the 
additional benefit provided by the PSF 0P-0SE M 3D  reconstruction has been 
demonstrated and compared to a standard AW -0SEM 2D algorithm. A future 
extension o f this work may include investigating spatial resolution uniformity 
towards the periphery o f the PET FOV. Basic point source measurements and more 
complex phantom experiments could be carried out for this purpose.
The topic o f TOF was substantially investigated in Chapter 8. Prior to investigating 
the impact o f incorporating TOF into image reconstruction, it has been demonstrated 
that the time, energy and spatial resolution parameters o f  the 4-Ring scanner do not 
indicate significant variations under changing count rate conditions. An 
improvement in image SNR o f the PSF 0P-0SEM 3D  algorithm has been quantified 
when TOF information is incorporated. Both experimental and clinical results 
demonstrated that TOF reduces noise and thereby enhances image SNR while 
maintaining contrast. However, the clinical assessment has shown that the gain in 
image SNR with TOF is larger for lesions in denser or larger body regions, such as 
the abdomen. An experimental setup confirmed this finding and demonstrated also 
that the largest performance gain with TOF can be observed for smaller structures. 
These observations agreed well with Budinger’s suggestion [48], which implies a 
proportional relationship between the gain in image SNR with TOF and the diameter 
o f  the object. In a final TOF investigation, it has been demonstrated that the 
incorporation o f TOF into image reconstruction can be employed to either reduce 
scan time or injected patient dose without compromising image SNR. This latter 
finding, the reduction o f injected dose, will be particularly valuable where radiation 
dose is limited, such as for infants and small children. The reduction in scan time
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may be utilized for patients who are, for example, claustrophobic and cannot be 
inside the scanner for a long period o f  time.
In general, it must be pointed out that these new methodologies have been developed 
in a very short period o f  time. The clinical impact o f  these recent advances has to be 
further explored and investigated, in combination but also on a single basis. While 
these new methodologies mature in clinical practice over the next few years, patient 
management is going to change. Appropriate and on-going training o f physicians 
and researchers in the field is required in order to understand and employ these new  
techniques in a way that w ill improve and benefit patient care.
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